KOL | Erika RM von MutiusComprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, ... |
Kol CV for Erika RM von Mutius
| Year | |
|---|---|
| 2022 | Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, Munich, Germany; Institute of Asthma and Allergy Prevention (IAP), Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH). Institute for Asthma and Allergy Prevention, Helmholtz Centre Munich, 85764 Neuherberg, Germany |
| 2021 | Dr von Hauner Children's Hospital, Ludwig Maximilian University, Munich, Germany |
| 2020 | German Center for Lung Research, CPC-M From the Institute of Asthma and Allergy Prevention, Helmholtz Centre Munich, Munich, and the Asthma and Airway Disease Research Center, University of Arizona, Tucson. |
| 2019 | Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany. Institute for Asthma and Allergy Prevention, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany Dr von Hauner Children's Hospital, Ludwig Maximilian University German Center for Lung Research (DZL) |
| 2018 | Member of the German Centre for Lung Research, Munich, Germany Direktorin, Institut für Asthma und Allergieprävention Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Ingolstädter Landstraße 1, 85764 Neuherberg |
| 2017 | Children Hospital and Children Polyclinic in the Dr. von Haunersches Children Hospital, Ludwig-Maximilians-University, Lindwurmstr. 4, 80337 Munich, Germany Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL) |
Erika RM von Mutius: Påvirke statistikk
Kjør rapport
| Concept | World rank |
|---|---|
| specific exposures cows | #1 |
| allergies existing cohort | #1 |
| protective 6 years | #1 |
| wheeze environmental determinants | #1 |
| advanced surveys | #1 |
| early development wheeze | #1 |
| helminth parasites exposure | #1 |
| tregs maternal atopy | #1 |
| children road traffic | #1 |
| evidence allergy prevention | #1 |
| unprocessed farm milk | #1 |
| role th2 immunity | #1 |
| transcription factors hlx1 | #1 |
| rhinitis predictor | #1 |
| kitchen visible mold | #1 |
| tenascin neuropeptide receptor | #1 |
| asthma rora | #1 |
| logistic models npsr1 | #1 |
| atopic dermatitis farm | #1 |
| gsdma expression | #1 |
| mite exposure risk | #1 |
| asthmatic farm children | #1 |
| netcomi functionality | #1 |
| lca male phenotype | #1 |
| asthma consumption | #1 |
| covariates potential confounding | #1 |
| positive sensitization | #1 |
| questionnaires childhood | #1 |
| farm specific exposures | #1 |
| epidemiological evidence consumption | #1 |
| bronchial hyperreactivity age | #1 |
| increased diversity food | #1 |
| farm exposure asthmatics | #1 |
| menarche allergic rhinitis | #1 |
| interaction npsr1 protein | #1 |
| lpa ppg stimulation | #1 |
| interaction rora | #1 |
| peak airborne moulds | #1 |
| estonia environmental differences | #1 |
| offspring atopic mothers | #1 |
| males pierced ears | #1 |
| auc spt | #1 |
| children farmers | #1 |
| pasture cohort | #1 |
| pasture cohort lca | #1 |
| lps recognition development | #1 |
| tubes rnastabilizing solution | #1 |
| year environmental exposures | #1 |
| predominant obstruction | #1 |
| children severe atopy | #1 |
| protection asthma | #1 |
| protective factors strategies | #1 |
| 95 nonatopic asthma | #1 |
| fever atopic sensitization | #1 |
| infant adolescent aging | #1 |
| excessive sige production | #1 |
| 115 iu | #1 |
| asthmatics asthma phenotypes | #1 |
| 12 months crowding | #1 |
| benzene current wheeze | #1 |
| association farm contact | #1 |
| nct02496468 | #1 |
| ddhay fever children | #1 |
| igg4 ige expression | #1 |
| solids development | #1 |
| introduction yogurt | #1 |
| wheeze sensitisation | #1 |
| dermatitis depending | #1 |
| wheeze farm living | #1 |
| interquartile range asthma | #1 |
| bacterial signals atopy | #1 |
| 95 asthma | #1 |
| airborne moulds actinomycetes | #1 |
| managing wheezing | #1 |
| association incident rhinoconjunctivitis | #1 |
| neonatal mice ahr | #1 |
| atopic sensitization early | #1 |
| allergies cohort | #1 |
| ilcs neonatal mice | #1 |
| aa ifih1 expression | #1 |
| 26 farms bavaria | #1 |
| menarche hormonal contraceptives | #1 |
| factors th1 | #1 |
| allergies viral infections | #1 |
| maschildren | #1 |
| prediction farm children | #1 |
| spts specific ige | #1 |
| npsr1 messenger receptors | #1 |
| association haplotype studies | #1 |
| aa nonallergic asthma | #1 |
| alpine farms | #1 |
| farm studies | #1 |
| edta tubes countries | #1 |
| immunity innate infant | #1 |
| ilcs inception | #1 |
| tregs asthmatics | #1 |
| farms wheeze | #1 |
| contact farm | #1 |
| ormdl3 gasdermin | #1 |
| groups rural areas | #1 |
| mice atopic sensitization | #1 |
| harmful workplace exposure | #1 |
| wheezing children wheezing | #1 |
| analyses isaac phase | #1 |
| genetic interaction npsr1 | #1 |
| asthma arabinogalactan | #1 |
| maternal farming | #1 |
| antipyretics increased risk | #1 |
| higher specificity asthma | #1 |
| bmi allergic dermatitis | #1 |
| exposure gstm1 deficiency | #1 |
| asthma tregs | #1 |
| regression approach order | #1 |
| allergic diseases hrqol | #1 |
| association spink5 420lys | #1 |
| barns samples | #1 |
| infant design | #1 |
| sige spt | #1 |
| rs11071559 | #1 |
| infancy jia | #1 |
| usage preventive measures | #1 |
| neonatal immune mechanisms | #1 |
| breastfeeding length | #1 |
| network construction comparison | #1 |
| hlx1 polymorphisms | #1 |
| puberty infant | #1 |
| acrossolar study | #1 |
| hrqol protective | #1 |
| asthma turkish children | #1 |
| farm cowsheds | #1 |
| followup solar | #1 |
| asthma west germany | #1 |
| tempo method | #1 |
| atopy farm | #1 |
| cord blood offspring | #1 |
| farm living | #1 |
| marked differences prevalence | #1 |
| latent classes populations | #1 |
| initial cohort pattern | #1 |
| cla allergoprotective capacity | #1 |
| physiciandiagnosed asthma groups | #1 |
| amish hutterite | #1 |
| solids relation | #1 |
| atopic sensitization birth | #1 |
| farming protective farm | #1 |
| farm rural children | #1 |
| personal cleanliness risk | #1 |
| recurrence atopic dermatitis | #1 |
| living farm | #1 |
| countries isaac phase | #1 |
| asthma concomitant asthma | #1 |
| farmrelated exposures | #1 |
| immune activation populations | #1 |
| 30 amish | #1 |
| cowshed dust cde | #1 |
| preschool children predictor | #1 |
| leipzig munich | #1 |
| asthma richness | #1 |
| homes farm dwellings | #1 |
| coding region il4ra | #1 |
| followup work discontent | #1 |
| failure☆ | #1 |
| food diversity year | #1 |
| tnc asthma | #1 |
| asthma rhinoconjunctivitis eczema | #1 |
| visible mold homes | #1 |
| environments asthma | #1 |
| gene expression ilt4 | #1 |
| pasture study spt | #1 |
| endotoxin exposure association | #1 |
| pets associations | #1 |
| prenatal animal | #1 |
| allergies year | #1 |
| perinatal influences | #1 |
| infant genetic polymorphism | #1 |
| egg aor | #1 |
| pasture lukas2 | #1 |
| germany dresden | #1 |
| immune responses birth | #1 |
| current asthma age | #1 |
| animal contact infancy | #1 |
| ige seasonal allergens | #1 |
| lpastimulation | #1 |
| spt atopic dermatitis | #1 |
| followup solar cohort | #1 |
| immune receptors birth | #1 |
| life fungi humans | #1 |
| feeding overweight | #1 |
| asthma risk pasture | #1 |
| farming environments | #1 |
| mattress dust association | #1 |
| samples farm dwellings | #1 |
| lumbricoides farmers children | #1 |
| cough soot | #1 |
| no2 traffic counts | #1 |
| farmers children | #1 |
| npsr1 rora | #1 |
| infants karelia | #1 |
| prevent allergic diseases | #1 |
| annual concentrations benzene | #1 |
| amish hutterite children | #1 |
| wheeze classes | #1 |
| age increased diversity | #1 |
| 1120 children | #1 |
| domestic asthma child | #1 |
| cutoff 3 mm | #1 |
| mrna expression year | #1 |
| munich leipzig | #1 |
| farm environments asthma | #1 |
| maternal farm | #1 |
| infant contact animals | #1 |
| atopic dermatitis increase | #1 |
| class pasture | #1 |
| egg positive sensitization | #1 |
| carriers hlx1 | #1 |
| boys fever | #1 |
| anti‐asthmatic drugs | #1 |
| fpr2 clec4e | #1 |
| association farm | #1 |
| ppg lpa ppg | #1 |
| epigenetic regulation mechanism | #1 |
| male poland quality | #1 |
| influential factors health | #1 |
| immune stimulation life | #1 |
| messenger surveys | #1 |
| asthma atopic disease | #1 |
| solar 2nd followup | #1 |
| hrqol farm children | #1 |
| children preschool conjunctivitis | #1 |
| bacterial groups prevalence | #1 |
| sige sensitizations symptoms | #1 |
| actinomycetes cowsheds | #1 |
| ige levels exposure | #1 |
| asthma questionnaire responses | #1 |
| h4 acetylation offspring | #1 |
| personal cleanliness | #1 |
| igg nglycosylation populations | #1 |
| association occupational disinfectants | #1 |
| normal censored | #1 |
| th2related genes | #1 |
| single microbial markers | #1 |
| epidemiologic phenotypes | #1 |
| agreement association | #1 |
| associations airwayrelated symptoms | #1 |
| study questionnaire responses | #1 |
| swinesheds | #1 |
| spts agreement | #1 |
| skin tests spt | #1 |
| farm milk | #1 |
| allergy‐protective effects | #1 |
| phenotype health variables | #1 |
| late introduction solids | #1 |
| parsifal‐study | #1 |
| wheeze bronchial | #1 |
| non‐farm children | #1 |
| psychosocial characteristics children | #1 |
| 95 agmr | #1 |
| cde source | #1 |
| jobs potential confounders | #1 |
| farm nonfarm children | #1 |
| south bavarian population | #1 |
| asthmatics hc | #1 |
| animal sheds barns | #1 |
| work ilc2s | #1 |
| 20 fall volume | #1 |
| worldwide asthma epidemic | #1 |
| topic puberty rhinitis | #1 |
| respiratory sounds immunity | #1 |
| farmers nonfarmers children | #1 |
| influential factors phenotype | #1 |
| allergic allergic dermatitis | #1 |
| 3 mm spt | #1 |
| allergies cohort studies | #1 |
| eczema regions | #1 |
| sum indicators | #1 |
| life inversely | #1 |
| stable dust extract | #1 |
| recurrent unremitting wheeze | #1 |
| farming allergies | #1 |
| positive sensitization egg | #1 |
| protective mechanisms asthma | #1 |
| ahr acinetobacter lwoffii | #1 |
| atopic dermatitis adolescence | #1 |
| rora neuropeptide receptor | #1 |
| protective farm environment | #1 |
| farm homes homes | #1 |
| increased atp2a3 fpr2 | #1 |
| consumption farm milk | #1 |
| adolescent agriculture | #1 |
| predominant hyperreactivity subsample | #1 |
| 105 years richness | #1 |
| risk hutterite children | #1 |
| cd4cd25hi isolated cells | #1 |
| associations maternal sensitization | #1 |
| hygiene hypothesis endotoxin | #1 |
| supplementation milk cla | #1 |
| maternal farm exposure | #1 |
| 17q21 polymorphisms | #1 |
| 95 hormonal contraceptives | #1 |
| 5–13‐year school children | #1 |
| computing microbial associations | #1 |
| west germany overweight | #1 |
| acrossolar | #1 |
| newborn interleukin17 leukocytes | #1 |
| igg1 galactosylation levels | #1 |
| asthma asthma bacteria | #1 |
| bifidobacterium breastfed infants | #1 |
| protective asthma | #1 |
| menarche hormonal | #1 |
| traditional farms | #1 |
| str bhr | #1 |
| moisture damage kitchen | #1 |
| crobiome data | #1 |
| endotoxin level production | #1 |
| childhood gondii seropositivity | #1 |
| farm dairy products | #1 |
| asthma genetic effects | #1 |
| farms farm homes | #1 |
| east germany allergic | #1 |
| environmental differences finland | #1 |
| late onset menarche | #1 |
| indicators total quantity | #1 |
| allergoprotective | #1 |
| farming children | #1 |
| 624 children | #1 |
| clec4e aa | #1 |
| gel variations gels | #1 |
| chapter 16 epidemiology | #1 |
| newborn leukocytes surveys | #1 |
| 18 months protective | #1 |
| stepwise procedure gene | #1 |
| analyses provocation time | #1 |
| allergic rhinitis puberty | #1 |
| solar study | #1 |
| study rural environment | #1 |
| asthma protective | #1 |
| allergy symptoms childhood | #1 |
| dgge asthma | #1 |
| polymorphisms lps recognition | #1 |
| allergy protective | #1 |
| bronchial response wheeze | #1 |
| farm exposure exposure | #1 |
| throat microbiota | #1 |
| unprocessed cows milk | #1 |
| antipyretics reduced risk | #1 |
| multicenter cohort prevalence | #1 |
| protective diversity | #1 |
| 3785 adolescents | #1 |
| cowsheds peak | #1 |
| dermatitis symptoms | #1 |
| isolated cd4cd25hi tregs | #1 |
| occupational disinfectants asthma | #1 |
| jobs asthma risk | #1 |
| protective effects exposure | #1 |
| cleanliness matter | #1 |
| ilt4 cb | #1 |
| city air pollution | #1 |
| allergies early phenotypes | #1 |
| 6 types cheese | #1 |
| allergies addition | #1 |
| complementary food year | #1 |
| vehicle traffic asthma | #1 |
| childhood asthma allergies | #1 |
| asthma allergies | #1 |
| farm exposure igg4 | #1 |
| gabriel advanced study | #1 |
| wheeze farmers children | #1 |
| predictor igg1 galactosylation | #1 |
| farm asthma | #1 |
| regulatory triggering receptor | #1 |
| cumulative incidence finland | #1 |
| cla content plasma | #1 |
| fpr2 aa | #1 |
| anthropometric data overweight | #1 |
| associations hscrp values | #1 |
| wheezing male respiratory | #1 |
| diversity consumed types | #1 |
| secretion life | #1 |
| derp1lpa | #1 |
| rs2738751 | #1 |
| asthma aor | #1 |
| asthma concomitant bhr | #1 |
| development allergic illnesses | #1 |
| atopic sensitization aor | #1 |
| allergies | #1 |
| hc aa | #1 |
| inhaled steroids dresden | #1 |
| school age early | #1 |
| bronchial obstruction hyperreactivity | #1 |
| mrna expression tregs | #1 |
| mite sensitization aor | #1 |
| development allergies | #1 |
| prevalence atopic sensitisation | #1 |
| male parents receptors | #1 |
| sensitised children wheeze | #1 |
| t1432c | #1 |
| atopic sensitization | #1 |
| tnc risk gene | #1 |
| participants solar | #1 |
| single taxa groups | #1 |
| microorganisms animal sheds | #1 |
| 1 ppg stimulation | #1 |
| transient wheezing age | #1 |
| farm living symptoms | #1 |
| nickel allergy asthma | #1 |
| provocation time | #1 |
| children amish children | #1 |
| indoor bacterial microbiota | #1 |
| farm lung function | #1 |
| pierced ears asthma | #1 |
| atopy allergen specificity | #1 |
| regular farm animal | #1 |
| adolescent aging asthma | #1 |
| 95 allergen | #1 |
| rs7164773 | #1 |
| actinomycetes peak | #1 |
| 5 years predictor | #1 |
| paediatric origins | #1 |
| asthma toll | #1 |
| atopic dermatitis jobs | #1 |
| sige cutoff | #1 |
| food items year | #1 |
| domestic child child | #1 |
| age asthma child | #1 |
| pollen dairy farms | #1 |
| kitchen living area | #1 |
| 57 911yearold children | #1 |
| traditional upbringing | #1 |
| symptoms gender ratio | #1 |
| expression 17q21 | #1 |
| farming environment development | #1 |
| children leipzig | #1 |
| persistence bronchial hyperreactivity | #1 |
| dampness childhood | #1 |
| phytohemagglutinin ormdl3 | #1 |
| 911 yrs | #1 |
| grass arabinogalactan mice | #1 |
| muramic acid wheezing | #1 |
| farm children microorganisms | #1 |
| protection hygiene hypothesis | #1 |
| farm milk consumption | #1 |
| association atopic sensitization | #1 |
| living environment children | #1 |
| network differences groups | #1 |
| snps wheeze | #1 |
| fever atopic | #1 |
| barns farm dwellings | #1 |
| asthma symptoms adolescence | #1 |
| dairying environment pollen | #1 |
| school children germany | #1 |
| spink5 kazal type | #1 |
| atopic disease bias | #1 |
| obstruktive atemwegserkrankungen | #1 |
| environments pasture | #1 |
| muramic acid concentration | #1 |
| associations dna fingerprinting | #1 |
| yogurt cows milk | #1 |
| prehireonset | #1 |
| crp early age | #1 |
| netcomi network construction | #1 |
| tnc npsr1 | #1 |
| allergic rhinitis childhood | #1 |
| asthma german | #1 |
| birth tbx21 | #1 |
| heattreated milk samples | #1 |
| farm indoor | #1 |
| environmental exposures protection | #1 |
| insight environmental factors | #1 |
| risk gene asthma | #1 |
| microbial exposure asthma | #1 |
| atopic eczema 95 | #1 |
| diversity protective effects | #1 |
| current contact asthma | #1 |
| newonset allergic rhinitis | #1 |
| kitchen moisture damage | #1 |
| amish environment | #1 |
| consumption asthma | #1 |
| 95 grass pollen | #1 |
| foxp3 cd4cd25hi | #1 |
| psychosocial characteristics asthma | #1 |
| accuracy regression approach | #1 |
| allergic illnesses | #1 |
| farm animals childhood | #1 |
| school university life | #1 |
| damage systemic inflammation | #1 |
| life antibiotic exposure | #1 |
| phase stratified sample | #1 |
| pets farm animals | #1 |
| development childhood asthma | #1 |
| methods solar cohort | #1 |
| asthma bacterial diversity | #1 |
| phenotypes atopic | #1 |
| stepwise protocol phase | #1 |
| associations indoor mould | #1 |
| exposure mattress dust | #1 |
| 035 iu sige | #1 |
| rnastabilizing solution | #1 |
| review hygiene hypothesis | #1 |
| treg marker genes | #1 |
| maternal atopy tregs | #1 |
| ddhay fever | #1 |
| farming exposure childhood | #1 |
| milkassociated cla | #1 |
| treatment childhood asthma | #1 |
| persistence allergic rhinitis | #1 |
| increased expression ormdl3 | #1 |
| asthma turkish | #1 |
| microbial exposure endotoxin | #1 |
| childhood bronchial hyperreactivity | #1 |
| transient wheeze age | #1 |
| analysis step package | #1 |
| occurrence allergy | #1 |
| animal sheds 28 | #1 |
| cbmcs ormdl3 | #1 |
| associations pet contact | #1 |
| allergies respiratory infections | #1 |
| aa immunity receptors | #1 |
| farmingrelated exposures | #1 |
| new microscope | #1 |
| netcomi network | #1 |
| children rural allergy | #1 |
| il13cd4 cells ilcs | #1 |
| functionality network differences | #1 |
| development preschool wheezing | #1 |
| 17q21 locus method | #1 |
| antibiotics allergies | #1 |
| 2nd followup challenges | #1 |
| 420lys | #1 |
| aa increased atp2a3 | #1 |
| health influential factors | #1 |
| doctor allergic rhinitis | #1 |
| lukas2 birth cohorts | #1 |
| dzl | #1 |
| overweight dresden | #1 |
| ml1 cohort studies | #1 |
| asthma indoor exposure | #1 |
| sige association | #1 |
| 812 children | #1 |
| repeated episodes fever | #1 |
| food allergy yogurt | #1 |
| allergies topic surveys | #1 |
| atopic dermatitis onset | #1 |
| incidence indoor allergens | #1 |
| strongest predictor atopy | #1 |
| risk tcell phenotypes | #1 |
| microorganisms farms | #1 |
| rural allergy endotoxin | #1 |
| stepwise protocol bhr | #1 |
| children diabimmune study | #1 |
| wheezing fever | #1 |
| abundances 6 otus | #1 |
| asthma microbiome analysis | #1 |
| environmental exposure age | #1 |
| sod3 sod3 snps | #1 |
| transient wheeze asthma | #1 |
| tobit regression ranks | #1 |
| interaction npsr1 polymorphisms | #1 |
| allergic rhinitis jia | #1 |
| 9 10yold children | #1 |
| lpastimulation cord blood | #1 |
| early age risk | #1 |
| pcr sscp method | #1 |
| agreement spts | #1 |
| transmaternal asthma protection | #1 |
| phase international | #1 |
| preventive measures counselling | #1 |
| fever farm | #1 |
| girls mechanism | #1 |
| otitis fever | #1 |
| studies microbial exposures | #1 |
| external microbial | #1 |
| work overload followup | #1 |
| rhinoconjunctivitis sex | #1 |
| gabriel advanced surveys | #1 |
| aa clec4e | #1 |
| soot benzene | #1 |
| preschool dermatitis questionnaires | #1 |
| health urbanrural differences | #1 |
| common infections infants | #1 |
| npsr1 interaction | #1 |
| environmental exposures asthma | #1 |
| asthma puberty | #1 |
| work overload work | #1 |
| comparison microbiome data | #1 |
| children isaac asthma | #1 |
| order covariates | #1 |
| animal farms substances | #1 |
| 6 years subtypes | #1 |
| microbial exposure sum | #1 |
| allergoprotective capacity | #1 |
| model hyperreactivity | #1 |
| grass pollen 95 | #1 |
| asthma diversity | #1 |
| followup farm living | #1 |
| solar cohort | #1 |
| living area risk | #1 |
| predictor immune activation | #1 |
| gpra gene | #1 |
| farm animals asthma | #1 |
| asthma bacteria | #1 |
| 9 bronchodilators | #1 |
| west germany allergic | #1 |
| wheezing w12 | #1 |
| protective atopic sensitization | #1 |
| prediction quality snps | #1 |
| rs11079788 | #1 |
| countries pasture study | #1 |
| bhr fall | #1 |
| 45yearold children protection | #1 |
| asthmatics innate leukocytes | #1 |
| farm milk asthma | #1 |
| asthmaprotective farm | #1 |
| allergic asthmatics asthmatics | #1 |
| tcells foxp3 | #1 |
| allergy prevention studies | #1 |
| pasture study tubes | #1 |
| 95 atopic sensitization | #1 |
| lower atopic sensitization | #1 |
| farmers anthroposophic families | #1 |
| unbalanced meat consumption | #1 |
| fever blood samples | #1 |
| lukas2 lca | #1 |
| model bronchial hyperreactivity | #1 |
| 17q21 polymorphisms ormdl3 | #1 |
| generations birth cohort | #1 |
| ilt4 cord blood | #1 |
| agriculture asthma | #1 |
| allergy exposures | #1 |
| children unification | #1 |
| farm animal exposure | #1 |
| atopic diseases association | #1 |
| subsample predominant obstruction | #1 |
| otus bacterial diversity | #1 |
| participation rates phase | #1 |
| parasitic infections predictor | #1 |
| 1120 german schoolchildren | #1 |
| richness farming | #1 |
| 95 puberty | #1 |
| asthma german children | #1 |
| score total quantity | #1 |
| children farm children | #1 |
| hlx1 polymorphisms influence | #1 |
| consumption allergic | #1 |
| yogurt diversity | #1 |
| lca feeding patterns | #1 |
| health services exposure | #1 |
| asthma bronchial response | #1 |
| germany breast feeding | #1 |
| relation late introduction | #1 |
| asthma symptoms adulthood | #1 |
| children automobiles child | #1 |
| cohorte pasture | #1 |
| protective farming | #1 |
| early phenotypes age | #1 |
| farm allergic rhinitis | #1 |
| childhood design | #1 |
| protective farm asthma | #1 |
| network construction netcomi | #1 |
| overweight marked differences | #1 |
| gabriel study | #1 |
| age bacterial endotoxin | #1 |
| phenotypes lca | #1 |
| coexpression igg1 | #1 |
| farm animals cats | #1 |
| protective effects diversity | #1 |
| patients neutrophil inflammation | #1 |
| 1314 newborn infants | #1 |
| atopic sensitisation fever | #1 |
| allergies personal cleanliness | #1 |
| coupled receptor polymorphisms | #1 |
| asthma interactions | #1 |
| unremitting wheeze | #1 |
| work overload school | #1 |
| oropharyngeal microbiota children | #1 |
| tregs age | #1 |
| exposure farming environment | #1 |
| atopy rural subjects | #1 |
| hlx1 snps cbmcs | #1 |
| dresden east germany | #1 |
| pets crowding | #1 |
| common inhalants | #1 |
| gene expression ormdl3 | #1 |
| farm dwellings children | #1 |
| allergic rhinitis menarche | #1 |
| lower atopy asthma | #1 |
| gsdma phytohemagglutinin | #1 |
| bacterial exposures associations | #1 |
| farm protects | #1 |
| linens child dust | #1 |
| current asthma soot | #1 |
| protection allergic diseases | #1 |
| diversity microbial exposure | #1 |
| germany prevalence differences | #1 |
| demethylation foxp3 demethylation | #1 |
| sensitisation early | #1 |
| crowding dry cough | #1 |
| 035 iu specificity | #1 |
| bhr str | #1 |
| anthroposophic families validity | #1 |
| child environmental pollutants | #1 |
| cd4cd25hi tcells | #1 |
| humans hypopharynx moraxella | #1 |
| atopic embryonic allergic | #1 |
| aor farm exposures | #1 |
| airborne fungi actinomycetes | #1 |
| juvenile crohn disease | #1 |
| girls allergic rhinitis | #1 |
| pollen concentration feeding | #1 |
| source arabinogalactan | #1 |
| fever milk consumption | #1 |
| unpasteurized cows milk | #1 |
| employment new onset | #1 |
| moisture mold exposure | #1 |
| maternal atopy secretion | #1 |
| incident wheezing asthma | #1 |
| exposure protective | #1 |
| bacterial exposures | #1 |
| infections hygiene hypothesis | #1 |
| persistence earlylife exposures | #1 |
| east germany leipzig | #1 |
| 95 late introduction | #1 |
| ema protective farm | #1 |
| farm fungi humans | #1 |
| histamine challenges age | #1 |
| jia domestic arthritis | #1 |
| antiasthma drugs children | #1 |
| association farm milk | #1 |
| polymorphisms tbx21 | #1 |
| agents reduced risk | #1 |
| unhygienic contact | #1 |
| “hygiene hypothesis | #1 |
| adolescent agriculture dust | #1 |
| farm exposure asthma | #1 |
| immunity newborn mothers | #1 |
| farm environments farms | #1 |
| il4ra association | #1 |
| loft farm milk | #1 |
| wheezing atopic sensitization | #1 |
| shop milk | #1 |
| wheeze asthma questions | #1 |
| dust parameters development | #1 |
| hyperreaktivität | #1 |
| features anthroposophic lifestyle | #1 |
| cowsheds childrens bedrooms | #1 |
| parents allergies | #1 |
| solar iii | #1 |
| children alliance asthma | #1 |
| pattern atopic sensitization | #1 |
| hrqol rural farm | #1 |
| protection yogurt | #1 |
| incident wheezing association | #1 |
| associations transient sensitization | #1 |
| maturation gut microbiome | #1 |
| leur relation | #1 |
| lumbricoides crude measure | #1 |
| yogurt year | #1 |
| bactoscan | #1 |
| atopy interactions | #1 |
| 585883 | #1 |
| gpra polymorphisms asthma | #1 |
| german peers | #1 |
| tolllike receptor farmers | #1 |
| lca clinical phenotypes | #1 |
| farm lifestyles | #1 |
| no2 allergic sensitisation | #1 |
| ddhay fever 95 | #1 |
| provocation time bhr | #1 |
| allergies generations | #1 |
| microbial exposure patterns | #1 |
| farming environments asthma | #1 |
| exposure muramic | #1 |
| incident wheezing | #1 |
| maternal farming activities | #1 |
| farm milk meat | #1 |
| allergic rhinitis type | #1 |
| hypopharynx moraxella | #1 |
| asthma wisc | #1 |
| 95 atopic eczema | #1 |
| cε germline transcript | #1 |
| immune responsiveness life | #1 |
| netcomi | #1 |
| ormdl3 gsdma expression | #1 |
| groups netcomi | #1 |
| microbes epigenetic mechanisms | #1 |
| ranks performance | #1 |
| allergyrisk factors | #1 |
| development asthma | #1 |
| rhinoconjunctivitis participation | #1 |
| actinomycetes alpine farms | #1 |
| tregs cd4cd25hi | #1 |
| rora snps | #1 |
| environmental microbial | #1 |
| wheezerelated latent classes | #1 |
| risk mite sensitization | #1 |
| heating children | #1 |
| incident wheezing women | #1 |
| unprocessed cow | #1 |
| yoghurt asthma risk | #1 |
| munich dresden | #1 |
| farm childhood asthma | #1 |
| moderate‐to‐adequate | #1 |
| cleanliness dust parameters | #1 |
| prehireonset odds ratio | #1 |
| aa hcs | #1 |
| dgge health outcomes | #1 |
| phase isaac programme | #1 |
| bronchial hyperreactivity adolescence | #1 |
| regular farm | #1 |
| overweight munich | #1 |
| occurrence generations | #1 |
| otus farming | #1 |
| 17q21 risk | #1 |
| cattle childrens bedrooms | #1 |
| increased prevalence cough | #1 |
| 048 95 95 | #1 |
| hyperreactive children | #1 |
| stimulation 45yearold children | #1 |
| europe protection | #1 |
| children beta 2agonists | #1 |
| allergies childhood phase | #1 |
| data fetal growth | #1 |
| 18 95 incidence | #1 |
| south bavarian | #1 |
| stepwise procedure risk | #1 |
| turkish children asthma | #1 |
| gpra polymorphisms | #1 |
| asthma food sensitization | #1 |
| parental questionnaires | #1 |
| 13 microbial influences | #1 |
| atopy microbial influences | #1 |
| allergic sensitization latex | #1 |
| 1 year occurrence | #1 |
| 5–13‐year | #1 |
| environmental allergens variety | #1 |
| selfreported nickel allergy | #1 |
| aor interquartile range | #1 |
| lpastimulation carriers | #1 |
| lukas2 umc | #1 |
| copd sod3 | #1 |
| protective cheese consumption | #1 |
| lps foxp3 demethylation | #1 |
| tbx21 hlx1 | #1 |
| polysaccharides cde | #1 |
| selection bias responders | #1 |
| higher hscrp values | #1 |
| 5 years aor | #1 |
| increased risk rhinoconjunctivitis | #1 |
| isaac phase data | #1 |
| hyperreactivity expiratory volume | #1 |
| cowsheds farm animals | #1 |
| cowsheds cattle | #1 |
| children atopic sensitization | #1 |
| protective childhood | #1 |
| allergen exposure age | #1 |
| methods 2nd followup | #1 |
| symptoms school age | #1 |
| asthma risk lca | #1 |
| exposure farm | #1 |
| 95 endotoxin exposure | #1 |
| determinants airway responsiveness | #1 |
| grass arabinogalactan | #1 |
| gasdermin gsdma | #1 |
| foxp3 demethylation tregs | #1 |
| protective effects asthma | #1 |
| expiratory volume lca | #1 |
| innate immunity receptors | #1 |
| increased risks rhinoconjunctivitis | #1 |
| farm children hrqol | #1 |
| clinical examinations challenges | #1 |
| allergies protective pet | #1 |
| feeding cattle cowsheds | #1 |
| package functionality | #1 |
| diseases farm | #1 |
| blood ormdl3 | #1 |
| milk asthma | #1 |
| atopic embryonic | #1 |
| dairy products protective | #1 |
| 7 yrs determinants | #1 |
| wheezing 3rd year | #1 |
| ascaris lumbricoides exposure | #1 |
| persistence adolescence | #1 |
| rora susceptibility gene | #1 |
| farm farm children | #1 |
| 95 asthmatic children | #1 |
| protective allergic diseases | #1 |
| farm fever | #1 |
| identification immune phenotypes | #1 |
| preschool wheezing aor | #1 |
| patients treg cells | #1 |
| development atopic sensitisation | #1 |
| reduced risk allergy | #1 |
| richness asthma | #1 |
| wheezing invertedu shape | #1 |
| asthma farm children | #1 |
| allergyprotective potential | #1 |
| repeated infections life | #1 |
| food sensitization egg | #1 |
| childhood asthma age | #1 |
| allergy cohort methods | #1 |
| infancy case status | #1 |
| followup solar iii | #1 |
| alliance asthma | #1 |
| concomitant bhr 95 | #1 |
| bamse npsr1 | #1 |
| 28 dust samples | #1 |
| tregs foxp3 demethylation | #1 |
| prenatal farm | #1 |
| changing gender ratio | #1 |
| microbiome data package | #1 |
| aetiology early years | #1 |
| potential confounders jobs | #1 |
| igg4 coexpression | #1 |
| mold subclinical inflammation | #1 |
| prognosis early wheeze | #1 |
| igein | #1 |
| insight asthma | #1 |
| serum ige levels | #1 |
| exposures pieces | #1 |
| new onset wheeze | #1 |
| protective exposures | #1 |
| life chronic asthma | #1 |
| children predominant hyperreactivity | #1 |
| allergen exposure life | #1 |
| allergic germany | #1 |
| protection childhood asthma | #1 |
| censored immunological | #1 |
| treatment 9 bronchodilators | #1 |
| children indoor mould | #1 |
| asthma risk class | #1 |
| early life insight | #1 |
| adolescents jobs | #1 |
| indoor microbiota development | #1 |
| children amish farms | #1 |
| 1133 children | #1 |
| w12 ddhay fever | #1 |
| wheeze active smoking | #1 |
| unifying computational tool | #1 |
| spink5 420lys | #1 |
| age dust microbiota | #1 |
| west germany munich | #1 |
| farm milk exposure | #1 |
| authors grass arabinogalactans | #1 |
| bronchial hyperreactivity wheezing | #1 |
| male saline solution | #1 |
| prenatal animal contact | #1 |
| 15ans | #1 |
| allergic diseases questionnaires | #1 |
| pet contact infancy | #1 |
| genetic association tnc | #1 |
| farming nasal samples | #1 |
| children 7 yrs | #1 |
| allergic rhinitis predictor | #1 |
| childhood asthma fever | #1 |
| atopic sensitization development | #1 |
| adolescence bronchial hyperreactivity | #1 |
| subtypes atopic dermatitis | #1 |
| children acrossolar cohort | #1 |
| 168fold | #1 |
| allergies endotoxin | #1 |
| domestic cats child | #1 |
| wholeto | #1 |
| asthma 105 years | #1 |
| mold problems kitchen | #1 |
| gene expression ilt3 | #1 |
| allergies atopic dermatitis | #1 |
| seasonal rural | #1 |
| “atopic march | #1 |
| farm reduced prevalence | #1 |
| farm children bavaria | #1 |
| asthmatic children result | #1 |
| th2related genes cytokines | #1 |
| atopic smokers baseline | #1 |
| tbx21 | #1 |
| observing children | #1 |
| lower prevalence asthma | #1 |
| pierced ears association | #1 |
| asthma austria allergic | #1 |
| rural children w12 | #1 |
| endotoxin allergy | #1 |
| dampness bronchial hyperreactivity | #1 |
| study parsifal | #1 |
| rora asthma susceptibility | #1 |
| bhr asthma child | #1 |
| aetiology atopic disease | #1 |
| helminths protective | #1 |
| childhood protective | #1 |
| allergic diseases protective | #1 |
| mold immune responsiveness | #1 |
| identified polymorphisms asthma | #1 |
| seasonal allergens | #1 |
| paper online questionnaires | #1 |
| prevalence environmental factors | #1 |
| study prehireonset | #1 |
| validity food questionnaire | #1 |
| increased food diversity | #1 |
| tbx21 hlx1 snps | #1 |
| farming environment protective | #1 |
| respiratory symptoms childhood | #1 |
| cd4creil13 | #1 |
| life protective | #1 |
| arabinogalactan cde | #1 |
| farm wheeze phenotypes | #1 |
| anthroposophic lifestyle features | #1 |
| mold problems children | #1 |
| quantitative confirmation associations | #1 |
| children early phenotypes | #1 |
| diagnosed fever 95 | #1 |
| bronchial hyperreactivity childhood | #1 |
| predictive models incidence | #1 |
| npsr1 tnc | #1 |
| lca pasture | #1 |
| girls late onset | #1 |
| kazal type spink5 | #1 |
| th2 th1 gsdma | #1 |
| questionnaire responses asthma | #1 |
| late introduction egg | #1 |
| farming asthma | #1 |
| menarche allergic | #1 |
| farm dwellings homes | #1 |
| environmental factors sensitization | #1 |
| farming environment role | #1 |
| crude measure exposure | #1 |
| infant inflammation crp | #1 |
| childhood allergy children | #1 |
| peptidoglycan ppg birth | #1 |
| gsdma expression secretion | #1 |
| allergic diseases cutoff | #1 |
| feeding patterns risk | #1 |
| endotoxin levels samples | #1 |
| fever spt cutoff | #1 |
| tregs life | #1 |
| alpine farm environments | #1 |
| 457 iu | #1 |
| crohns disease atopy | #1 |
| preschool children rhinitis | #1 |
| data netcomi | #1 |
| wheeze farming exposure | #1 |
| asthma symptoms community | #1 |
| germany allergic | #1 |
| endotoxin levels stables | #1 |
| association ilt4 | #1 |
| classical definitions lca | #1 |
| childrens bedrooms cowsheds | #1 |
| phenotypes atopic sensitization | #1 |
| dresden munich | #1 |
| epidemiologic phenotype | #1 |
| allergen exposure associations | #1 |
| factor school behavior | #1 |
| igg1 galactosylation predictor | #1 |
| fever atopic dermatitis | #1 |
| ilcs administration | #1 |
| life maternal atopy | #1 |
| 12 months doctor | #1 |
| childhood dampness | #1 |
| asthma dresden | #1 |
| hypersensitivity infections | #1 |
| exposure farm children | #1 |
| regulatory responses protection | #1 |
| current wheeze benzene | #1 |
| children dresden | #2 |
| foxp3 demethylation | #2 |
| improvements fdr score | #2 |
| dust endotoxin allele | #2 |
| traditional farm | #2 |
| asthma hygiene hypothesis | #2 |
| inflammatory diseases allergy | #2 |
| farmlike indoor microbiota | #2 |
| onset male recurrence | #2 |
| asthma symptoms fever | #2 |
| exposure farmers children | #2 |
| expression innate | #2 |
| gels bands | #2 |
| exposures farm | #2 |
| allergic asthma degradation | #2 |
| levels alk samples | #2 |
| viable listeria spp | #2 |
| atopy early life | #2 |
| dairying eczema | #2 |
| farmers asthma symptoms | #2 |
| fieldworkers dust collection | #2 |
| allergies cd14 expression | #2 |
| atopic smokers | #2 |
| lower atopy | #2 |
| low sensitization rates | #2 |
| pregnancy specific ige | #2 |
| bronchial hyperresponsiveness allergic | #2 |
| olive pollen dander | #2 |
| age asthma cohort | #2 |
| atopic eczema causation | #2 |
| eczema conjunctivitis eczema | #2 |
| opposite direction children | #2 |
| fieldworkers absolute levels | #2 |
| processed cow | #2 |
| adaptor protein rhinitis | #2 |
| adult farmers role | #2 |
| parent asthma | #2 |
| atopic diseases subjects | #2 |
| tbx21 gene | #2 |
| environmental microorganisms | #2 |
| genetic variation card4 | #2 |
| adult arm alliance | #2 |
| current paracetamol 95 | #2 |
| alternaria animals animals | #2 |
| atopic dermatitis wheeze | #2 |
| coaacetate | #2 |
| fever west germany | #2 |
| immunoglobulin nod1 | #2 |
| development atopic diseases | #2 |
| hc ca2 | #2 |
| ages current paracetamol | #2 |
| association allergic diseases | #2 |
| south bavaria | #2 |
| doctors diagnosis aor | #2 |
| environmental exposures mother | #2 |
| exposure life | #2 |
| peptidoglycan ppg | #2 |
| exposure lifestyle factors | #2 |
| dendritic cells dust | #2 |
| 645 children | #2 |
| allergic rhinitis adolescence | #2 |
| studies farms | #2 |
| study design participation | #2 |
| allele cd14 1721 | #2 |
| il13 gene linkage | #2 |
| associations hscrp levels | #2 |
| bronchitis east germany | #2 |
| farming nonfarming families | #2 |
| 95 047 95 | #2 |
| multivariate analyses haying | #2 |
| sensitization patterns inhalant | #2 |
| arg130gln polymorphism linkage | #2 |
| th2 cytokines ilc2s | #2 |
| bhr west germany | #2 |
| asthma phenotypes negative | #2 |
| socks alk samples | #2 |
| life current symptoms | #2 |
| bhr individual level | #2 |
| nocturnal symptoms spirometry | #2 |
| children bronchial hyperresponsiveness | #2 |
| dander artemisia | #2 |
| maternal immunity gondii | #2 |
| allele card4 21596 | #2 |
| protein rhinitis allergic | #2 |
| asthmaassociated | #2 |
| role maternal exposures | #2 |
| measles vaccination infection | #2 |
| atopic dermatitis childhood | #2 |
| card4 21596 children | #2 |
| farming mothers ppg | #2 |
| atopic eczema phenotypes | #2 |
| cd14 maternal exposures | #2 |
| developing allergies | #2 |
| siblings atopic children | #2 |
| bacteriological properties | #2 |
| life pvalues | #2 |
| excessive edna production | #2 |
| healthcare precision medicine | #2 |
| wheeze 12 | #2 |
| asthma cohort | #2 |
| ors affluent countries | #2 |
| indoor bacterial | #2 |
| farm animals symptoms | #2 |
| affluent countries associations | #2 |
| relation dust endotoxin | #2 |
| frequency nocturnal symptoms | #2 |
| protection allergy | #2 |
| asthma adolescence | #2 |
| nonfarming families | #2 |
| agriculture allergens | #2 |
| wheeze bronchial hyperresponsiveness | #2 |
| demethylation foxp3 | #2 |
| order sensitized patients | #2 |
| 95 school level | #2 |
| higher foxp3 | #2 |
| 17q21 | #2 |
| interactions asthma | #2 |
| pha th17 lineage | #2 |
| followup university | #2 |
| causation environmental associations | #2 |
| eczema farm exposures | #2 |
| current exposure cats | #2 |
| children farm | #2 |
| amish farms | #2 |
| immune responses function | #2 |
| germany asthma | #2 |
| eczema allergic dermatitis | #2 |
| increase worldwide | #2 |
| influence cord | #2 |
| cd4 cells offspring | #2 |
| eczema affluent | #2 |
| asthma crp | #2 |
| subsample children | #2 |
| data maternal weight | #2 |
| children nonfarm homes | #2 |
| lifelong farm exposure | #2 |
| affluent countries eczema | #2 |
| th17 lineage markers | #2 |
| munich participants | #2 |
| pha maternal farming | #2 |
| nonfarming mothers lipid | #2 |
| th17 markers | #2 |
| pha farming mothers | #2 |
| life rural children | #2 |
| antit2 biological therapy | #2 |
| grass pollen dander | #2 |
| highrisk predictors | #2 |
| geneenvironment interactions asthma | #2 |
| socks dust | #2 |
| rna russia | #2 |
| affluent countries centers | #2 |
| children affluent countries | #2 |
| dust samples levels | #2 |
| ifnγ levels snps | #2 |
| patients childhood symptoms | #2 |
| associations lessaffluent countries | #2 |
| consumption unprocessed | #2 |
| messenger receptors tenascin | #2 |
| collected dust indoor | #2 |
| nonfarm homes children | #2 |
| frequency nocturnal asthma | #2 |
| c4ma3 biomarker | #2 |
| card4 association | #2 |
| asthma control pa | #2 |
| farmers children children | #2 |
| childhood symptoms relapse | #2 |
| milk cd14 | #2 |
| allergen levels socks | #2 |
| study participants levels | #2 |
| allergies farming status | #2 |
| severity spirometric measures | #2 |
| farming exposure | #2 |
| ppg pha | #2 |
| amish hutterite homes | #2 |
| early life prevalence | #2 |
| prenatal farm exposure | #2 |
| beta1 endotoxin | #2 |
| prediction asthma | #2 |
| imposed social isolation | #2 |
| agmr 95 | #2 |
| asthma parsifal | #2 |
| card4 protein rhinitis | #2 |
| ga²len harmonization | #2 |
| symptom control pa | #2 |
| sputum extracellular | #2 |
| exposure farming | #2 |
| premature respiratory | #2 |
| gmcsf ifnγ levels | #2 |
| snps inflammatory diseases | #2 |
| environmental microorganisms children | #2 |
| nonfarm children | #2 |
| farming families | #2 |
| antibiotic asthma risk | #2 |
| immunoglobulin life | #2 |
| farming environment allergies | #2 |
| phase isaac | #2 |
| childhood phase | #2 |
| nocturnal asthma life | #2 |
| lipid lpa | #2 |
| microbial exposure risk | #2 |
| farming anthroposophic | #2 |
| lessaffluent countries adolescents | #2 |
| relapse newonset | #2 |
| human microbiota asthma | #2 |
| bhr tirana | #2 |
| influences development | #2 |
| current interpretation | #2 |
| university baseline | #2 |
| childhood obesoty | #2 |
| symptom control bmi | #2 |
| values edna concentrations | #2 |
| isaac prevalence rates | #2 |
| farm milk pregnancy | #2 |
| animal exposure levels | #2 |
| halle west germany | #2 |
| fev1 score associations | #2 |
| work discontent | #2 |
| polymorphisms il13 gene | #2 |
| il4 il13 pathway | #2 |
| alk samples fieldworkers | #2 |
| tregs cord blood | #2 |
| histamine challenges | #2 |
| pa interrelations | #2 |
| fieldworkers house dust | #2 |
| farms reference | #2 |
| bm190th | #2 |
| newonset asthma symptoms | #2 |
| lipid ppg | #2 |
| alk samples | #2 |
| atopic developing countries | #2 |
| serum levels c4ma3 | #2 |
| ages strongest associations | #2 |
| eczema symptom prevalence | #2 |
| cd14 genotypes asthma | #2 |
| test inhalent | #2 |
| il4 gene | #2 |
| cases objective measurements | #2 |
| consumption unpasteurized milk | #2 |
| neu5gc exposure | #2 |
| asthma protection | #2 |
| endotoxin allergen exposure | #2 |
| increase parent | #2 |
| paracetamol fever | #2 |
| farmers child cross | #2 |
| parsifal study phenotypes | #2 |
| cd4cd25hi foxp3 | #2 |
| doctors diagnosed asthma | #2 |
| farm children | #2 |
| allele specific ige | #2 |
| alliance ages | #2 |
| tirana mumbai | #2 |
| association atopic children | #2 |
| positive spt sige | #2 |
| antiidiotypic aspergillosis | #2 |
| neu5gc role | #2 |
| life increased risk | #2 |
| nocturnal asthma severity | #2 |
| individual level bhr | #2 |
| current symptoms asthmaassociated | #2 |
| consumption farm | #2 |
| time breastfed children | #2 |
| hutterite farm children | #2 |
| antiige therapy response | #2 |
| associations atopy | #2 |
| negative volatile organic | #2 |
| specificity lca | #2 |
| snps il4 gene | #2 |
| asthma symptoms eczema | #2 |
| environmental microbial exposure | #2 |
| followup ndvi | #2 |
| allergic disorders children | #2 |
| affluent countries | #2 |
| allergies genetic variation | #2 |
| new onset wheezing | #2 |
| atopic sensitization 14 | #2 |
| cd14 1721 children | #2 |
| 95 protective factors | #2 |
| bronchial hyperresponsiveness children | #2 |
| highdna | #2 |
| 19th century allergic | #2 |
| asthma symptoms children | #2 |
| study participants fieldworkers | #2 |
| positive maternal record | #2 |
| eczema farmers children | #2 |
| asthmaassociated aor | #2 |
| interval156 | #2 |
| asthma meeting | #2 |
| sod3 transcript | #2 |
| asthma observed | #2 |
| lessaffluent countries | #2 |
| t2inflammation | #2 |
| igg4 ige levels | #2 |
| polymorphisms card4 | #2 |
| animal sheds pregnancy | #2 |
| rora asthma | #2 |
| phase prevalence rates | #2 |
| maternal contact protective | #2 |
| severe exacerbations feno | #2 |
| childhood lca | #2 |
| artemisia olive pollen | #2 |
| microbial exposure study | #2 |
| difference endotoxin levels | #2 |
| aa hc | #2 |
| standardized procedure centres | #2 |
| rhinitis adolescents | #2 |
| 14 260 | #2 |
| higher greenness quartile | #2 |
| atopic sensitization upregulation | #2 |
| card4 21596 | #2 |
| cd14 1721 | #2 |
| fev1 fdr | #2 |
| eczema lessaffluent countries | #2 |
| school level 95 | #2 |
| breathomics asthma | #2 |
| fdr clinical response | #2 |
| c4ma3 asthma | #2 |
| farming environment mother | #2 |
| sensitized patients order | #2 |
| allergic diseases allergies | #2 |
| role helminths | #2 |
| quartile work discontent | #2 |
| alk samples levels | #2 |
| age allergic rhinitis | #2 |
| improvements fdr | #2 |
| cd14 1721 association | #2 |
| children bronchial obstruction | #2 |
| microbial agents association | #2 |
| bronchial challenge children | #2 |
| protect development | #2 |
| fev1 fdr fdr | #2 |
| living farms | #2 |
| association opposite direction | #2 |
| asthma child dermatitis | #2 |
| allergic tolllike receptor | #2 |
| isaac atopic eczema | #2 |
| early immune maturation | #2 |
| probability incidence | #2 |
| domestic child dust | #2 |
| cats eczema | #2 |
| leipzig halle | #2 |
| pattern missing values | #2 |
| statistical analysis performance | #2 |
| exposure environmental microorganisms | #2 |
| wheeze bronchial responsiveness | #2 |
| dresden higher greenness | #2 |
| increased risk employment | #2 |
| participants dresden | #2 |
| strachan | #2 |
| bronchial hyperresponsiveness exposure | #2 |
| farming families allergies | #2 |
| 047 95 gg | #2 |
| immunoglobulin analyses children | #2 |
| tregs demethylation | #2 |
| microbial influences | #2 |
| arabinogalactan isolated | #3 |
| endotoxin levels asthma | #3 |
| bhr pcdh1 polymorphisms | #3 |
| asthma major | #3 |
| european ancestry asthma | #3 |
| col29a1 polymorphisms | #3 |
| breastfeeding overweight | #3 |
| t12888c | #3 |
| exposure helminths | #3 |
| risk nonatopic asthma | #3 |
| 1q31 locus | #3 |
| col29a1 polymorphisms eczema | #3 |
| c746t | #3 |
| g1258a | #3 |
| pcr sscp analysis | #3 |
| children african ancestry | #3 |
| children farming | #3 |
| atopic sensitisation | #3 |
| 1431c | #3 |
| farming status | #3 |
| population german | #3 |
| il15 gene asthma | #3 |
| markers fetal growth | #3 |
| asthma endotoxin levels | #3 |
| prenatal protection asthma | #3 |
| atopy dresden | #3 |
| albania antibody specificity | #3 |
| locus dennd1b | #3 |
| samples 1q31 locus | #3 |
| crude measure | #3 |
| protective farm | #3 |
| asthma bordetella | #3 |
| network construction | #3 |
| maternal tlr | #3 |
| asthma pcdh1 | #3 |
| irf1 interferon expression | #3 |
| adam33 snps | #3 |
| paf seasonal allergens | #3 |
| stat6 haplotype | #3 |
| domestic asthma | #3 |
| cowshed dust | #3 |
| populations illness surveys | #3 |
| asthma cattle | #3 |
| rhinitis increased risk | #3 |
| col29a1 variants eczema | #3 |
| current asthma rhinoconjunctivitis | #3 |
| substances protection | #3 |
| 53152 | #3 |
| eosinophil pathway genes | #3 |
| atopic female germany | #3 |
| doctors diagnosis | #3 |
| atopic dermatitis aor | #3 |
| age 7–10 years | #3 |
| 45yearold children | #3 |
| onset asthma child | #3 |
| eczema farmers | #3 |
| fever aor | #3 |
| protocadherin‐1 | #3 |
| c2892 | #3 |
| paracetamol risk | #3 |
| allergic diseases children | #3 |
| growing farm | #3 |
| asthma genetic severity | #3 |
| asthma atopic sensitization | #3 |
| biomaterial collection | #3 |
| allergic disequilibrium rhinitis | #3 |
| f78 | #3 |
| eczema strong association | #3 |
| gni measurements | #3 |
| throat microbiota asthma | #3 |
| sod3 variants | #3 |
| hygiene hypothesis | #3 |
| asthma tolllike receptors | #3 |
| increased treg cells | #3 |
| protein rhinitis | #3 |
| phase international study | #3 |
| mmp9 variants mmp9 | #3 |
| munich polymorphism | #3 |
| amino acid cx3cr1 | #3 |
| tlr2 receptor function | #3 |
| asthma 1431c | #3 |
| sod3 extracellular matrix | #3 |
| ppg expression | #3 |
| cowshed dust extract | #3 |
| 95ci nonatopic asthma | #3 |
| allergyprotective | #3 |
| countries endotoxin levels | #3 |
| polymorphisms hlx1 gene | #3 |
| stat1 gene variations | #3 |
| hlx1 gene development | #3 |
| environmental dusts | #3 |
| cd14 association | #3 |
| prenatal asthma protection | #3 |
| blood allergen | #3 |
| domestic arthritis | #3 |
| experimental asthma progeny | #3 |
| hlx1 gene variants | #3 |
| german children munich | #3 |
| nonatopic asthma 95ci | #3 |
| nf kappa polymorphism | #3 |
| lwoffii f78 | #3 |
| susceptibility col29a1 expression | #3 |
| today1 | #3 |
| prenatal protection | #3 |
| paf sensitisation | #3 |
| effects single snps | #3 |
| anthroposophic children | #3 |
| farm dust endotoxin | #3 |
| hygiene hypothesis development | #3 |
| il5 c746 allergic | #3 |
| 1000 enfants | #3 |
| prevalence asthma | #3 |
| 1q31 locus dennd1b | #3 |
| tlr2 amino acid | #3 |
| responses innate | #3 |
| il15 associations | #3 |
| individual level questionnaires | #3 |
| persistent flexural eczema | #3 |
| pcdh1 asthma | #3 |
| wheeze allergy | #3 |
| dennd1b chromosome | #3 |
| severity moisture damage | #3 |
| farm animals farm | #3 |
| dcs a20 induction | #3 |
| animal sheds | #3 |
| il5 c746t | #3 |
| hlx1 gene | #3 |
| bavaria obesity | #3 |
| role neu5gc | #3 |
| cx3cr1 polymorphisms atopy | #3 |
| protection contre | #3 |
| asthma protection progeny | #3 |
| il5 il5 c746 | #3 |
| t3085 | #3 |
| individual level centers | #3 |
| il15 gene variants | #3 |
| progeny asthma | #3 |
| work work overload | #3 |
| questionnaires physical examination | #3 |
| farms asthma | #3 |
| puberty risk factors | #3 |
| european science foundation | #3 |
| allergy a20 induction | #3 |
| microorganisms dust | #3 |
| role atopic sensitization | #3 |
| col29a1 genetic variants | #3 |
| blatella | #3 |
| perennial allergens paf | #3 |
| il15 il15 associations | #3 |
| childhood asthma community | #3 |
| organic waste storage | #3 |
| eosinophils matrix metalloproteinase | #3 |
| life development | #3 |
| rhinoconjunctivitis atopic eczema | #3 |
| c39134a | #3 |
| asthma subphenotypes | #3 |
| 9 mmp9 mmp9 | #3 |
| monocytes lps stimulation | #3 |
| wheezing neutrophils | #3 |
| seasonal allergens atopy | #3 |
| asthma farming environment | #3 |
| children isaac phase | #3 |
| culture techniques study | #3 |
| young adult europe | #3 |
| atopic mothers | #3 |
| bacterial diversity asthma | #3 |
| food year | #3 |
| —study | #3 |
| allergic inflammation polymorphisms | #3 |
| moraxella colonization | #3 |
| farm contact | #3 |
| allergy protection | #3 |
| allergic phenotypes correction | #3 |
| asthma genetic association | #3 |
| dennd1b asthma | #3 |
| col29a1 polymorphisms susceptibility | #3 |
| genetic variation crth2 | #3 |
| paf allergic | #3 |
| conjunctivitis paf | #3 |
| characteristics respiratory | #3 |
| allergic phenotype polymorphism | #3 |
| mmp9 variants risk | #3 |
| duration prevalence | #3 |
| dogs exposure | #3 |
| stat6 gene regulation | #3 |
| rural areas europe | #3 |
| eczema col29a1 | #3 |
| female fetus immunity | #3 |
| vivo expression irf1 | #3 |
| rhinoconjunctivitis paf | #3 |
| bias asthma bias | #3 |
| eczema international study | #3 |
| rural dwellings | #3 |
| 280met | #3 |
| 3099 children | #3 |
| asthma identified | #3 |
| associations pcdh1 | #3 |
| atopic diseases mutations | #3 |
| asthma amino acid | #3 |
| farm dwellings | #3 |
| overweight germany | #3 |
| c1407t | #3 |
| forward initiative | #3 |
| united kingdom albania | #3 |
| ferme | #3 |
| atopic asthma effects | #3 |
| parent prevalence | #3 |
| allergic asthmatics aa | #3 |
| cx3cr1 polymorphisms polymorphism | #3 |
| protection development | #3 |
| 1431c specific ige | #3 |
| affluent countries atopy | #3 |
| bhr haplotypes humans | #3 |
| sige asthma | #3 |
| putative functional role | #3 |
| dresden odds ratio | #3 |
| ile117thr | #3 |
| isaac polymorphisms | #3 |
| endotoxin dust samples | #3 |
| rare tlr2 mutations | #3 |
| eosinophil pathway | #3 |
| cohort alliance | #3 |
| tlr2 polymorphisms | #3 |
| regular contact | #3 |
| food correction | #3 |
| children negative spts | #3 |
| asthma snp rs2786098 | #3 |
| gni rho | #3 |
| cytokine cluster bhr | #3 |
| pcdh1 polymorphisms associations | #3 |
| crosssectional population | #3 |
| role asthma prevalence | #3 |
| crth2 influences development | #3 |
| prevalence allergies | #3 |
| eczema isaac phase | #3 |
| farming farm | #3 |
| rhinoconjunctivitis conjunctivitis | #3 |
| polymorphisms gm csf | #3 |
| col29a1 expression eczema | #3 |
| bdnf polymorphisms asthma | #3 |
| lukas2 birth | #3 |
| children bronchial hyperreactivity | #3 |
| jobrelated chronic stress | #3 |
| life allergic diseases | #3 |
| col29a1 eczema | #3 |
| germany west german | #3 |
| mmp9 influence development | #3 |
| sensitisation affluent countries | #3 |
| auc asthma | #3 |
| microbiota farm | #3 |
| endotoxin milk | #3 |
| disequilibrium rhinitis allergic | #3 |
| adam33 polymorphisms asthma | #3 |
| occurrence rhinitis | #3 |
| treatment asthma phenotypes | #3 |
| role adam33 polymorphisms | #3 |
| lower risk allergy | #4 |
| nonfarming | #4 |
| parent odds ratio | #4 |
| allergy international study | #4 |
| crp blood leukocytes | #4 |
| sas genetics | #4 |
| early identification atopy | #4 |
| eczema flg mutations | #4 |
| development atopic | #4 |
| a20 induction | #4 |
| rs2786098 | #4 |
| incident sensitization | #4 |
| childhood protect | #4 |
| lifetime prevalence asthma | #4 |
| bacillus licheniformis spores | #4 |
| microbial compounds | #4 |
| benzene no2 | #4 |
| cheese consumption | #4 |
| gene expression receptors | #4 |
| asthma induction | #4 |
| stables farm milk | #4 |
| cough bronchitis | #4 |
| environmental dust samples | #4 |
| stable dust | #4 |
| increase eczema prevalence | #4 |
| tlr2 mutations | #4 |
| late phenotype | #4 |
| glu420lys | #4 |
| allergic il5 | #4 |
| children farms | #4 |
| predictor wheezing | #4 |
| aetiology asthma | #4 |
| h20like homeobox | #4 |
| cd4cd25hi tregs | #4 |
| groups taxa | #4 |
| asthma phenotype children | #4 |
| cord blood lipid | #4 |
| t2high asthma | #4 |
| occurrence atopic dermatitis | #4 |
| genotypes cd14 | #4 |
| human genetic nod1 | #4 |
| ilc2s human asthma | #4 |
| antibiotics antipyretics | #4 |
| 95 gene expression | #4 |
| tolllike receptors receptor | #4 |
| farm environment development | #4 |
| asthma symptoms association | #4 |
| asthma current symptoms | #4 |
| sounds rhinitis | #4 |
| development atopic sensitization | #4 |
| asthma symptoms adults | #4 |
| prevalence random | #4 |
| atopic dermatitis birth | #4 |
| fetal growth asthma | #4 |
| initial data analysis | #4 |
| candidate genes wheeze | #4 |
| parental allergic rhinitis | #4 |
| dust personal | #4 |
| adolescents duration | #4 |
| infections early | #4 |
| lukas2 | #4 |
| fever 17 | #4 |
| eczema questionnaires adolescent | #4 |
| il4r tlr4 | #4 |
| immunity receptors | #4 |
| col29a1 gene | #4 |
| microbes asthma | #4 |
| asthma hygiene | #4 |
| current symptoms asthma | #4 |
| asthma 3 | #4 |
| 5 13 years | #4 |
| pro27ser | #4 |
| study centers phase | #4 |
| environmental factors development | #4 |
| allergic diseases humans | #4 |
| birthcohort study | #4 |
| anthroposophic families | #4 |
| occupational allergy risks | #4 |
| phase 2 allergies | #4 |
| heating prevalence | #4 |
| asthma atopic diseases | #4 |
| risk factor symptoms | #4 |
| asthma snps | #4 |
| cromolyns | #4 |
| flexural eczema | #4 |
| children munich | #4 |
| children maternal overweight | #4 |
| alliance cohort | #4 |
| asthma medication exposure | #4 |
| east germany bhr | #4 |
| high‐sensitivity c‐reactive protein | #4 |
| ige levels associations | #4 |
| leisure time activity | #4 |
| childhood asthma | #4 |
| wheeze ige levels | #4 |
| inhalant patients | #4 |
| cx3cr1 polymorphisms | #4 |
| lrti asthma | #4 |
| genetic rhinitis allergic | #4 |
| genes il4r | #4 |
| particle boluses | #4 |
| spt sige | #4 |
| common sensitizations | #4 |
| fever eczema | #4 |
| fatty acids allergic | #4 |
| doctors diagnosis asthma | #4 |
| factors wheeze | #4 |
| n2267 | #4 |
| col29a1 expression | #4 |
| gabriel advanced | #4 |
| dietary habits children | #4 |
| early life basis | #4 |
| wheezing onset | #4 |
| current asthma bhr | #4 |
| participants fieldworkers | #4 |
| birth atopic dermatitis | #4 |
| wheeze bhr | #4 |
| allergies children | #4 |
| adult lung disease | #4 |
| exposure microbial | #4 |
| allergic ecuador eczema | #4 |
| life childhood | #4 |
| exposure cats | #4 |
| mother role | #4 |
| permanovas | #4 |
| secretory receptors allergic | #4 |
| asthma auc | #4 |
| children mattresses | #4 |
| predictors visits | #4 |
| minimum battery | #4 |
| allergic dermatitis allergic | #4 |
| risk atopic dermatitis | #4 |
| promoter region arg130gln | #4 |
| questionnaires populations | #4 |
| licheniformis spores | #4 |
| c746 | #4 |
| agreement spt | #4 |
| endotoxin relation | #4 |
| cats pregnancy | #4 |
| rare tlr2 | #4 |
| neonatal window | #4 |
| fever year | #4 |
| german children bavaria | #4 |
| prenatal asthma | #4 |
| genetic nod1 | #4 |
| questionnaires adolescent eczema | #4 |
| questionnaires eczema | #4 |
| feeding prevalence | #4 |
| cowsheds | #4 |
| 99th dahlem conference | #4 |
| indoor pollen | #4 |
| milk consumption age | #5 |
| phänotypen | #5 |
| associations wheeze | #5 |
| female germany allergic | #5 |
| asthma girls | #5 |
| current symptoms rhinoconjunctivitis | #5 |
| delayed manifestation | #5 |
| nod1 variation | #5 |
| helsinki alert | #5 |
| genetic variants tbx21 | #5 |
| ormdl3 gsdma | #5 |
| neu5gc mice | #5 |
| visits predictors | #5 |
| cowshed | #5 |
| atopy airway hyperresponsiveness | #5 |
| flexural eczema strength | #5 |
| communitybased random sample | #5 |
| processing intensity | #5 |
| influence ige | #5 |
| children validity | #5 |
| verlaufsformen | #5 |
| 14452 | #5 |
| mmp9 influence | #5 |
| asthma medication 95 | #5 |
| pregnancy year | #5 |
| receptors innate immunity | #5 |
| popular terms | #5 |
| cats risk factor | #5 |
| c2892t | #5 |
| rhinitis increase | #5 |
| atopic eczema allergic | #5 |
| endotoxin protection | #5 |
| risk atopic | #5 |
| genetic asthma | #5 |
| children current wheeze | #5 |
| asthma endotoxins | #5 |
| young adults methods | #5 |
| n1046 | #5 |
| parental reports asthma | #5 |
| mechanism environmental factors | #5 |
| inverse association overweight | #5 |
| atopy flexural eczema | #5 |
| hlx1 polymorphisms development | #5 |
| hyperreactivity child | #5 |
| 26 farms | #5 |
| il13cd4 | #5 |
| allergystudy | #5 |
| pattern sensitization | #5 |
| nonfarmers children | #5 |
| eczema relation | #5 |
| allergic diseases exposure | #5 |
| hlx1 variants | #5 |
| dogs symptoms | #5 |
| ige regulation | #5 |
| thr280met | #5 |
| cd4cd25hi | #5 |
| 2q14 | #5 |
| linkage development | #5 |
| farming mothers | #5 |
| tbx21 combination | #5 |
| rs3771300 | #5 |
| taxa groups | #5 |
| lung health disease | #5 |
| wisconsin infant | #5 |
| severe atopy | #5 |
| duration jobs | #5 |
| il13cd4 cells | #5 |
| cow milk samples | #5 |
| moisture mold problems | #5 |
| dresden | #5 |
| tbx21 promoter activity | #5 |
| trigger factors asthma | #5 |
| consumption 4 years | #5 |
| atopic sensitization asthma | #5 |
| exposure rhinitis | #5 |
| 95 reverse causation | #5 |
| combination hlx1 polymorphisms | #5 |
| subtypes risk | #5 |
| asthma child dust | #5 |
| milk odds | #5 |
| combination hlx1 variants | #5 |
| incident wheeze | #5 |
| rural subjects | #5 |
| jf1 msf | #5 |
| participation behaviour | #5 |
| life questionnaires switzerland | #5 |
| cd14 gene expression | #5 |
| disinfectants asthma | #5 |
| allergen 95 | #5 |
| west german children | #5 |
| milk exposure | #5 |
| environmental dust | #5 |
| childhood isaac phase | #5 |
| tbx21 gene variants | #5 |
| tnc nps | #5 |
| puberty menarche | #5 |
| ors atopy | #5 |
| tests bronchitis | #5 |
| timing exposures | #5 |
| tbx21 polymorphisms development | #5 |
| ors positive association | #5 |
| atopic dermatitis age | #5 |
| adulthood asthma | #5 |
| agriculture animals | #5 |
| 2nd followup | #5 |
| airway responsiveness age | #5 |
| 95 populationattributable risk | #5 |
| sensitization atopic | #5 |
| ornonaffluent | #5 |
| allergic rhinitis wheeze | #5 |
| moulds actinomycetes | #5 |
| onset disease germany | #6 |
| strategies disease | #6 |
| 14 genes tripeptidylpeptidases | #6 |
| protection allergies | #6 |
| new locus time | #6 |
| complete screening | #6 |
| tests asthma | #6 |
| fever wheezing | #6 |
| allergic diseases | #6 |
| farm nonfarm | #6 |
| sensitisation exposure | #6 |
| steiner schools | #6 |
| atemwegserkrankungen | #6 |
| asthma authors | #6 |
| natural atopic dermatitis | #6 |
| current contact | #6 |
| rora npsr1 | #6 |
| 7 years association | #6 |
| allergic epistasis | #6 |
| children farming environment | #6 |
| allergic immunologic receptors | #6 |
| longitudinal populations | #6 |
| devenues | #6 |
| 939 children | #6 |
| genetic variants 17q12q21 | #6 |
| central europe interactions | #6 |
| distinct underlying mechanisms | #6 |
| susceptibility gene asthma | #6 |
| hypertonic skin tests | #6 |
| asthma transition | #6 |
| pair deubiquitinating enzyme | #6 |
| pair male nod2 | #6 |
| systemic inflammation age | #6 |
| deubiquitinating enzyme tao | #6 |
| countries albania | #6 |
| allergic markers | #6 |
| data 7 years | #6 |
| german nationality | #6 |
| parsifal | #6 |
| lung barrier | #6 |
| children east germany | #6 |
| childhood asthma phenotypes | #6 |
| european dairy farms | #6 |
| sscp method | #6 |
| abschnitten | #6 |
| genetic variants time | #6 |
| microorganisms samples | #6 |
| comprehensive questionnaires | #6 |
| primary preventive strategies | #6 |
| progression asthma | #6 |
| dogs environmental exposure | #6 |
| sounds surveys | #6 |
| yearly interviews | #6 |
| bolus dispersion | #6 |
| nd132656 | #6 |
| bavarian preschool children | #6 |
| 17q12q21 earlier onset | #6 |
| 16q12 region | #6 |
| allergy tests children | #6 |
| tlr1 tlr10 | #6 |
| oropharyngeal microbiota | #6 |
| children positive spt | #6 |
| prevent allergic | #6 |
| asthma allergic sensitisation | #6 |
| cold air challenge | #6 |
| inversely asthma | #6 |
| lowgrade inflammation hscrp | #6 |
| fever atopy | #6 |
| allergoprotective properties | #6 |
| rhinoconjunctivitis eczema | #6 |
| study rarer snps | #6 |
| responders frequency | #6 |
| food allergy 95 | #6 |
| no2 current asthma | #6 |
| asthma context | #6 |
| childhood asthma genes | #6 |
| tripeptidylpeptidases subunit p40 | #6 |
| overweight data | #6 |
| asthma austria | #6 |
| nonaffluent | #6 |
| central europe asthma | #6 |
| childhood aa | #6 |
| 5 regions tao | #6 |
| polymorphisms stat6 gene | #6 |
| allergens needed | #6 |
| il33 17q12q21 | #6 |
| dipeptidyl peptidases tripeptidylpeptidases | #6 |
| rhinoconjunctivitis atopic | #6 |
| 11094 | #6 |
| asthma genotypes | #6 |
| lifestyle factors symptoms | #6 |
| dust collection | #6 |
| interactions farm exposures | #6 |
| eating environmental | #6 |
| isaac programme | #6 |
| pierced ears | #6 |
| atopic dermatitis association | #7 |
| allergy antibiotics | #7 |
| hypertonic sensitivity | #7 |
| pbmcs asthmatics | #7 |
| strategies asthma | #7 |
| farm exposure | #7 |
| interleukin4 sequence analysis | #7 |
| association cord blood | #7 |
| farm life | #7 |
| pasture study | #7 |
| preanalytix | #7 |
| endotoxin allergen | #7 |
| fetal development allergic | #7 |
| reference exposure | #7 |
| questionnaires phase | #7 |
| child dust | #7 |
| grass rphl | #7 |
| nonfarm homes | #7 |
| infectious diseases phenotype | #7 |
| biomarker immune activation | #7 |
| asthma environmental factors | #7 |
| children international study | #7 |
| infantis populations | #7 |
| exposure farms | #7 |
| inverse association consumption | #7 |
| chemokine cx3cl1 cx3cr1 | #7 |
| farm homes | #7 |
| 5 harmonization | #7 |
| fever atopic asthma | #7 |
| children regular contact | #7 |
| highrisk occupations | #7 |
| inhalant age | #7 |
| hypersensitivity male | #7 |
| bhr current asthma | #7 |
| questionnaires allergic | #7 |
| viral infections development | #7 |
| log2fold | #7 |
| exposure neu5gc | #7 |
| steiner school | #7 |
| children breast | #7 |
| birth function | #7 |
| seasonal sensitivity allergic | #7 |
| european science | #7 |
| level variety | #7 |
| childrens bedrooms | #7 |
| genetic predisposition role | #7 |
| allergic atopic embryonic | #7 |
| asthma fever | #7 |
| adult farmers | #7 |
| polymorphisms il4 gene | #7 |
| 15245 | #7 |
| isaac eczema | #7 |
| perennial allergen | #7 |
| school age asthma | #7 |
| wheeze 12 months | #7 |
| large centres | #7 |
| asthma school age | #7 |
| steiner school children | #7 |
| environmental factors children | #7 |
| stat1 gene | #7 |
| lung sod3 | #7 |
| pasture birth | #7 |
| immunologic receptors allergic | #7 |
| 95 endotoxin | #7 |
| cells dust | #7 |
| paracetamol year | #7 |
| environmental exposure endotoxin | #7 |
| invading microorganism | #7 |
| symptoms adulthood | #7 |
| childhoodonset disease | #7 |
| hutterite children | #7 |
| foxp3 blood | #7 |
| secretory receptors | #7 |
| wheeze atopy | #7 |
| indoor moisture | #7 |
| fieldworkers | #7 |
| birth cohorts report | #7 |
| rhinitis early childhood | #7 |
| diversity introduction | #7 |
| juvenile inflammatory | #7 |
| amish children | #7 |
| atopic europe | #7 |
| pregnancy atopic dermatitis | #7 |
| children prognosis | #7 |
| breastfeeding prevalence | #7 |
| influence neonatal | #7 |
| functional phenotypes | #7 |
| murine offspring | #7 |
| lower risk asthma | #7 |
| lymphoid cells asthma | #7 |
| levels farm | #7 |
| centers increase | #7 |
| aerosol bolus dispersion | #7 |
| antibiotics year | #8 |
| il15 snps | #8 |
| gabriela study | #8 |
| atopic sensitization prevalence | #8 |
| repeats sequence homology | #8 |
| 3113 children | #8 |
| asthma physiciandiagnosed asthma | #8 |
| bronchial histamine challenge | #8 |
| p11×10−8 | #8 |
| diversity year | #8 |
| dogs risk factor | #8 |
| amish child | #8 |
| th2 cells ilc2s | #8 |
| finlande | #8 |
| proteins dendritic cells | #8 |
| asthma 08 | #8 |
| eczema asthma child | #8 |
| mice children | #8 |
| hlx1 | #8 |
| chromosome 2q14 | #8 |
| children reference | #8 |
| childhood asthma atopy | #8 |
| indoor microbiota | #8 |
| exposure dogs | #8 |
| amino acid asthma | #8 |
| 824 children | #8 |
| asthma analyses | #8 |
| age 911 years | #8 |
| c4ma3 | #8 |
| rs8076131 | #8 |
| chromosome childhoodonset disease | #8 |
| asthma child conjunctivitis | #8 |
| p3×10−9 | #8 |
| asthma atopic sensitisation | #8 |
| current asthma data | #8 |
| asthma birth weight | #8 |
| sensitization mite | #8 |
| inhalant europe | #8 |
| diet year | #8 |
| childhoodonset disease elevation | #8 |
| university work | #8 |
| il13 variants | #8 |
| invertedu shape | #8 |
| cows milk age | #8 |
| factor analysis factor | #8 |
| association wheeze | #8 |
| austrian schoolchildren | #8 |
| p7×10−14 | #8 |
| association food diversity | #8 |
| 17q12q21 | #8 |
| children anthroposophic families | #8 |
| crohns disease polymorphisms | #8 |
| genetic risk asthma | #8 |
| asthmaprotective | #8 |
| gabriela | #8 |
| 95 food allergy | #8 |
| agmr | #8 |
| asthma bias | #8 |
| asthma maternal smoking | #8 |
| study rural | #8 |
| allergy epidemiology | #8 |
| sensitization patterns | #8 |
| influence cytokine | #8 |
| surveyed children | #8 |
| lipid peptidoglycan | #8 |
| airwayrelated symptoms | #8 |
| allergies childhood | #8 |
| ppg stimulation | #8 |
| allergy study | #8 |
| children anthroposophic | #8 |
| immunity gene expression | #8 |
| hrqol questions | #8 |
| fever atopic sensitisation | #8 |
| age positive spts | #8 |
| p4×10−9 | #8 |
| igg1 galactosylation | #8 |
| early age exposure | #8 |
| highthroughput sequencing data | #8 |
| international variations | #8 |
| 1314yrolds | #9 |
| col29a1 variants | #9 |
| microbial substances | #9 |
| 105 years age | #9 |
| partial nonresponders | #9 |
| ecuador eczema | #9 |
| cytokines environmental | #9 |
| exposure farming environments | #9 |
| allergic seasonal risk | #9 |
| study asthma | #9 |
| allergic phenotypes | #9 |
| asthma infant | #9 |
| life female germany | #9 |
| eczema weight | #9 |
| regular exposure | #9 |
| life prenatal exposure | #9 |
| positive spts | #9 |
| n7498 | #9 |
| levels allergens | #9 |
| 5 european | #9 |
| gwas approaches | #9 |
| asthma allergy symptoms | #9 |
| autriche | #9 |
| allergic preschool conjunctivitis | #9 |
| asthma early life | #9 |
| random subsample | #9 |
| cord blood cytokines | #9 |
| atopic sensitization children | #9 |
| polymorphisms development | #9 |
| factors sensitization | #9 |
| subspecies bifidobacterium | #9 |
| ausprägungen | #9 |
| ribosomal 16s risk | #9 |
| regulatory th17 cells | #9 |
| asthma child child | #9 |
| 1 npsr1 | #9 |
| asthma child | #9 |
| microbial exposure | #9 |
| chromosome ige levels | #9 |
| farming environment | #9 |
| ige levels gwas | #9 |
| igg4 ige | #9 |
| germany munich | #9 |
| animals supplementation | #9 |
| bronchial hyper‐responsiveness | #9 |
| kazal type | #9 |
| association wheezing | #9 |
| asthma respiratory conditions | #9 |
| symptoms 12 months | #9 |
| unprocessed milk | #9 |
| fcer1a susceptibility locus | #9 |
| 1314 children | #9 |
| npsr1 snps | #9 |
| asthma symptoms baseline | #9 |
| conjunctivitis cross | #9 |
| tbx21 promoter | #9 |
| teenagers asthma | #9 |
| drug development strategies | #9 |
| relation environment | #9 |
| prevalence atopic | #9 |
| young german | #9 |
| rad50 gene chromosome | #9 |
| allergic inflammation patients | #9 |
| relation asthma | #9 |
| association stat6 variation | #9 |
| asthma risk | #9 |
| dennd1b | #9 |
| skinprick | #9 |
| low levels hscrp | #9 |
| role human asthma | #9 |
| clinical response score | #9 |
| rural farm | #9 |
| asthma antibiotics | #9 |
| longitudinal follow‐up | #9 |
| life ahr | #9 |
| new zealand bhr | #10 |
| bdnf gene variants | #10 |
| missing values paper | #10 |
| blood samples tubes | #10 |
| centers prevalence rates | #10 |
| ilt3 ilt4 | #10 |
| indoor heating | #10 |
| phase protocol | #10 |
| substances development | #10 |
| mattress dust | #10 |
| interrelations risk factors | #10 |
| infection allergic | #10 |
| ige levels asthma | #10 |
| hormonal factors role | #10 |
| association atopic | #10 |
| context eczema | #10 |
| ratio asthma | #10 |
| mothers contact | #10 |
| mechanisms oral tolerance | #10 |
| n1138 | #10 |
| asthma chromosome | #10 |
| international study asthma | #10 |
| gabriel advanced studies | #10 |
| leipzig east germany | #10 |
| endotoxin muramic acid | #10 |
| urban rural area | #10 |
| production cord blood | #10 |
| farm exposures asthma | #10 |
| consumption raw | #10 |
| young german adults | #10 |
| farm children children | #10 |
| airway hyperresponsiveness children | #10 |
| prevalence differences | #10 |
| reservoir method | #10 |
| life allergen | #10 |
| new onset rhinitis | #10 |
| 1992–2001 | #10 |
| bias exposure | #10 |
| atopic dermatitis 95 | #10 |
| rural school children | #10 |
| humans hypersensitivity | #10 |
| asthma nocturnal | #10 |
| predictors health utilization | #10 |
| 45 saline | #10 |
| house dust endotoxin | #10 |
| bhr prevalence | #10 |
| genetic probability receptors | #10 |
| association new onset | #10 |
| countries centres | #10 |
| early life immunity | #10 |
| latex children | #10 |
| study occupational | #10 |
| adult cases controls | #10 |
| receptors immunity | #10 |
| parsifal study | #11 |
| school beginners | #11 |
| pregnancy early life | #11 |
| allergy risks | #11 |
| children rural | #11 |
| farm exposures | #11 |
| asthma lower | #11 |
| protective development | #11 |
| asthma bacterial | #11 |
| lebensbedingungen | #11 |
| allergic disease children | #11 |
| occupational disinfectants | #11 |
| symptoms allergic rhinoconjunctivitis | #11 |
| german schoolchildren | #11 |
| newborn male polymorphism | #11 |
| samples persons | #11 |
| wheeze aor | #11 |
| atopic dust | #11 |
| overweight body mass | #11 |
| microbiome lung | #11 |
| subsequent development asthma | #11 |
| reduced risk asthma | #11 |
| npsr1 polymorphisms | #11 |
| wheeze year | #11 |
| blood foxp3 | #11 |
| fetal ige | #11 |
| asthma risk participants | #11 |
| children school entry | #11 |
| tbx21 polymorphisms | #11 |
| association respiratory health | #11 |
| factors agriculture | #11 |
| farm buildings | #11 |
| active smoking association | #11 |
| ige measurements | #11 |
| allergic asthma conjunctivitis | #11 |
| transient wheezing | #11 |
| early life development | #11 |
| genotyped polymorphisms | #11 |
| persistent uncontrolled asthma | #11 |
| cytokines allergic inflammation | #11 |
| health outcomes countries | #11 |
| atopy | #11 |
| tuberculosis notification rates | #11 |
| german multicentre | #12 |
| asthma epidemic | #12 |
| overweight breast | #12 |
| bhr wheeze | #12 |
| transient wheeze | #12 |
| validated questions | #12 |
| farm | #12 |
| 7 years data | #12 |
| hypersensitivity immunity | #12 |
| age 105 years | #12 |
| children background | #12 |
| skin prick testing | #12 |
| doctor asthma | #12 |
| participants allergic rhinitis | #12 |
| rural environments | #12 |
| children exposed children | #12 |
| standard deviation skewness | #12 |
| birth cohorts asthma | #12 |
| incident asthma 95 | #12 |
| male respiratory | #12 |
| asthma candidate gene | #12 |
| 95 nox | #12 |
| east germany munich | #12 |
| munich west germany | #12 |
| stepwise protocol | #12 |
| asthma disease humans | #12 |
| sensitization birth | #12 |
| healthy children asthma | #12 |
| backgroundasthma | #12 |
| polymorphism asthma | #12 |
| exposure asthma symptoms | #12 |
| association moisture | #12 |
| damage mold | #12 |
| children low levels | #12 |
| asthma parent | #12 |
| current paracetamol | #12 |
| early priming | #12 |
| pet contact | #12 |
| multicentre allergy | #12 |
| child environmental | #12 |
| cattle child | #12 |
| infection analyses | #12 |
| ige grass | #12 |
| polymorphisms bdnf gene | #12 |
| symptoms atopic | #12 |
| female humans hypersensitivity | #12 |
| young adults school | #12 |
| fever exposure | #12 |
| management childhood asthma | #12 |
| increase prevalence | #12 |
| mattress dust samples | #12 |
| dermatitis phenotypes | #12 |
| asthmatic cohort | #12 |
| childhood isaac | #13 |
| spt specific ige | #13 |
| local immunity | #13 |
| childhood allergy | #13 |
| asthma mental health | #13 |
| asthma community | #13 |
| farm dust | #13 |
| developing microbiota | #13 |
| switzerland children | #13 |
| eastern western germany | #13 |
| dresden germany | #13 |
| occupational exposure disinfectants | #13 |
| subjects jobs | #13 |
| sx1 | #13 |
| nod1 gene | #13 |
| expression ormdl3 | #13 |
| rural schoolchildren | #13 |
| groups phenotype | #13 |
| ibd sle | #13 |
| farm animal contact | #13 |
| children inhaled steroids | #13 |
| allergic sensitisation children | #13 |
| asthma snp | #13 |
| asthma nocturnal symptoms | #13 |
| hygiene hypersensitivity | #13 |
| atopic eczema symptoms | #13 |
| asthma outcomes patients | #13 |
| farming exposures | #13 |
| n349 | #13 |
| antibiotic exposure pregnancy | #13 |
| cord adult blood | #13 |
| asthma rhinoconjunctivitis | #13 |
| asthma bronchial | #13 |
| children raised | #13 |
| npsr1 | #13 |
| wheezing ages | #13 |
| polymorphisms influence | #13 |
| rhinitis allergens | #13 |
| northern indiana | #13 |
| children polymorphisms | #13 |
| th1cells | #13 |
| positive spts age | #14 |
| german children | #14 |
| cross environmental exposure | #14 |
| rhinitis conjunctivitis | #14 |
| 7 polymorphisms | #14 |
| nonaffluent countries | #14 |
| asthma step | #14 |
| detailed questionnaires | #14 |
| breast feeding children | #14 |
| th2 commitment | #14 |
| il15 gene | #14 |
| changing gender | #14 |
| atopic environmental | #14 |
| upper respiratory symptoms | #14 |
| 10‐year‐old children | #14 |
| air challenge | #14 |
| maternal sensitization | #14 |
| allergic sensitization age | #14 |
| burden prevalence | #14 |
| exacerbations fev1 | #14 |
| polymorphisms ormdl3 | #14 |
| introduction complementary food | #14 |
| preventive development | #14 |
| role lung microbiome | #14 |
| untypical | #14 |
| asthma bronchial hyperresponsiveness | #14 |
| farm rural | #14 |
| late introduction | #14 |
| increased risk age | #14 |
| standardised questionnaires | #14 |
| respiratory atopic | #14 |
| fx5 | #14 |
| diseases atopic | #14 |
| delayed introduction solids | #14 |
| asthma1 | #14 |
| incidence rhinitis | #14 |
| farming lifestyle | #14 |
| mrna expression vivo | #14 |
| 3099 | #14 |
| innate infant | #14 |
| symptoms rhinoconjunctivitis | #14 |
| diabimmune study | #14 |
| nocturnal symptoms | #15 |
| skin prick tests | #15 |
| respective tlrs | #15 |
| rhinitis puberty | #15 |
| immunity asthma | #15 |
| allele2 | #15 |
| dogs children | #15 |
| allele evidence | #15 |
| children early | #15 |
| asthma allergy | #15 |
| unpasteurized | #15 |
| factors bronchial | #15 |
| allergy risk | #15 |
| sensitization indoor allergens | #15 |
| children allele | #15 |
| diabimmune | #15 |
| ω3 polyunsaturated | #15 |
| street residence | #15 |
| bronchial hyperreactivity | #15 |
| puberty rhinitis | #15 |
| association asthma symptoms | #15 |
| ahr male mice | #15 |
| bronchial responsiveness children | #15 |
| epidemiological studies exposure | #15 |
| pregnancy protective | #15 |
| 17q21 locus | #15 |
| mold problems | #15 |
| contact farm animals | #15 |
| lung microbiome health | #16 |
| sas institute | #16 |
| 9 11 | #16 |
| association atopy | #16 |
| diseases allergy | #16 |
| allergic diseases childhood | #16 |
| increased food | #16 |
| asthma farm | #16 |
| n1133 | #16 |
| protocadherin1 | #16 |
| microbial environment | #16 |
| nonatopic asthma children | #16 |
| newborn phenotype | #16 |
| endotoxin house | #16 |
| seasonal surveys questionnaires | #16 |
| chronic asthma children | #16 |
| clinical response measures | #16 |
| bacteria respiratory tract | #16 |
| polymorphisms atopy | #16 |
| microbial exposures | #16 |
| childhood asthma asthma | #16 |
| burden childhood asthma | #16 |
| 7 year | #16 |
| 80 chromosomes | #16 |
| asthma asthma risk | #16 |
| wheeze trajectories | #16 |
| exposure atopic | #16 |
| hutterite | #16 |
| multi‐centre study | #16 |
| neuropeptide receptor npsr1 | #17 |
| eczema exposure | #17 |
| pregnancy gene expression | #17 |
| single microbial | #17 |
| allergic asthma aa | #17 |
| epidemiologic dermatitis | #17 |
| levels microbial | #17 |
| animals domestic | #17 |
| age 7 years | #17 |
| child allergic | #17 |
| ga2len skin | #17 |
| function school | #17 |
| aerosol bolus | #17 |
| humans preschool haemophilus | #17 |
| bavarian | #17 |
| asthma environment | #17 |
| munich | #17 |
| asthma associations | #17 |
| asthma immune responses | #17 |
| munich germany | #17 |
| dust extract | #17 |
| factors atopic | #17 |
| rhinoconjunctivitis | #17 |
| persistent sensitization | #17 |
| atopy childhood | #17 |
| asthma biomarkers humans | #17 |
| respiratory health children | #17 |
| asthma 95 | #17 |
| variants increase | #17 |
| 7 yrs | #18 |
| atopy rhinitis | #18 |
| immune adaptation | #18 |
| childrens mattresses | #18 |
| female humans asthma | #18 |
| edna concentrations | #18 |
| polymorphism genetic receptors | #18 |
| cb production | #18 |
| current wheezers | #18 |
| meat children | #18 |
| asthma phenotyping | #18 |
| anthroposophic lifestyle | #18 |
| underlying responses | #18 |
| german populations | #18 |
| asthma exposure | #18 |
| trajectories asthma | #18 |
| pregnancy 6 years | #18 |
| maternallyacquired mice mice | #18 |
| type employment | #18 |
| eczema 95 | #18 |
| maternal contact | #18 |
| phenotypes children | #18 |
| preschool dna ribosomal | #18 |
| protective microbiota | #18 |
| measles infection | #18 |
| col29a1 | #18 |
| ormdl3 gene | #18 |
| asthma 6 years | #18 |
| increase childhood | #18 |
| wheeze | #18 |
| cbmcs | #18 |
| mef75 | #18 |
| children german | #18 |
| birth 13 years | #19 |
| crp levels age | #19 |
| atopic dermatitis studies | #19 |
| tcell phenotypes | #19 |
| cary | #19 |
| arg130gln | #19 |
| seasonal risk | #19 |
| asthma allergy development | #19 |
| viable bacterial counts | #19 |
| disease atopic | #19 |
| asthma bronchiale | #19 |
| receptors innate immune | #19 |
| higher levels endotoxin | #19 |
| susceptibility human | #19 |
| atopy phenotypes | #19 |
| linkage disequilibrium polymorphisms | #19 |
| life exposures | #19 |
| hscrp age | #19 |
| german center | #19 |
| developing asthma | #19 |
| life diversity | #19 |
| poor symptom control | #19 |
| newonset symptoms | #19 |
| sounds risk | #19 |
| rural children | #19 |
| 3 years life | #19 |
| receptors innate | #19 |
| child crosssectional studies | #19 |
| asthma | #19 |
| innate mice models | #19 |
| ilt4 | #19 |
| microbial association networks | #19 |
| expression treg | #19 |
| asthma report | #19 |
| symptoms asthma | #19 |
| farming activities | #19 |
| children current | #19 |
| regulatory tolllike receptor | #19 |
| life asthma risk | #19 |
| school university | #20 |
| mice sod3 | #20 |
| 6 haplotype | #20 |
| gender ratio | #20 |
| inbred balb spores | #20 |
| isaac | #20 |
| infant colonization | #20 |
| breast feeding risk | #20 |
| dermatitis early | #20 |
| specific ige food | #20 |
| atopy snps | #20 |
| symptoms wheeze | #20 |
| unhygienic | #20 |
| life farm | #20 |
| npsr1 nps | #20 |
| stables | #20 |
| unboiled | #20 |
| allergic disease prevalence | #20 |
| adults childhood | #20 |
| pvalues patients | #20 |
| persistent uncontrolled | #20 |
| gene expression measurements | #20 |
| children living | #20 |
| westernized countries | #20 |
| asthma trajectories | #20 |
| disease germany | #20 |
| animal exposure | #20 |
| haplotype studies | #20 |
| asthma nonatopic asthma | #20 |
| farm environments | #20 |
| dust female humans | #20 |
| rora | #21 |
| children east | #21 |
| patients degradation | #21 |
| bifidobacterium colonization | #21 |
| current asthma wheeze | #21 |
| childhood background | #21 |
| asthma review | #21 |
| environmental microbiome | #21 |
| n1062 | #21 |
| pregnancy production | #21 |
| network differences | #21 |
| pseudocroup | #21 |
| eczema atopy | #21 |
| studies eczema | #21 |
| tlr2 receptor | #21 |
| atopic asthma children | #21 |
| environment lifestyle | #21 |
| plasma erythrocyte membranes | #21 |
| turkish children | #21 |
| c589t | #21 |
| farm environment | #21 |
| ige igg4 | #21 |
| children inhaled | #21 |
| gstm1 deficiency | #21 |
| germany humans germany | #21 |
| bhr 95 | #21 |
| prevalence rates symptoms | #21 |
| markers early | #21 |
| hypersensitivity infant | #21 |
| tripeptidylpeptidases | #21 |
| development allergic diseases | #21 |
| unremitting | #21 |
| allergic rhinitis 95 | #22 |
| exposure germany | #22 |
| lower prevalences | #22 |
| neonatal immune responses | #22 |
| 17q21 asthma | #22 |
| samples dust | #22 |
| crth2 th2 cells | #22 |
| seasonal risk factors | #22 |
| lps risk | #22 |
| respiratory diseases children | #22 |
| immune maturation | #22 |
| isaac childhood | #22 |
| living germany | #22 |
| gabriel | #22 |
| β1→3glucans | #22 |
| chromosome asthma | #22 |
| highschool | #22 |
| r753q | #22 |
| feeding obesity | #22 |
| childhood atopy | #22 |
| food diversity | #22 |
| endotoxin house dust | #22 |
| objective sought | #22 |
| muramic acid | #22 |
| alleles asthma | #22 |
| 95 prenatal exposure | #22 |
| npsr1 gene | #22 |
| effective airway | #22 |
| asthmatic phenotypes | #22 |
| traffic counts | #23 |
| child cross | #23 |
| asthma 12 months | #23 |
| microbiota respiratory | #23 |
| association atopic asthma | #23 |
| asthma agents | #23 |
| 7 prevalence | #23 |
| isaac phase | #23 |
| childhood allergies | #23 |
| southern bavaria | #23 |
| children adulthood | #23 |
| nonfarm | #23 |
| farm childhood | #23 |
| gross national | #23 |
| fecal microbiota children | #23 |
| hillerød | #23 |
| breast feeding asthma | #23 |
| bronchial challenge tests | #23 |
| new onset | #23 |
| rapid alternative | #23 |
| single taxa | #23 |
| asthma cats | #23 |
| nonlinear relations | #23 |
| symptoms atopic eczema | #23 |
| asthma aa | #24 |
| allergic dermatitis | #24 |
| tobit regression | #24 |
| phenotypes childhood | #24 |
| children indoor | #24 |
| wheeze symptoms | #24 |
| 2fold risk | #24 |
| west german | #24 |
| doctor diagnosed | #24 |
| asthma cross | #24 |
| countrys | #24 |
| current symptoms | #24 |
| asthma 5 years | #24 |
| haying | #24 |
| allergic respiratory symptoms | #24 |
| eczema susceptibility | #24 |
| asthma prevention | #24 |
| asthma age | #24 |
| gene expression immunity | #24 |
| differences asthma prevalence | #24 |
| dust endotoxin | #24 |
| bronchitis child | #24 |
| asthma early | #24 |
| contact livestock | #24 |
| 4 phenotypes | #24 |
| exposure road traffic | #24 |
| asthma bhr | #24 |
| prevention asthma | #25 |
| farm animals | #25 |
| il13 pathway | #25 |
| methods association | #25 |
| antibiotic year | #25 |
| igg1 ige | #25 |
| risk atopic diseases | #25 |
| 5030 | #25 |
| environmental determinants | #25 |
| sensitization early | #25 |
| cytokines children | #25 |
| exposure paracetamol | #25 |
| car traffic | #25 |
| 2 12 months | #25 |
| expression ige | #25 |
| levels mite | #26 |
| asthma syndrome | #26 |
| sputum eosinophils feno | #26 |
| farms humans | #26 |
| clinical phenotypes children | #26 |
| early atopic | #26 |
| environmental asthma | #26 |
| 3rd year | #26 |
| 5 european countries | #26 |
| early phenotypes | #26 |
| fev1 bhr | #26 |
| microbiota asthma | #26 |
| risk factors probability | #26 |
| allergen sensitisation | #26 |
| risk allergic sensitization | #26 |
| blood samples children | #26 |
| card4 | #26 |
| written questionnaire | #26 |
| trendwise | #26 |
| increased treg | #26 |
| wheezing childhood | #26 |
| child conjunctivitis | #26 |
| asthma childhood | #27 |
| visible mould | #27 |
| respiratory infections year | #27 |
| childhood origins | #27 |
| 9 11 years | #27 |
| association childhood asthma | #27 |
| single snps | #27 |
| specific ige levels | #27 |
| prevalence fever | #27 |
| ilt3 | #27 |
| children parental asthma | #27 |
| children asthma symptoms | #27 |
| consumption raw milk | #27 |
| wheeze childhood | #27 |
| prevention allergic diseases | #27 |
| asthmatic participants | #27 |
| factors year | #27 |
| 035 iu | #27 |
| allergens europe | #27 |
| asthma child cross | #27 |
| npsr1 asthma | #27 |
| asthma environmental | #27 |
| prevalence atopic eczema | #27 |
| muramic | #27 |
| 10 years data | #28 |
| dust children | #28 |
| childhood asthma risk | #28 |
| analysis lca | #28 |
| early identification children | #28 |
| levels sensitization | #28 |
| higher hrqol | #28 |
| host factors infection | #28 |
| pregnancy increase | #28 |
| atopic phenotypes | #28 |
| il13 polymorphisms | #28 |
| ige therapy | #28 |
| immune phenotypes | #28 |
| weekly diaries | #28 |
| recurrence persistence | #28 |
| feno fev1 | #28 |
| east germany | #28 |
| gene asthma | #28 |
| bioair | #29 |
| mite sensitization | #29 |
| questionnaires urban | #29 |
| polymorphisms identified | #29 |
| preschool environmental | #29 |
| farming | #29 |
| centers prevalence | #29 |
| primary prevention asthma | #29 |
| enhanced expression genes | #29 |
| women males | #29 |
| acinetobacter lwoffii | #29 |
| vivo age | #29 |
| polymorphisms il13 | #29 |
| dust indoor | #29 |
| rad50 gene | #29 |
| adult agriculture | #29 |
| anthroposophy | #29 |
| early years life | #29 |
| pblc | #29 |
| pediatric asthma patients | #29 |
| boys asthma | #30 |
| affluent | #30 |
| biodiversity child | #30 |
| dismutase 3 | #30 |
| asthma childhood asthma | #30 |
| viral infections asthma | #30 |
| incidence recurrence | #30 |
| effective ways | #30 |
| il10 snps | #30 |
| centres countries | #31 |
| moisture damage | #31 |
| questionnaires asthma | #31 |
| probability persistence | #31 |
| il10 polymorphisms | #31 |
| ribosomal preschool dna | #31 |
| atopy children | #31 |
| asthma atopic | #31 |
| bronchial obstruction | #31 |
| card4 nod1 | #31 |
| traditional farming | #31 |
| childhood infectious | #31 |
| enhancer marks | #31 |
| atopic food | #31 |
| persons european ancestry | #31 |
| children diagnosed asthma | #31 |
| symptoms childhood | #32 |
| studies dermatitis | #32 |
| germany leipzig | #32 |
| microbial components | #32 |
| prick tests | #32 |
| living environments | #32 |
| atopic diseases | #32 |
| gata3 gene | #32 |
| obese children age | #32 |
| linked polymorphisms | #32 |
| microbial environments | #32 |
| allergic diseases age | #32 |
| transferase deficiency | #32 |
| preschool day | #32 |
| doctordiagnosed | #32 |
| rural regions | #32 |
| association paracetamol | #32 |
| disease childhood | #32 |
| susceptibility asthma | #32 |
| huge burden | #32 |
| african ancestry asthma | #32 |
| asthma odds ratio | #32 |
| cohorts asthma | #32 |
| européens | #32 |
| epidemiology asthma | #32 |
| r2447x | #32 |
| infants countries | #32 |
| multiancestry association | #33 |
| specificity skin tests | #33 |
| immune cell enhancer | #33 |
| genetic epigenesis allergic | #33 |
| eczema prevalence | #33 |
| bhr fev1 | #33 |
| asthma associations loci | #33 |
| allergic genetic epigenesis | #33 |
| multiancestry association study | #33 |
| imputation data | #33 |
| participants questionnaire | #34 |
| year life | #34 |
| bradykinin receptor gene | #34 |
| infant contact | #34 |
| studies dust | #34 |
| participants childhood | #34 |
| development atopy | #34 |
| health utilization children | #34 |
| indoor mould | #34 |
| pattern frequency | #34 |
| new onset symptoms | #34 |
| endotoxins environmental | #34 |
| curve asthma | #34 |
| asthma risk children | #34 |
| dust microbiota | #34 |
| asthma atopic eczema | #34 |
| clec4e | #34 |
| pregnancy maternal health | #34 |
| bacterial farms | #34 |
| tests surveys | #34 |
| mite allergen exposure | #34 |
| fascinating | #34 |
| children cross | #35 |
| tagging polymorphisms | #35 |
| preschool fatty acids | #35 |
| urbanrural differences | #35 |
| feno lung function | #35 |
| 95 atopic dermatitis | #35 |
| western lifestyle | #35 |
| nonatopic mothers | #35 |
| asthma asthma phenotypes | #35 |
| anthroposophic | #35 |
| prick testing | #35 |
| analysis steps | #35 |
| diseases rhinitis | #35 |
| wingedhelix | #35 |
| raw cows milk | #35 |
| endotoxin levels | #35 |
| asthma conjunctivitis | #35 |
| germany haplotypes | #35 |
| western germany | #35 |
| risk asthma | #35 |
| farms female | #35 |
| exposure genetic | #36 |
| asthma dendritic cells | #36 |
| 1 stimulation | #36 |
| chapter 1 epidemiology | #36 |
| leipzig | #36 |
| tolerance biomarkers | #36 |
| prevalence childhood asthma | #36 |
| skin test reactivity | #36 |
| 16s rrna data | #36 |
| maternal exposures | #36 |
| maternal vitamin intake | #36 |
| earlylife exposures | #37 |
| nasal samples | #37 |
| lifestyle environment | #37 |
| asthma candidate | #37 |
| 8263 | #37 |
| allemagne | #37 |
| native milk | #37 |
| incidence persistence | #37 |
| ril33 | #37 |
| case status | #37 |
| itchy | #38 |
| development allergic | #38 |
| endotoxin asthma | #38 |
| ormdl3 expression | #38 |
| mouse model asthma | #38 |
| atopy prevalence | #38 |
| nps npsr1 | #38 |
| foxp3 levels | #38 |
| wisc | #38 |
| life increased | #38 |
| asthma cough | #38 |
| asthma allergens | #38 |
| eczema environmental | #38 |
| dust asthma | #38 |
| association ndvi | #38 |
| allergy birth | #38 |
| maximum expiratory flow | #38 |
| innate immunity genes | #38 |
| reverse causation | #38 |
| recurrence risk factors | #38 |
| amish | #38 |
| haploview | #39 |
| seasonal perennial | #39 |
| levels house | #39 |
| maternal health pregnancy | #39 |
| c589 | #39 |
| diversity environmental | #39 |
| igg nglycosylation | #39 |
| allergic symptoms children | #39 |
| traffic asthma | #39 |
| ige switching | #39 |
| polymorphisms asthma | #39 |
| protect children | #39 |
| genetic rhinitis | #39 |
| degradation patients | #39 |
| adulthood risk factors | #39 |
| wheezing phenotypes | #39 |
| isolated polysaccharides | #40 |
| biodiversity health | #40 |
| eczema | #40 |
| children bronchial | #40 |
| preschool conjunctivitis | #40 |
| antibiotics development | #40 |
| transcription 6 | #40 |
| animal farms | #40 |
| symptoms allergic | #40 |
| mite exposure | #40 |
| crosssectional studies | #40 |
| 4606 | #40 |
| treg cells patients | #41 |
| eczema phenotypes | #41 |
| small airway dysfunction | #41 |
| effects asthma | #41 |
| risk factors health | #41 |
| allergens age | #41 |
| stress young | #41 |
| farm residence | #41 |
| asthma wheeze | #41 |
| discotheques | #41 |
| allergic child | #41 |
| german cities | #41 |
| onset year | #42 |
| dust female | #42 |
| microbiome data | #42 |
| pcdh1 | #42 |
| polymorphism single nucleotide | #42 |
| food questionnaire | #42 |
| bronchiale | #42 |
| 95 antibiotics | #42 |
| international patterns | #42 |
| dermatitis food | #43 |
| sensitized subjects | #43 |
| increased regulatory | #43 |
| asthma onset | #43 |
| worldwide variations | #43 |
| treg th17 cells | #43 |
| asthma food | #43 |
| subspecies infantis | #43 |
| time asthma | #43 |
| prevalence symptoms | #44 |
| sequential switching | #44 |
| diseases childhood | #44 |
| facklamia | #44 |
| microbiome asthma | #44 |
| increased risk symptoms | #44 |
| atopic diseases asthma | #44 |
| gsdma | #44 |
| work overload | #44 |
| national institute allergy | #44 |
| asthma food allergy | #44 |
| asthma cystic fibrosis | #44 |
| atp2a3 | #44 |
| followup physical activity | #44 |
| 97th | #44 |
| early childhood infections | #44 |
| cells cord | #44 |
| developing countries children | #44 |
| wide variations | #44 |
| biodiversity hypothesis | #45 |
| questionnaire responses | #45 |
| dust endotoxins | #45 |
| bamse | #45 |
| animals pregnancy | #45 |
| fever 95 | #45 |
| 7445 | #45 |
| sensitization inhalant | #45 |
| exposure early life | #45 |
| antiasthma drugs | #45 |
| birth 12 months | #45 |
| phenotype respiratory | #45 |
| severe atopic eczema | #45 |
| traffic exposure | #45 |
| farm animal | #46 |
| prevalence bhr | #46 |
| evidence gene | #46 |
| adolescence differences | #46 |
| prevalence current wheeze | #46 |
| spt reactivity | #46 |
| asthma gwas | #46 |
| asthma cluster | #46 |
| improvement reduction | #46 |
| atopic diseases children | #46 |
| control physical | #46 |
| receptor tolllike receptors | #46 |
| prevalence diseases | #46 |
| humans hygiene | #46 |
| efraim | #47 |
| tirana | #47 |
| germany east | #47 |
| wheeze phenotypes | #47 |
| analysis step | #47 |
| factors asthma | #47 |
| international study | #47 |
| franche | #47 |
| 95 eczema | #47 |
| prevalence rhinoconjunctivitis | #47 |
| children atopic disease | #47 |
| airways diseases | #48 |
| cluster children | #48 |
| doctordiagnosed asthma | #48 |
| frequent wheeze | #48 |
| polymorphisms il4 | #48 |
| parental interviews | #48 |
| asthma adjusted | #48 |
| lung function spirometry | #48 |
| asthma biological | #48 |
| prevalences asthma | #48 |
| fungal flora | #48 |
| halle | #48 |
| breath volatile | #48 |
| wheeze age | #48 |
| asthma risk loci | #48 |
| perennial allergens | #48 |
| fcer1a | #49 |
| milk farm | #49 |
| risk factors incidence | #49 |
| children paracetamol | #49 |
| chromosome susceptibility | #49 |
| children female humans | #49 |
| n228 | #49 |
| unpasteurized milk | #50 |
| pcrsscp | #50 |
| diversity food | #50 |
| bacterial markers | #50 |
| exposures asthma | #50 |
| background atopic | #50 |
| beta13glucans | #50 |
| physiciandiagnosed | #50 |
| longum subsp infantis | #50 |
| children cities | #51 |
| igg1 igg4 | #51 |
| asthma maternal | #51 |
| allergy symptoms | #51 |
| populationattributable risk | #51 |
| lwoffii | #51 |
| asthma dust | #51 |
| association allergic | #51 |
| maintenant | #51 |
| common chronic disease | #51 |
| conjugated mice mice | #51 |
| country prevalence | #51 |
| identified polymorphisms | #51 |
| association atopic dermatitis | #51 |
| microbial burden | #51 |
| eczema childhood | #52 |
| ige sige | #52 |
| geneenvironment interactions | #52 |
| bmi asthma | #52 |
| sensitization children | #52 |
| gpra | #52 |
| wheeze cough | #52 |
| epidemiologischen | #52 |
| milk consumption | #52 |
| prevalence wheeze | #52 |
| 9357 | #52 |
| doctor diagnosis | #52 |
| specific protective | #52 |
| infant study | #52 |
| age wheezing | #52 |
| indoor endotoxin | #52 |
| itchy rash | #52 |
| outdoor pollution | #53 |
| adam33 asthma | #53 |
| children current asthma | #53 |
| ige children | #53 |
| life exposure | #53 |
| atopic eczema children | #53 |
| 2q32 | #53 |
| il13 gene | #53 |
| early life exposure | #53 |
| estonian children | #54 |
| nonmicrobial | #54 |
| cross sectional studies | #54 |
| animals asthma | #54 |
| male prevalence | #54 |
| asthma odds | #54 |
| female germany life | #54 |
| prevalence wheezing | #54 |
| stepwise procedure | #55 |
| bacterial microbiota | #55 |
| prevalence association | #55 |
| samples farm | #55 |
| cough wheeze | #55 |
| year asthma | #55 |
| cd14 tolllike receptor | #56 |
| alex study | #56 |
| strong protective | #56 |
| tuberculosis notification | #56 |
| adult asthma patients | #56 |
| immunoglobulin interleukin13 | #56 |
| maternal ige | #56 |
| asthma atopy | #56 |
| random samples | #56 |
| atopy development | #56 |
| visible mold | #56 |
| pollutant exposure | #57 |
| member 1 polymorphism | #57 |
| diseases methods | #57 |
| derp1 | #57 |
| 3785 | #57 |
| life atopic dermatitis | #57 |
| mononuclear lipid | #57 |
| eczema flg | #57 |
| adam33 polymorphisms | #57 |
| mef50 | #57 |
| prevention allergic | #57 |
| atopy wheeze | #57 |
| asthma allergic rhinoconjunctivitis | #57 |
| diseases children | #58 |
| total serum | #58 |
| hypersensitivity immunoglobulin | #58 |
| specificity asthma | #58 |
| stat6 gene | #58 |
| early asthma | #58 |
| eczema female | #58 |
| reported parents | #58 |
| th17 lineage | #59 |
| farm families | #59 |
| milk cla | #59 |
| 1q31 | #59 |
| 6 years age | #59 |
| finland estonia | #59 |
| german participants | #59 |
| asthma morbidity children | #59 |
| development childhood | #60 |
| allergic surveys | #60 |
| rna yield | #60 |
| beta 2agonists | #60 |
| birth school age | #60 |
| preschool wheezing | #60 |
| iedap | #60 |
| predictors incidence | #60 |
| implicated genes | #61 |
| seasonal skin tests | #61 |
| species colonization | #61 |
| exposure asthma | #61 |
| breastfed children | #61 |
| atopy eczema | #61 |
| estonia finland | #62 |
| immunoglobulin infant | #62 |
| large german | #62 |
| childhoodonset asthma | #62 |
| respiratory sounds | #62 |
| asthma birth | #62 |
| persistence asthma | #62 |
| development airway hyperresponsiveness | #62 |
| life immune | #62 |
| hyperreactivity bronchial | #63 |
| indoor allergen exposure | #63 |
| exposure assessed | #63 |
| dermatitis risk | #63 |
| cystic fibrosis abpa | #63 |
| children regions | #63 |
| total quantity | #63 |
| atopic | #63 |
| asthma breast | #63 |
| children role | #63 |
| endotoxin level | #63 |
| helminth ascariasis ascaris | #64 |
| newborn lymphocyte | #64 |
| allergenspecific ige | #64 |
| dust parameters | #64 |
| children centers | #64 |
| no2 benzene | #64 |
| differential networks | #64 |
| childhood allergic diseases | #65 |
| animal contact | #65 |
| healthy controls children | #65 |
| risk wheezing | #65 |
| dust extracts | #66 |
| atopic symptoms | #66 |
| allergic rhinitis age | #66 |
| sensitization allergic | #66 |
| prevalence current asthma | #66 |
| living area | #66 |
| preschool haemophilus humans | #66 |
| immunological data | #66 |
| ga²len | #66 |
| umc | #66 |
| respiratory allergies | #67 |
| 2 questionnaires | #67 |
| pa obesity | #67 |
| ige expression | #67 |
| maternal atopy | #67 |
| biomarkers predictors | #67 |
| weight boys | #68 |
| early wheeze | #68 |
| antibiotic sales | #68 |
| mère | #68 |
| ige allergens | #69 |
| atopic disease children | #70 |
| asthma complex | #70 |
| sod3 | #70 |
| hypersensitivity immunization | #70 |
| suisse | #70 |
| gene gene interaction | #70 |
| allergic disorders | #70 |
| occurrence progression | #71 |
| allergic sensitization children | #71 |
| atopic rhinitis | #71 |
| barns | #71 |
| prenatal vitamin | #71 |
| small airway function | #71 |
| unprocessed | #71 |
| breathomics | #71 |
| tlr2 tlr1 | #71 |
| association occupational exposure | #72 |
| persistent asthma children | #72 |
| infantis | #72 |
| 158 95 | #72 |
| children wheeze | #72 |
| molecular fingerprinting | #72 |
| factor asthma | #72 |
| european ancestry association | #73 |
| sounds respiratory | #73 |
| onset allergic | #73 |
| gni | #73 |
| ormdl3 | #73 |
| west humans | #74 |
| food allergy asthma | #74 |
| severe eczema | #74 |
| exposure europe | #74 |
| risk wheeze | #74 |
| health services children | #74 |
| children hrqol | #75 |
| standardized procedure | #75 |
| total serum ige | #75 |
| maternal immunity | #75 |
| rfel | #75 |
| chromosome 17q21 | #75 |
| asthma genome | #75 |
| asthmatic mothers | #75 |
| food inhalant | #76 |
| rural differences | #76 |
| microbial molecules | #76 |
| wheezing | #76 |
| asthma case | #76 |
| allergy childhood | #76 |
| symptoms eczema | #76 |
| eczema children | #76 |
| sexspecific association | #77 |
| hyperresponsiveness bhr | #77 |
| diversity microbial | #77 |
| 9 mmp9 | #77 |
| asthma healthy | #77 |
| childhood | #78 |
| edta tubes | #78 |
| blood cytokines | #78 |
| turkish origin | #78 |
| rhinitis atopic | #78 |
| wheezing illnesses | #78 |
| mothers asthma | #78 |
| 6399 | #78 |
| findings prevalence | #78 |
| years odds | #78 |
| sensitisation children | #78 |
| neuropeptide receptor | #79 |
| milk yoghurt | #79 |
| seasonal asthma | #79 |
| 95 protection | #79 |
| genes innate immunity | #79 |
| interactions snps | #79 |
| ige skin | #80 |
| dander | #80 |
| cats child | #80 |
| symptoms 12 | #81 |
| prevalence respiratory | #81 |
| development atopic dermatitis | #81 |
| microbial agents | #81 |
| childhood wheeze | #81 |
| forkhead box protein | #81 |
| lower prevalence | #81 |
| children european | #82 |
| laryngitis | #82 |
| concentrations so2 | #82 |
| 13 14 | #82 |
| bacterial viral infections | #82 |
| age 45 | #82 |
| age prevalence | #82 |
| introduction solids | #82 |
| ribosomal pcr | #82 |
| total fat content | #83 |
| children siblings | #83 |
| hypersensitivity risk | #83 |
| study population patients | #83 |
| study pcr | #83 |
| current wheezing | #83 |
| gut commensals | #83 |
| cleanliness | #83 |
| microbial stimulation | #83 |
| reporter genetic predisposition | #83 |
| specific exposures | #84 |
| 4732 | #84 |
| oligoarticular juvenile | #84 |
| tests child | #84 |
| new asthma | #84 |
| control pa | #84 |
| atopy risk | #85 |
| single nucleotide rna | #85 |
| bronchial responsiveness | #85 |
| n134 | #85 |
| européenne | #85 |
| α1 antitrypsin | #85 |
| children feeding | #86 |
| ige levels | #86 |
| truck traffic | #86 |
| infant inflammation | #86 |
| hyper responsiveness | #86 |
| wheeze prevalence | #86 |
| bifidobacterium species | #86 |
| arabinogalactan | #86 |
| comté | #86 |
| influential factors | #87 |
| 95 fever | #87 |
| genes asthma | #87 |
| exposure associations | #87 |
| age asthma | #87 |
| analysis respiratory | #87 |
| visits asthma | #87 |
| allergy tests | #88 |
| pollution allergens | #88 |
| asthma polymorphisms | #88 |
| rhinitis risk | #88 |
| tolllike receptors tlrs | #88 |
| exposure tobacco smoke | #88 |
| rphl | #89 |
| bronchial hyper | #89 |
| asthma children | #89 |
| asthma phenotypes | #89 |
| aged 6 | #89 |
| critical time window | #90 |
| children area | #90 |
| allergic seasonal surveys | #90 |
| current exposure | #90 |
| joint workshop | #91 |
| development eczema | #91 |
| filaggrin mutations | #91 |
| newborn limit | #91 |
| asthma school | #91 |
| newborn leukocytes | #91 |
| sensitisation | #92 |
| mononuclear polymorphism | #92 |
| allergic rhinitis symptoms | #93 |
| previous studies association | #93 |
| south germany | #93 |
| rs2305480 | #93 |
| geführt | #93 |
| preschool haemophilus | #93 |
| east west germany | #93 |
| experimental asthma | #93 |
| low levels exposure | #93 |
| pertussis infection | #94 |
| tregulatory cells | #94 |
| zpbp2 | #94 |
| asthma loci | #95 |
| greater consumption | #95 |
| asthma common | #95 |
| nickel allergy | #95 |
| fed children | #95 |
| 16q12 | #95 |
| university life | #95 |
| international variation | #95 |
| eczema symptoms | #95 |
| expression toll | #95 |
| dust environmental | #96 |
| expression th1 | #96 |
| airway dysfunction | #96 |
| anaphylaxie | #96 |
| dysbalance | #96 |
| onset wheeze | #96 |
| allergic sensitisation | #96 |
| trigger factors | #96 |
| lps recognition | #96 |
| nonfarmers | #96 |
| cumulative prevalence | #96 |
| inhalant allergens | #97 |
| schoolchildren aged | #97 |
| 95 overweight | #97 |
| indoor factors | #97 |
| city air | #97 |
| regulatory treg | #97 |
| seasonal sensitivity | #98 |
| factors school | #98 |
| children germany | #98 |
| age 3 years | #98 |
| background asthma | #98 |
| childhood adulthood | #98 |
| tlr1 tlr2 | #98 |
| earlyonset asthma | #99 |
| seasonal surveys | #99 |
| comprehensive questionnaire | #99 |
| rural school | #99 |
| asthma inflammation | #99 |
| current wheeze | #99 |
| years aor | #99 |
| children atopic | #99 |
| eastern germany | #99 |
| isaac questionnaire | #100 |
| childhood atopic dermatitis | #100 |
| preschool crosssectional studies | #100 |
| summarised | #101 |
| mef25 | #101 |
| weight girls | #101 |
| genetic factors susceptibility | #101 |
| expression measurements | #101 |
| raw cow | #101 |
| retinoid acid | #102 |
| effects respiratory | #102 |
| ige concentrations | #102 |
| factors wheezing | #102 |
| risk factors persistence | #102 |
| tenascin tnc | #102 |
| irf1 gene | #103 |
| sensitization eczema | #103 |
| 4264 | #103 |
| children increased risk | #103 |
| hdm exposure | #103 |
| years early | #103 |
| exposure milk | #104 |
| children relation | #104 |
| sensitization childhood | #104 |
| hutterites | #105 |
| arabinogalactans | #105 |
| high‐sensitivity | #105 |
| hyperreactivity | #105 |
| pollen concentration | #105 |
| physiciandiagnosed asthma | #106 |
| questionnaires switzerland | #106 |
| children contact | #106 |
| animal dander | #106 |
| wheezing disorders | #106 |
| blood ige | #106 |
| prevalence atopy | #106 |
| detailed questionnaire | #107 |
| underlying factor | #107 |
| puberty age | #107 |
| socs4 | #107 |
| breast feeding | #108 |
| overweight 95 | #108 |
| inverse associations | #108 |
| fever episodes | #108 |
| complex syndrome | #109 |
| healthy children children | #109 |
| moulds | #109 |
| allergic perennial rhinitis | #109 |
| asthma wheezing | #109 |
| publication air pollution | #109 |
| air pollution children | #109 |
| genotype germany | #110 |
| atopic eczema humans | #110 |
| folgenden | #110 |
| female germany | #110 |
| p≤003 | #110 |
| rs7216389 | #110 |
| il4ra | #111 |
| parental questionnaire | #111 |
| milk samples | #112 |
| olive pollen | #112 |
| tbox transcription factor | #112 |
| 1314 | #112 |
| female histones | #112 |
| environmental study | #112 |
| flg variants | #113 |
| phenotypes asthma | #113 |
| risk allergic | #113 |
| allergic | #113 |
| indoor asthma | #113 |
| experimental allergic asthma | #113 |
| allergic disease | #114 |
| occupational allergy | #114 |
| parent reported | #114 |
| mould exposure | #114 |
| tests bronchial | #114 |
| challenge data | #114 |
| asthma sensitization | #114 |
| foxp3 locus | #115 |
| cord blood ige | #115 |
| increased diversity | #115 |
| notification rates | #115 |
| cough children | #115 |
| igg4 responses | #115 |
| immune responsiveness | #116 |
| regulatory th17 | #116 |
| aged 9 | #116 |
| exclusive breast feeding | #116 |
| psychosocial characteristics | #117 |
| children underwent | #117 |
| glutathione transferase gst | #117 |
| skinprick tests | #118 |
| living rural | #118 |
| reference children | #118 |
| west germany | #118 |
| germany humans | #118 |
| allergic sensitization | #118 |
| indoor microbial | #118 |
| ratio prevalence | #118 |
| ancestry asthma | #119 |
| children wheezing | #119 |
| delayed introduction | #119 |
| switching immunoglobulin | #119 |
| skin prick | #119 |
| levels endotoxin | #120 |
| association chromosome | #120 |
| fibrolysis | #120 |
| childhood risk factors | #120 |
| environment children | #120 |
| lung function measurements | #121 |
| common aeroallergens | #121 |
| dampness | #121 |
| allergens asthma | #121 |
| factors rural | #121 |
| vitamin supplementation pregnancy | #121 |
| symptom control | #121 |
| aliments | #121 |
| life early | #122 |
| preventive potential | #122 |
| 300 people | #122 |
| tlr10 | #122 |
| hayfever | #123 |
| frequency pattern | #123 |
| urban traffic | #123 |
| passive smoke exposure | #124 |
| severe eosinophilic asthma | #124 |
| active asthma | #124 |
| germany prevalence | #124 |
| atopic manifestations | #124 |
| common inhalant | #125 |
| potted plants | #125 |
| immunologic tolllike receptor | #125 |
| il18r1 | #125 |
| eczema patients | #126 |
| await | #126 |
| prevalence allergic diseases | #126 |
| paediatric studies | #126 |
| effects prevalence | #126 |
| 3 infections | #126 |
| asthma background | #126 |
| exposure pets | #126 |
| sensitization development | #126 |
| allergens child | #127 |
| 95 ors | #127 |
| prävalenz | #127 |
| test reactivity | #127 |
| environmental allergens | #127 |
| exposure endotoxin | #127 |
| caspase recruitment domain | #127 |
| adaptive cells | #127 |
| parent questionnaire | #127 |
| bdnf polymorphisms | #128 |
| receptors male | #129 |
| bdnf gene | #129 |
| microbial markers | #129 |
| medall | #130 |
| hypersensitivity respiratory | #131 |
| severe eosinophilic | #131 |
| asthma objective | #131 |
| factors allergens | #131 |
| sensitization allergens | #131 |
| protein allergy | #131 |
| common allergens | #131 |
| test study | #131 |
| respiratory symptoms children | #131 |
| expression receptors | #132 |
| effects development | #132 |
| male occupational | #132 |
| asthma adolescent | #132 |
| immunoglobulin inflammation | #132 |
| diseases asthma | #132 |
| bavaria | #133 |
| early age | #133 |
| pollen prevalence | #133 |
| understanding natural | #133 |
| age 7 | #133 |
| 7 years age | #134 |
| allergy | #134 |
| dpp10 | #134 |
| body composition bmi | #135 |
| 95 ages | #135 |
| childhood risk | #135 |
| prevalence rhinitis | #135 |
| crth2 | #135 |
| asthma young | #136 |
| eczema risk | #136 |
| allergic phenotype | #136 |
| bronchial response | #136 |
| 60 iu | #136 |
| exposure children | #137 |
| snps asthma | #137 |
| actinomycetes | #137 |
| ms4a2 | #137 |
| mechanisms asthma | #137 |
| ga2len | #137 |
| 6 7 | #137 |
| pollutants allergens | #138 |
| mattress | #138 |
| reduced prevalence | #138 |
| sensitized children | #138 |
| snps interactions | #138 |
| asthma development | #138 |
| asthma atopic dermatitis | #138 |
| régions | #138 |
| sebacate | #139 |
| listeria spp | #139 |
| serum ige | #139 |
| milk animals | #139 |
| 3 14 | #139 |
| allergen levels | #139 |
| pollution asthma | #139 |
| pasture | #140 |
| largest reduction | #140 |
| exposure symptoms | #140 |
| duration type | #140 |
| tregs foxp3 | #140 |
| microbiota children | #140 |
| asthma genes | #141 |
| exposure indoor | #141 |
| age 6 years | #141 |
| indoor allergens | #142 |
| factors difference | #142 |
| cla content | #142 |
| asthma bronchitis | #142 |
| questionnaires illness surveys | #142 |
| n183 | #142 |
| susceptibility children | #142 |
| unifrac | #143 |
| pregnancy early | #143 |
| asthma defined | #144 |
| snps chromosome | #144 |
| pet exposure | #144 |
| replication association | #144 |
| exposure year | #144 |
| incident asthma | #144 |
| inconclusive | #144 |
| dermatitis asthma | #145 |
| children allergy | #145 |
| expositions | #145 |
| onset menarche | #145 |
| lower airways | #146 |
| allergy testing | #146 |
| interleukin13 interleukin4 | #146 |
| prematurely born children | #146 |
| airway mechanics | #146 |
| prevalence skin | #146 |
| health outcomes children | #146 |
| study centers | #147 |
| original article | #147 |
| biomarkers child | #147 |
| germany west | #148 |
| feno patients | #148 |
| children 6 | #148 |
| association early | #148 |
| early immune | #149 |
| atopic outcomes | #149 |
| indoor allergen | #149 |
| perennial rhinitis allergic | #150 |
| fall fev1 | #150 |
| pregnancy respiratory | #150 |
| profound differences | #151 |
| confer protection | #151 |
| wheeze children | #151 |
| wheezing children | #151 |
| 105 years | #151 |
| prevalence childhood | #151 |
| established asthma | #152 |
| immunomodulatory molecules | #152 |
| consumption dairy products | #152 |
| bhr | #152 |
| distribution asthma | #152 |
| children review | #152 |
| environmental exposure | #152 |
| exposure increased | #152 |
| asthma dermatitis | #153 |
| hens egg | #153 |
| wheeze asthma | #153 |
| tagging single | #153 |
| common respiratory | #153 |
| function measurements | #153 |
| hormonal factors | #154 |
| cd28null | #154 |
| onset association | #155 |
| neighboring countries | #155 |
| tests sex factors | #155 |
| bronchial challenge | #155 |
| association asthma | #156 |
| atopic children | #156 |
| neu5gc | #157 |
| development allergy | #157 |
| absolute levels | #157 |
| positive spt | #157 |
| gene 3 | #157 |
| severity frequency | #157 |
| bacterial lysates | #158 |
| lower diversity | #158 |
| early environmental | #158 |
| asthma females | #158 |
| paediatric asthma | #158 |
| children asthma | #159 |
| developing immune | #159 |
| patients controlled asthma | #159 |
| prevention allergy | #159 |
| allergic seasonal | #160 |
| children rhinitis | #160 |
| reported prevalence | #160 |
| german adults | #160 |
| microbiome diversity | #160 |
| children homes | #160 |
| spts | #160 |
| preventive measure | #161 |
| asthma presence | #161 |
| wheeze rhinitis | #161 |
| atopy asthma | #161 |
| newborn longitudinal | #161 |
| female humans allergic | #162 |
| children lower | #162 |
| immune pathways | #162 |
| parental asthma | #162 |
| perennial rhinitis | #163 |
| exposure prevalence | #163 |
| environmental associations | #163 |
| specific ige | #163 |
| kindl | #164 |
| sscp | #164 |
| sensitised | #164 |
| atopic dermatitis | #165 |
| asthma ige | #165 |
| atopic eczema | #165 |
| children sensitized | #165 |
| 5q31 | #166 |
| illness surveys questionnaires | #166 |
| feeding child | #166 |
| ige asthma | #166 |
| epidemiologie | #166 |
| infant respiratory | #166 |
| preschool cross | #167 |
| studies exposure | #167 |
| adolescent allergens | #167 |
| disease life | #167 |
| air pollutant concentrations | #167 |
| preadolescent children | #167 |
| year children | #168 |
| current asthma | #168 |
| years lung | #168 |
| regulatory treg cells | #169 |
| stratification patients | #169 |
| workplace young | #169 |
| 2688 | #169 |
| airway size | #169 |
| chronic inflammatory disease | #170 |
| inhalant | #171 |
| nucleotide rna | #171 |
| aged 13 | #171 |
| sensitization pollen | #171 |
| adolescent analysis | #171 |
| skin prick test | #172 |
| ifnγ levels | #172 |
| studien | #172 |
| nucleotide pregnancy | #172 |
| prevalence current | #172 |
| endotoxins female | #172 |
| sheds | #172 |
| risk score model | #173 |
| unifying concept | #173 |
| antipyretics | #174 |
| risk atopy | #174 |
| patients nocturnal | #175 |
| female humans questionnaires | #175 |
| small airway | #175 |
| mice asthma | #175 |
| repeated infections | #176 |
| asthma attack | #176 |
| sensitization common | #176 |
| school level | #176 |
| serine protease inhibitor | #176 |
| wheezers | #177 |
| sensitization pattern | #177 |
| life respiratory function | #177 |
| situ hybridization infant | #177 |
| sensitization asthma | #178 |
| aa patients | #178 |
| 9p24 | #178 |
| childhood infections | #178 |
| genetic severity | #178 |
| nocturnal asthma | #179 |
| standardized methodology | #179 |
| childhood adolescence | #179 |
| objective measurements | #179 |
| w12 | #179 |
| traffic characteristics | #179 |
| sputum neutrophils | #179 |
| studies environmental | #179 |
| socks | #180 |
| asthma genetic | #180 |
| breastfed infant | #180 |
| environmental predictors | #181 |
| bacterial count | #181 |
| mattresses | #181 |
| children environmental | #181 |
| lung function testing | #181 |
| vitamin asthma | #182 |
| immunemediated diseases | #182 |
| dermatitis children | #182 |
| differences hrqol | #182 |
| dust levels | #182 |
| children levels | #183 |
| vocational training | #183 |
| tlr signaling | #183 |
| german population | #183 |
| environmental microbiology | #183 |
| exposure humans | #183 |
| mögliche | #183 |
| incidence allergic | #185 |
| life prevalence | #185 |
| school district | #185 |
| work asthma | #186 |
| protein child | #187 |
| asthma body | #188 |
| tests children | #188 |
| environmental exposures | #188 |
| qpcrs | #188 |
| development allergic disease | #188 |
| selfselection | #188 |
| childhood early adulthood | #188 |
| tlr genes | #189 |
| jf1 | #189 |
| inversely | #190 |
| bacterial groups | #190 |
| association antibiotic | #190 |
| mother pregnancy | #190 |
| muscle mass patients | #190 |
| type duration | #190 |
| wheezing age | #190 |
| early wheezing | #190 |
| atopic dermatitis children | #191 |
| cd14 gene | #191 |
| blood gene | #191 |
| dry cough | #191 |
| adjusted irr | #192 |
| pyroglyphidae | #192 |
| longum subsp | #192 |
| cε | #193 |
| model allergic | #193 |
| adam33 | #193 |
| milk serum | #193 |
| eosinophilic asthma | #195 |
| prevalence severity | #195 |
| estonian | #195 |
| caspase recruitment | #196 |
| enthusiasm | #197 |
| review asthma | #197 |
| germany switzerland | #197 |
| earlylife | #198 |
| questionnaire data | #198 |
| decreased prevalence | #199 |
| representative population | #199 |
| rhinitis eczema | #199 |
| upper lower airways | #200 |
| complex interplay | #202 |
| bacteria role | #202 |
| allergy infectious diseases | #202 |
| bronchial hyperresponsiveness bhr | #203 |
| patients europe | #203 |
| paediatrician | #203 |
| patients aa | #204 |
| difference prevalence | #204 |
| phenotyped | #204 |
| 13 years age | #205 |
| dermatitis atopic | #205 |
| amebocyte | #205 |
| new locus | #205 |
| 3034 | #206 |
| allergen specific | #206 |
| asthma respiratory symptoms | #207 |
| factors atopy | #207 |
| asthma methods | #207 |
| male phenotype | #208 |
| allergic asthmatics | #208 |
| diagnosed asthma | #208 |
| karelia | #208 |
| studies germany | #208 |
| prevalence obesity | #209 |
| sensitization age | #209 |
| higher diversity | #209 |
| glycolylneuraminic acid | #209 |
| col4a3 | #209 |
| studies cytokines | #209 |
| innate adaptive immunity | #209 |
| newborn logistic | #209 |
| symptoms children | #210 |
| bhr asthma | #210 |
| core microbiome | #210 |
| epithelial barrier function | #210 |
| bronchial provocation | #210 |
| influence development | #211 |
| exposure sensitization | #211 |
| cats dogs | #211 |
| low prevalence | #211 |
| tlr4 cd14 | #212 |
| asthma allergic | #212 |
| methodssubjects | #212 |
| asthma animals | #212 |
| birth 6 | #212 |
| atopic dermatitis asthma | #212 |
| patients uncontrolled asthma | #213 |
| 1872 | #213 |
| exposure allergens | #213 |
| distinct clusters | #213 |
| cohort methods | #213 |
| 00035 | #214 |
| prevalence allergic | #214 |
| reverse causality | #214 |
| asthma allergic diseases | #214 |
| rural environment | #214 |
| expression cd14 | #214 |
| workplace exposure | #214 |
| life allergic | #215 |
| mast cell chymase | #216 |
| obesity overweight | #216 |
| regulatory responses | #216 |
| il2rb | #218 |
| atopic female | #218 |
| disinfectants | #219 |
| child dna | #219 |
| microbial products | #219 |
| geneticist | #219 |
| causation | #219 |
| allergy development | #220 |
| steiner | #220 |
| variants asthma | #220 |
| pierced | #220 |
| schistosoma schistosomiasis | #221 |
| method participants | #221 |
| homogenised | #221 |
| increased asthma | #222 |
| sensitization rates | #222 |
| 90 children | #222 |
| environmental epidemiology | #223 |
| symptoms baseline | #223 |
| groups asthma | #224 |
| german study | #225 |
| sibship size | #225 |
| sensitization allergen | #226 |
| alpha1 antitrypsin | #226 |
| conjunctivitis allergic | #226 |
| german | #226 |
| school age | #227 |
| provocative concentration | #227 |
| lung health | #228 |
| allergic diseases asthma | #228 |
| data asthma | #228 |
| specific stimulation | #228 |
| 95 obesity | #228 |
| test spt | #228 |
| road traffic | #229 |
| healthy worker | #229 |
| understanding asthma | #229 |
| wheezing asthma | #229 |
| tuberculosis prevalence | #229 |
| cord blood cells | #230 |
| asthma allergic rhinitis | #230 |
| butyryl | #230 |
| umwelt | #230 |
| asthma phenotype | #230 |
| allergy prevention | #231 |
| cord blood cb | #231 |
| 20 fall | #232 |
| health variables | #232 |
| nonallergic asthma | #232 |
| subgroup children | #232 |
| discontent | #232 |
| living conditions | #232 |
| innate leukocytes | #233 |
| prevalence overweight | #233 |
| lively | #233 |
| complementary food | #234 |
| hyperreactive | #234 |
| dermatophagoides pteronyssinus | #234 |
| fourth grade | #235 |
| n144 | #235 |
| levels asthma | #236 |
| resequenced | #236 |
| exposure pregnancy | #236 |
| specific allergen | #236 |
| puberty girls | #238 |
| finland france | #238 |
| strategies prevention | #239 |
| incidence asthma | #239 |
| neutrophilic asthma | #240 |
| preschool cytokines | #241 |
| regulatory th1 | #242 |
| age exposure | #243 |
| th2 immunity | #243 |
| immune development | #243 |
| receptor 1 | #245 |
| adjusted odds ratio | #245 |
| adaptor protein polymorphism | #245 |
| muropeptides | #246 |
| fungal dna ribosomal | #246 |
| fever asthma | #247 |
| role development | #247 |
| nasal microbiota | #247 |
| prick test | #247 |
| patients healthcare | #248 |
| children analysis | #248 |
| factors allergic | #249 |
| class analysis | #249 |
| baseline incidence | #249 |
| clinical science | #250 |
| therapy severe | #250 |
| biological therapy | #251 |
| tlr2 gene | #251 |
| communism | #252 |
| cold air | #253 |
| china factors | #253 |
| contact animals | #253 |
| asthma symptoms | #253 |
| hormonal influences | #254 |
| lowgrade inflammation | #255 |
| atopic disease | #255 |
| preschool dermatitis | #256 |
| h4 acetylation | #256 |
| low pa | #256 |
| human asthma | #257 |
| 454pyrosequencing | #257 |
| body mass children | #257 |
| adolescent asthma | #257 |
| association expression | #258 |
| niaid | #258 |
| airborne fungi | #259 |
| epidemiological studies | #259 |
| prediction quality | #259 |
| 2051 | #260 |
| rhinitis allergic | #260 |
| life symptoms | #260 |
| age 6 | #260 |
| life asthma | #260 |
| exposure early | #260 |
| discriminate | #261 |
| early life | #261 |
| eczema atopic | #261 |
| westernization | #261 |
| interferon expression | #262 |
| utilization health services | #262 |
| spink5 | #262 |
| physician diagnosed | #263 |
| milk pregnancy | #263 |
| alpha1antitrypsin | #263 |
| protein 15 | #263 |
| development immune | #263 |
| children associations | #264 |
| tightly linked | #265 |
| latex sensitization | #265 |
| exposure traffic | #265 |
| indoor exposures | #265 |
| nox concentrations | #266 |
| increase asthma | #266 |
| early work | #267 |
| settled dust | #267 |
| age 13 years | #267 |
| pollen sensitization | #268 |
| prick | #269 |
| fever children | #269 |
| rhinitis | #269 |
| hypersensitivity immune | #270 |
| allergen extracts | #270 |
| symptom prevalence | #270 |
| conditions asthma | #271 |
| relation body mass | #272 |
| child chromosomes | #272 |
| study centres | #273 |
| dipeptidyl peptidases | #273 |
| asthma control patients | #274 |
| objective markers | #274 |
| inflammatory properties | #275 |
| exposure female | #276 |
| host microbiome | #276 |
| dust samples | #277 |
| male microbiota | #277 |
| future asthma | #277 |
| extracellular polysaccharides | #277 |
| increased exposure | #278 |
| study birth | #279 |
| hire | #280 |
| tests allergens | #280 |
| remedy | #280 |
| questionnaires adolescent | #281 |
| child dermatitis | #282 |
| adolescent animals | #282 |
| 6 years | #282 |
| allergies asthma | #282 |
| collection methods | #284 |
| randomeffects | #284 |
| impulse oscillometry | #284 |
| population burden | #285 |
| 17 children | #285 |
| allergic symptoms | #286 |
| tests respiratory | #287 |
| differences asthma | #287 |
| cells ilc2s | #287 |
| gg 95 | #288 |
| geometric ratio | #288 |
| hdms | #289 |
| pollution air | #289 |
| epidemiological surveys | #289 |
| risk factors children | #290 |
| data normalization | #290 |
| role asthma | #290 |
| asthma increased | #291 |
| allergic manifestations | #291 |
| eczema food | #292 |
| asthma factors | #292 |
| allergic perennial | #293 |
| environnement | #293 |
| longitudinal cohort study | #293 |
| cohort participants | #293 |
| recruitment domain | #293 |
| answered | #293 |
| indoor exposure | #293 |
| exposure environmental | #293 |
| asthma data | #294 |
| cbmc | #294 |
| mucosal surfaces | #296 |
| pollution respiratory | #297 |
| smoke pollution | #297 |
| bifidobacterium | #298 |
| global synthesis | #298 |
| obesity asthma | #299 |
| nonatopic | #299 |
| unification | #299 |
| exposure benzene | #299 |
| paxgene | #299 |
| exposure allergic | #299 |
| infancy development | #300 |
| risk allergy | #303 |
| asthma drugs | #306 |
| analysis phase | #307 |
| lumbricoides | #307 |
| reported association | #307 |
| antigens dermatophagoides | #308 |
| severe exacerbations | #308 |
| mucosal microbiota | #309 |
| messenger tlymphocytes | #309 |
| 2623 | #309 |
| ige sensitization | #309 |
| neonatal immune | #309 |
| exposure childhood | #309 |
| factors early | #311 |
| controlled asthma | #311 |
| midexpiratory | #312 |
| atopic march | #312 |
| birth cohort studies | #312 |
| allergy age | #313 |
| asthma inflammatory | #313 |
| signal transducer activator | #314 |
| skin examination | #314 |
| variance animals antigens | #315 |
| jusqu | #315 |
| genotyping data | #315 |
| bacillus spores | #315 |
| 2 toll | #316 |
| independent study | #316 |
| older siblings | #317 |
| child comorbidity | #318 |
| adjustment covariates | #318 |
| pregnancy expression | #318 |
| compared children | #319 |
| fpr2 | #320 |
| il5 il13 | #320 |
| bmi united states | #320 |
| chronic airway inflammation | #321 |
| mfi20 | #321 |
| moisturizer | #323 |
| children birth | #324 |
| ige responses | #325 |
| maximal expiratory | #325 |
| stratified sample | #326 |
| 2 yrs | #326 |
| airway hyperresponsiveness ahr | #326 |
| flg mutations | #327 |
| ichthyosis vulgaris | #327 |
| bedrooms | #328 |
| selfadministered questionnaire | #328 |
| active smoking | #328 |
| recurrent wheeze | #328 |
| extracellular dna | #329 |
| male milk | #330 |
| glycolylneuraminic | #330 |
| accuracy analysis | #331 |
| dermatophagoides asthma | #331 |
| reference equations | #331 |
| pollutant levels | #331 |
| demethylation | #331 |
| floor dust | #331 |
| streptococcaceae | #333 |
| asthma biomarkers | #333 |
| onset asthma | #333 |
| upper respiratory | #334 |
| development sensitization | #334 |
| reduced lung function | #334 |
| children controls | #335 |
| asthma china | #336 |
| boluses | #336 |
| prevalence surveys | #337 |
| predictive risk factors | #337 |
| risk current | #337 |
| 1st year | #337 |
| 3113 | #338 |
| childhood atopic | #338 |
| risk eczema | #339 |
| respiratory outcomes | #339 |
| asthma parents | #340 |
| medical advice | #340 |
| exposure development | #341 |
| adultonset asthma | #341 |
| humans prevalence | #341 |
| filaggrin gene | #342 |
| persistent wheeze | #342 |
| kitchen | #342 |
| nonatopic asthma | #343 |
| age introduction | #343 |
| age 9 | #344 |
| breast fed | #345 |
| hypersensitivity | #346 |
| stat6 transcription | #346 |
| 90th | #348 |
| childhood onset | #349 |
| exposed children | #350 |
| rates asthma | #350 |
| increasing prevalence | #350 |
| prevalence | #350 |
| factors surveys | #351 |
| th1 th2 cells | #353 |
| activator transcription | #354 |
| repeated episodes | #356 |
| freeways | #358 |
| purposepatients | #359 |
| genetic interaction | #359 |
| subsequent asthma | #360 |
| kazal | #360 |
| regression approach | #360 |
| children cohort | #361 |
| asthma disease | #361 |
| strength association | #361 |
| eurotium | #361 |
| cord blood | #363 |
| age 3 | #363 |
| expression asthma | #363 |
| farming practices | #364 |
| food sensitization | #364 |
| allergic outcomes | #364 |
| austria germany | #365 |
| annual concentrations | #365 |
| children reported | #366 |
| chronic inflammatory disorders | #366 |
| lactadherin | #368 |
| atopic status | #369 |
| single snp | #370 |
| earlylife exposure | #370 |
| expression tlr2 | #370 |
| adolescent air | #370 |
| austria switzerland | #371 |
| testing procedures | #371 |
| 1159 | #371 |
| conclusionwe | #371 |
| time activity | #373 |
| east west | #373 |
| obesity prevalence | #373 |
| asthmatic symptoms | #374 |
| paragraphs | #374 |
| performance accuracy | #374 |
| 22 countries | #374 |
| asthma current | #374 |
| smoking asthma | #375 |
| foxp3 tregs | #375 |
| upper respiratory tract | #376 |
| asthma cases | #376 |
| associations exposure | #377 |
| positional cloning | #377 |
| cows milk | #377 |
| statistical approaches | #377 |
| parental reports | #379 |
| mite allergens | #379 |
| population studies | #379 |
| dietary strategies | #381 |
| pieces | #382 |
| inverse association | #383 |
| unifying | #384 |
| preschool cohort studies | #384 |
| measles vaccination | #384 |
| normal lung function | #385 |
| latex | #386 |
| chronic asthma | #386 |
| impaired lung function | #386 |
| bronchial | #386 |
| alliance | #388 |
| gene environment | #389 |
| allergie | #390 |
| critical window | #391 |
| haplotype analyses | #391 |
| immunological analysis | #391 |
| potential association | #391 |
| 11 year | #392 |
| cde | #393 |
| mmp9 gene | #394 |
| 14 year | #394 |
| early feeding | #394 |
| risk sensitization | #394 |
| linear regressions | #395 |
| increased risk asthma | #395 |
| polymorphism gene | #395 |
| immunological mechanisms | #396 |
| th2 th1 | #398 |
| respiratory health | #399 |
| study polymorphisms | #399 |
| salmeterol xinafoate | #399 |
| receptor cx3cr1 | #400 |
| antiviral responses | #401 |
| 2033 | #402 |
| receptor polymorphisms | #402 |
| regions countries | #402 |
| analysis asthma | #403 |
| length time | #403 |
| exposure animals | #403 |
| plea | #404 |
| allergens | #405 |
| study agreement | #405 |
| timothy grass | #405 |
| cells asthma | #406 |
| production ifngamma | #406 |
| allergen exposure | #406 |
| 071 | #407 |
| childhood allergic | #407 |
| mugwort | #407 |
| geneenvironment interaction | #409 |
| data cohort | #409 |
| mold exposure | #410 |
| endotoxin exposure | #411 |
| living room | #411 |
| common occurrence | #411 |
| blood rna | #413 |
| blood cb | #413 |
| gene variations | #413 |
| ige synthesis | #414 |
| germany | #415 |
| childhood exposure | #416 |
| mite allergen | #416 |
| facemasks | #416 |
| house dust | #417 |
| 7 years | #418 |
| bronchial hyperresponsiveness | #418 |
| illness asthma | #418 |
| extended haplotypes | #419 |
| alimentary | #420 |
| age 2 years | #420 |
| population sample | #420 |
| prenatal factors | #421 |
| halfwidth | #421 |
| confers protection | #424 |
| tnc | #424 |
| cytokine secretion | #426 |
| asthma eczema | #427 |
| parasitic infections | #427 |
| asthma treatment | #428 |
| duration breastfeeding | #429 |
| childhood eczema | #429 |
| tlr1 | #430 |
| childrens hospitals | #430 |
| allergic conditions | #431 |
| clinical examinations | #432 |
| risk overweight | #433 |
| 441 | #433 |
| specific sensitization | #434 |
| respiratory allergic | #434 |
| age odds ratio | #438 |
| allergy diagnosis | #438 |
| decrements | #438 |
| tobit | #438 |
| conundrum | #440 |
| annual prevalence | #441 |
| asthma gene | #441 |
| population asthma | #442 |
| inception | #443 |
| male odds | #443 |
| fecal microbiota | #443 |
| chronic inflammatory diseases | #443 |
| cell phenotypes | #444 |
| asthma effects | #444 |
| persisting | #444 |
| increase bmi | #445 |
| observed differences | #445 |
| specific serum | #446 |
| asthma respiratory | #446 |
| exposure respiratory | #448 |
| ethnic origin | #449 |
| allergic rhinoconjunctivitis | #449 |
| 033 | #450 |
| allergy food | #450 |
| adult asthmatics | #451 |
| n149 | #452 |
| associations asthma | #452 |
| including asthma | #455 |
| school entry | #456 |
| pregnancy increased risk | #457 |
| dermatophagoides farinae | #457 |
| germany health | #458 |
| allergic risk | #460 |
| provocation tests | #460 |
| mice role | #460 |
| external environment | #460 |
| airway hyper | #462 |
| westernized | #463 |
| rural health | #464 |
| asthma higher | #464 |
| asthma control test | #465 |
| environmental factors | #466 |
| cells innate | #467 |
| opposite effects | #467 |
| postal questionnaire | #467 |
| alex | #468 |
| severity asthma | #468 |
| immunocap | #468 |
| so2 concentrations | #469 |
| nod1 signaling | #470 |
| early identification | #470 |
| clinical asthma | #470 |
| microbial counts | #471 |
| emphasised | #471 |
| asthma rhinitis | #471 |
| exposure | #471 |
| birth cohorts | #473 |
| antibiotics children | #473 |
| fodder | #473 |
| 1133 | #474 |
| yrs | #474 |
| champ | #476 |
| cross sectional survey | #476 |
| exposure antibiotics | #477 |
| early exposure | #481 |
| risk severity | #482 |
| childhood environment | #483 |
| asthma association | #484 |
| total immunoglobulin | #484 |
| subphenotypes | #485 |
| children | #486 |
| atopic disorders | #486 |
| immunity genes | #486 |
| prospective birth cohort | #487 |
| phenotypes | #487 |
| exposure data | #489 |
| potential confounding | #489 |
| studies rhinitis | #490 |
| genes environment | #490 |
| multicenter cohort | #491 |
| snp association | #494 |
| uncontrolled asthma | #495 |
| polymorphisms association | #495 |
| age 10 | #496 |
| lifestyles | #496 |
| children jia | #497 |
| southern germany | #497 |
| housing animal | #497 |
| individual level | #498 |
| asthma severe | #498 |
| phenotype polymorphism | #498 |
| omega6 fatty acids | #500 |
| respiratory hypersensitivity | #500 |
| birth age | #501 |
| lung function children | #503 |
| asthma susceptibility | #503 |
| sensitizations | #504 |
| diet diversity | #505 |
| tests specific | #505 |
| white children | #505 |
| methods studies | #505 |
| ranks | #508 |
| allergy children | #508 |
| prevalence rates | #509 |
| childhood respiratory | #509 |
| rna samples | #509 |
| housing humans | #510 |
| stimulation lps | #511 |
| perennial | #511 |
| il15 | #513 |
| age 10 years | #514 |
| europe female | #514 |
| asthma prevalence | #515 |
| children exposed | #515 |
| infections asthma | #516 |
| cities china | #516 |
| receptor tlr | #516 |
| levels children | #516 |
| asthma bronchiolitis | #516 |
| cd4cd25high | #517 |
| dpps | #518 |
| atopic conditions | #519 |
| th2 immune | #519 |
| haplotype association | #520 |
| neutrophils eosinophils | #522 |
| eczema asthma | #522 |
| p0041 | #523 |
| children maternal | #523 |
| polymorphisms snps | #523 |
| age 1 year | #523 |
| risk factors asthma | #523 |
| rural areas | #524 |
| time window | #524 |
| adolescence age | #525 |
| maternal vitamin | #525 |
| trans fatty acids | #526 |
| baseline participants | #528 |
| bmi increased risk | #528 |
| obesity body mass | #528 |
| c‐reactive protein | #529 |
| blood humans | #529 |
| 117 95 | #529 |
| allergens animals | #529 |
| edifice | #530 |
| persistent asthma | #530 |
| environmental bacteria | #531 |
| obesity smoking | #531 |
| samples children | #532 |
| protect | #532 |
| oral tolerance | #533 |
| allergic airway inflammation | #534 |
| children methods | #535 |
| immune stimulation | #536 |
| topic rhinitis | #537 |
| il4r | #538 |
| blood eosinophil counts | #539 |
| industrialised | #540 |
| adolescence early adulthood | #541 |
| human microbiota | #541 |
| airway symptoms | #542 |
| lipopolysaccharide receptors | #543 |
| rubella virus | #543 |
| immunological markers | #543 |
| pregnancy asthma | #543 |
| cypress | #544 |
| pathomechanisms | #545 |
| regulatory cell | #546 |
| 17q12 | #547 |
| antitrypsin alpha | #547 |
| greenness | #548 |
| floorcoverings | #549 |
| oligoarticular | #549 |
| hypersensitivity humans | #550 |
| isotype switching | #553 |
| epidemic proportions | #553 |
| association children | #553 |
| lung microbiome | #554 |
| multidisciplinary study | #554 |
| mental health patients | #555 |
| children parental | #555 |
| asthma status | #556 |
| overweight prevalence | #556 |
| allergic rhinitis asthma | #558 |
| aqlq | #558 |
| 1129 | #559 |
| blood eosinophils | #560 |
| letzten | #560 |
| activity body | #561 |
| reduced exposure | #564 |
| inhaled steroids | #566 |
| 2 immunity | #566 |
| hormonal contraceptives | #566 |
| 077 | #567 |
| immune regulatory | #569 |
| initial observations | #570 |
| tripeptidyl | #570 |
| exposure matrix | #570 |
| asthma symptom | #571 |
| health urban | #571 |
| diseases prevalence | #575 |
| levels total | #575 |
| affluence | #575 |
| hcs patients | #575 |
| creactive protein levels | #579 |
| atopic asthma | #579 |
| followups | #580 |
| oro | #580 |
| association obesity | #581 |
| age controls | #581 |
| flanking regions | #582 |
| asthma population | #582 |
| fdr | #582 |
| asthma severity | #584 |
| tlr6 | #584 |
| uht | #584 |
| function asthma | #585 |
| bacterial microbiome | #588 |
| gsdmb | #589 |
| n63 | #590 |
| longum | #590 |
| skin test | #591 |
| 1 antitrypsin | #592 |
| endotoxin concentrations | #593 |
| holiday | #593 |
| il1rl1 | #596 |
| gasdermin | #596 |
| factors respiratory | #596 |
| model asthma | #597 |
| pathogenesis asthma | #598 |
| advising | #598 |
| total specific | #598 |
| zeigen | #598 |
| galactosylation | #600 |
| genetic environmental | #600 |
| active immunity | #601 |
| factors humans | #602 |
| pregnancy maternal | #603 |
| 048 | #603 |
| statistical analyses | #604 |
| hladqa1 | #604 |
| humans human | #604 |
| sensitization | #606 |
| agents asthma | #606 |
| microbes | #606 |
| microbiome studies | #607 |
| ige production | #608 |
| allergic rhinitis | #610 |
| 2 inflammation | #610 |
| infant feeding practices | #611 |
| bolus | #612 |
| work life | #612 |
| 11–13 | #612 |
| regulatory molecules | #612 |
| pollen allergens | #616 |
| aged allergens | #619 |
| albania | #619 |
| chronic stress | #619 |
| urban populations | #620 |
| arthropod proteins | #621 |
| life age | #621 |
| body plethysmography | #621 |
| deep phenotyping | #622 |
| unstimulated | #623 |
| radioallergosorbent | #623 |
| functional features | #625 |
| endotoxin | #627 |
| data prevalence | #627 |
| 779 | #627 |
| crosssectional | #629 |
| protective properties | #629 |
| smoking surveys | #632 |
| school children | #632 |
| models asthma | #633 |
| exacerbating | #635 |
| feeding patterns | #635 |
| settled | #635 |
| child asthma | #636 |
| children atopic dermatitis | #637 |
| standardized questionnaire | #637 |
| lifetime prevalence | #638 |
| igg glycosylation | #639 |
| factors urban | #639 |
| european children | #639 |
| clustering approach | #641 |
| grass pollen | #642 |
| innate immunity | #642 |
| humans microbiota | #643 |
| years increased | #645 |
| symptoms | #646 |
| innate lung | #647 |
| pollen concentrations | #648 |
| participation rates | #650 |
| health rural | #650 |
| kindern | #650 |
| life children | #650 |
| pets | #650 |
| glucocorticoid induced | #652 |
| helsinki | #653 |
| comprehensive analysis | #654 |
| dermatitis allergic | #654 |
| prospective studies association | #656 |
| 16 countries | #658 |
| common chronic | #659 |
| latent classes | #662 |
| age 1 | #662 |
| conclusion data | #663 |
| cd14 expression | #664 |
| abpa | #665 |
| di2ethylhexyl | #665 |
| hygiene | #665 |
| pvalues | #666 |
| hypertonic saline | #667 |
| chemokine cx3cl1 | #668 |
| adult lung | #669 |
| standardized questionnaires | #670 |
| birth cohort | #671 |
| susceptibility locus | #672 |
| central european | #672 |
| cellules | #673 |
| études | #674 |
| jobs | #676 |
| ilc2s | #677 |
| age 45 years | #679 |
| common infections | #680 |
| female forced | #681 |
| protective | #681 |
| random sample | #681 |
| dairy farm | #681 |
| egg allergy | #682 |
| cohorte | #683 |
| recurrent wheezing | #685 |
| dietary habits | #685 |
| childhood experiences | #686 |
| factors air | #688 |
| european community | #692 |
| major gene | #693 |
| doctor | #693 |
| turkish | #694 |
| factors skin | #695 |
| physical examination | #699 |
| rhinitis symptoms | #702 |
| microbial flora | #703 |
| risk obesity | #703 |
| hypersensitivity inflammation | #703 |
| sensitization food | #703 |
| tao | #707 |
| dramatic increase | #708 |
| microbial interactions | #708 |
| 459 | #708 |
| immune activation | #709 |
| perpetuation | #709 |
| immunologic tlymphocytes | #712 |
| population surveys | #712 |
| children time | #713 |
| pregnancy children | #718 |
| bacterial spores | #720 |
| mediated diseases | #721 |
| allergy asthma | #722 |
| ratio aor | #724 |
| sensitized patients | #727 |
| function children | #727 |
| 95 males | #734 |
| alias | #734 |
| il4 il13 | #738 |
| population adolescent | #741 |
| linkage chromosome | #741 |
| fractional exhaled | #742 |
| nonasthmatic | #742 |
| farms | #743 |
| treg cell | #745 |
| type 5 | #748 |
| traffic air | #748 |
| ifih1 | #749 |
| children low | #753 |
| earlier study | #754 |
| total lung | #755 |
| h20 | #758 |
| environment interactions | #758 |
| aeroallergens | #759 |
| moderate levels | #764 |
| indoor dust | #766 |
| edn1 | #768 |
| air trapping | #768 |
| allergists | #769 |
| pulmonary function tests | #769 |
| hscrp levels | #769 |
| pattern recognition receptors | #770 |
| hyperresponsiveness | #770 |
| blood leukocytes | #770 |
| asthma adults | #771 |
| strabismus surgery | #772 |
| term impact | #773 |
| incidence longitudinal | #773 |
| nucleotide receptors | #773 |
| volume humans | #777 |
| rhinitis children | #781 |
| new associations | #784 |
| studies asthma | #784 |
| factors incidence | #785 |
| children allergic | #785 |
| nonallergic | #788 |
| factors tobacco | #788 |
| shortness breath | #789 |
| asthma therapy | #791 |
| gis | #793 |
| male metaanalysis | #793 |
| children health | #794 |
| βdiversity | #795 |
| airway hyperresponsiveness | #795 |
| distinct trajectories | #796 |
| natural habitat | #796 |
| personalization | #798 |
| pc20 | #798 |
| card15 | #799 |
| protective effects | #799 |
| 45 years | #800 |
| pair 1 chromosomes | #801 |
| confer | #802 |
| allergen | #805 |
| age 4 years | #806 |
| infant food | #807 |
| dairy farms | #808 |
| exposure age | #810 |
| bifidobacterium longum | #810 |
| tenascin | #810 |
| pteronyssinus | #811 |
| subclinical inflammation | #811 |
| bacillus licheniformis | #813 |
| peak flow | #813 |
| initial data | #814 |
| boiled | #814 |
| onset age | #815 |
| foe | #816 |
| foxp3 | #817 |
| brevibacterium | #818 |
| positive skin | #819 |
| 0053 | #820 |
| food infant | #821 |
| skin tests | #822 |
| breastfeeding duration | #822 |
| spt | #827 |
| trier | #830 |
| studies respiratory | #830 |
| prevention strategies | #831 |
| asthma health | #832 |
| current analysis | #833 |
| rad50 | #833 |
| promoter polymorphisms | #834 |
| regularly | #835 |
| igg4 | #835 |
| farinae | #835 |
| snps haplotypes | #835 |
| adolescent age | #837 |
| cx3cr1 | #838 |
| exhaled breath | #838 |
| parental smoking | #839 |
| public health problem | #839 |
| toll receptors | #839 |
| asthma bronchi | #839 |
| subsequent development | #840 |
| cladosporium | #841 |
| chronification | #844 |
| fetal blood | #845 |
| modifies | #845 |
| potted | #849 |
| innate | #849 |
| bacterial endotoxin | #850 |
| maternal exposure | #850 |
| allergen sensitization | #852 |
| inspections | #854 |
| 17q | #855 |
| provocation | #856 |
| infant health | #856 |
| infant infant | #858 |
| age 5 | #861 |
| repeatedly | #861 |
| paracetamol | #862 |
| questionnaires young adult | #864 |
| receptors tlrs | #864 |
| asthma lung | #864 |
| volatile organic | #865 |
| birth cohort study | #866 |
| airway eosinophilia | #866 |
| ige | #866 |
| cumulative incidence | #874 |
| outdoor air pollution | #874 |
| latent class analysis | #875 |
| hmos | #878 |
| dermatitis | #878 |
| microbiome humans | #879 |
| 057 | #880 |
| 1940 | #880 |
| 12q | #884 |
| ifngamma tnfalpha | #886 |
| 856 | #888 |
| brink | #888 |
| oscillometry | #890 |
| european populations | #891 |
| bacterial counts | #892 |
| subsample | #895 |
| exposure study | #895 |
| esl | #896 |
| asthma incidence | #896 |
| impact asthma | #900 |
| inflammation airway | #902 |
| immunoglobulin ige | #902 |
| breastfed | #904 |
| respiration disorders | #905 |
| allergen induced | #907 |
| adult asthma | #908 |
| shortness | #908 |
| microbiome composition | #910 |
| children overweight | #910 |
| microbiota development | #912 |
| complex disease | #917 |
| cow milk | #917 |
| immunity innate | #919 |
| peripheral blood samples | #920 |
| methods cross | #920 |
| 710 | #920 |
| estonia | #923 |
| prospective birth | #927 |
| sectional population | #928 |
| sounds | #928 |
| biomérieux | #929 |
| ilcs | #929 |
| participants baseline | #932 |
| lactococcus lactis | #939 |
| 026 | #939 |
| dermatophagoides | #940 |
| potential confounders | #940 |
| 13 years | #940 |
| floors | #942 |
| life style | #944 |
| microbiome host | #949 |
| 055 | #950 |
| identification genes | #952 |
| environmental effects | #952 |
| 454 pyrosequencing | #953 |
| 1120 | #954 |
| asthma exercise | #954 |
| genotyped | #954 |
| solids | #954 |
| polymorphisms | #954 |
| human life | #955 |
| infections child | #957 |
| fever | #959 |
| children countries | #959 |
| exposures | #961 |
| domestic | #961 |
| rhinitis asthma | #961 |
| nasal secretions | #964 |
| disease asthma | #964 |
| cytokines female | #965 |
| immunoglobulin male | #965 |
| obesity children | #966 |
| innsbruck | #970 |
| readings | #971 |
| fev | #973 |
| immunization immunoglobulin | #973 |
| onset child child | #974 |
| teenagers | #975 |
| gondii infection | #976 |
| orphan receptor | #976 |
| bmi physical activity | #977 |
| nucleotide promoter | #978 |
| respiratory conditions | #979 |
| 682 | #981 |
| xinafoate | #981 |
| receptor gene | #981 |
| yearly | #982 |
| 1333 | #983 |
| small effects | #984 |
| child cohort | #986 |
| adolescents asthma | #987 |
| 12 months age | #990 |
| c3h hej | #991 |
| 068 | #991 |
| pasteurization | #991 |
| hercules | #992 |
| asthma humans | #992 |
| function development | #992 |
| sectional | #994 |
| design methods | #994 |
| immunoglobulin class | #995 |
| diagnosis asthma | #998 |
| respiratory symptoms | #1001 |
| bradykinin receptors | #1003 |
| yoghurt | #1005 |
| rural population | #1006 |
| ppg | #1006 |
| maternally | #1006 |
| linens | #1009 |
| preventive measures | #1010 |
| pt15 | #1012 |
| asthma outcomes | #1014 |
| timeframe | #1016 |
| phytohemagglutinin | #1017 |
| 039 | #1017 |
| association physical activity | #1018 |
| median levels | #1019 |
| strongest associations | #1020 |
| asthma medication | #1021 |
| western countries | #1022 |
| sought | #1024 |
| raw milk | #1027 |
| asthma adult | #1029 |
| outcome variables | #1030 |
| upper airways | #1031 |
| genomewide association | #1033 |
| 096 | #1033 |
| asthmatic children | #1035 |
| veillonella | #1037 |
| cell child | #1038 |
| breastmilk | #1039 |
| dairying | #1039 |
| nod1 | #1042 |
| disease children | #1046 |
| milieu | #1046 |
| missing values | #1047 |
| exposure conditions | #1048 |
| controls age | #1051 |
| severe allergic | #1057 |
| il5 | #1058 |
| hobbies | #1059 |
| infant gut | #1059 |
| metalloprotease | #1060 |
| pregnancy prospective | #1062 |
| class switching | #1064 |
| signaling adaptor | #1065 |
| rural | #1066 |
| predictor | #1066 |
| 8 12 | #1068 |
| skin sensitization | #1068 |
| gnp | #1069 |
| moraxella | #1070 |
| margarine | #1070 |
| central europe | #1070 |
| prevalence prospective | #1071 |
| expression humans | #1072 |
| interrelation | #1075 |
| large population | #1077 |
| cross sectional study | #1077 |
| box transcription | #1079 |
| west east | #1079 |
| trflp | #1080 |
| risk development | #1081 |
| factors child | #1081 |
| life respiratory | #1082 |
| allergic airway | #1083 |
| cells tregs | #1083 |
| study areas | #1083 |
| children prevalence | #1086 |
| sufferers | #1086 |
| maternal asthma | #1089 |
| gene expression data | #1090 |
| lca | #1090 |
| exposure delayed | #1091 |
| longduration | #1094 |
| disintegrin | #1095 |
| proteins polymorphism | #1096 |
| nationality | #1096 |
| 930 | #1097 |
| supplementary data | #1098 |
| overweight bmi | #1101 |
| enfants | #1103 |
| forkhead | #1103 |
| studies evidence | #1104 |
| conjunctivitis | #1104 |
| adolescence adulthood | #1105 |
| cd14 | #1106 |
| 248 | #1116 |
| weight risk | #1116 |
| risk gene | #1117 |
| characteristically | #1117 |
| associations observed | #1118 |
| meat consumption | #1119 |
| prevalences | #1122 |
| association exposure | #1123 |
| intermediate phenotypes | #1125 |
| newonset | #1126 |
| lung function decline | #1127 |
| il12b | #1127 |
| sscp analysis | #1127 |
| based clustering | #1128 |
| taxonomies | #1130 |
| endotoxins | #1130 |
| expiratory flow | #1132 |
| age birth | #1132 |
| 859 | #1134 |
| based birth | #1136 |
| pet ownership | #1144 |
| log2 | #1144 |
| gondii | #1145 |
| allergic asthma | #1145 |
| patients severe asthma | #1146 |
| pediatric asthma | #1146 |
| 837 | #1152 |
| skewness | #1152 |
| humans respiratory | #1153 |
| environmental tobacco | #1154 |
| regions china | #1154 |
| dust mite | #1156 |
| disease cohort | #1156 |
| 862 | #1158 |
| deciphering | #1159 |
| countries prevalence | #1160 |
| epidemiological evidence | #1164 |
| 027 | #1165 |
| anti ige | #1165 |
| rarer | #1168 |
| preschool cohort | #1169 |
| inbred balb receptors | #1172 |
| crowding | #1173 |
| genomewide | #1176 |
| receptors ige | #1178 |
| farmers | #1179 |
| phase behaviour | #1180 |
| croup | #1183 |
| contre | #1184 |
| serum immunoglobulin | #1184 |
| food allergens | #1186 |
| asthma bronchodilator | #1189 |
| new paradigm | #1189 |
| levels measured | #1190 |
| exhaled | #1194 |
| respiratory tract | #1196 |
| censored | #1197 |
| children association | #1200 |
| management children | #1206 |
| rorc | #1207 |
| bacterial taxa | #1208 |
| fungi humans | #1211 |
| sedentary lifestyle | #1211 |
| risk childhood | #1214 |
| flg | #1215 |
| regulatory cells tregs | #1216 |
| food hypersensitivity | #1218 |
| risk children | #1218 |
| orphan | #1219 |
| bradykinin | #1220 |
| eosinophilic inflammation | #1221 |
| day life | #1223 |
| factor activity | #1225 |
| 047 | #1229 |
| male pregnancy | #1233 |
| balb ovalbumin | #1234 |
| gene variants | #1236 |
| th1 th2 | #1236 |
| age menarche | #1236 |
| adult allergens | #1240 |
| european population | #1241 |
| antitrypsin | #1243 |
| small children | #1243 |
| ulm | #1247 |
| protective factors | #1250 |
| objective aim | #1251 |
| pertussis | #1252 |
| early years | #1252 |
| airway hyperreactivity | #1253 |
| food items | #1253 |
| peripheral blood leukocytes | #1253 |
| shop | #1256 |
| questionnaires | #1256 |
| debated | #1257 |
| telephone interviews | #1260 |
| lung function | #1260 |
| mite | #1262 |
| studies gene | #1263 |
| disease case | #1264 |
| yogurt | #1267 |
| temperature humidity | #1268 |
| overweight children | #1274 |
| occupational exposures | #1277 |
| fev1 forced | #1281 |
| pollution indoor | #1281 |
| children exposure | #1282 |
| shannon | #1284 |
| infections risk | #1284 |
| immunomodulating | #1289 |
| diseases occupational | #1289 |
| pollution exposure | #1292 |
| potential risk factors | #1293 |
| 182 | #1295 |
| body sites | #1296 |
| tests risk | #1299 |
| age baseline | #1301 |
| gme | #1302 |
| topic polymorphism | #1303 |
| explain | #1303 |
| venipuncture | #1306 |
| endotypes | #1309 |
| factor development | #1312 |
| lymphocytes regulatory | #1312 |
| industrially | #1314 |
| th1 cytokines | #1314 |
| 038 | #1318 |
| sought determine | #1320 |
| epidemiological survey | #1322 |
| harmonization | #1322 |
| cell numbers | #1322 |
| objective investigate | #1327 |
| cleaning | #1329 |
| neuraminic | #1329 |
| lrti | #1330 |
| concerted | #1330 |
| zusammenfassung | #1331 |
| prevalence rural | #1331 |
| respiratory allergy | #1332 |
| gambia | #1332 |
| sponsorship | #1335 |
| induced sputum | #1335 |
| loft | #1337 |
| passive smoking | #1340 |
| 897 | #1342 |
| mass breast | #1343 |
| multiple testing | #1346 |
| puberty | #1347 |
| airway function | #1349 |
| th2 cells | #1351 |
| expired | #1353 |
| oxide feno | #1353 |
| irf1 | #1353 |
| atopic humans | #1354 |
| toxoplasma gondii | #1355 |
| 267 | #1357 |
| reduction risk | #1358 |
| 16 18 | #1358 |
| science foundation | #1359 |
| asthmatics | #1359 |
| 2 innate | #1360 |
| lung microbiota | #1363 |
| france germany | #1366 |
| 279 | #1366 |
| maternal immune | #1367 |
| asthma female | #1369 |
| innate lymphoid | #1374 |
| whey proteins | #1378 |
| preventive strategies | #1381 |
| austria | #1382 |
| total ige | #1383 |
| common forms | #1383 |
| lactococcus | #1386 |
| studies lung | #1387 |
| management asthma | #1388 |
| disagreement | #1389 |
| environmental | #1389 |
| childhood adult | #1390 |
| early intervention | #1395 |
| milk proteins | #1403 |
| q21 | #1404 |
| severe atopic | #1404 |
| risk developing | #1404 |
| fef25 | #1406 |
| airway inflammation | #1407 |
| air samples | #1410 |
| indoor | #1412 |
| dust exposure | #1415 |
| sige | #1417 |
| baseline followup | #1417 |
| immune mechanisms | #1418 |
| bronchodilators | #1418 |
| microbial | #1419 |
| hapmap | #1421 |
| il13 | #1421 |
| bronchitis | #1422 |
| longitudinal cohort | #1422 |
| male multivariate | #1427 |
| pulmonary eosinophilia | #1429 |
| pair 17 | #1429 |
| timepoint | #1433 |
| asthmatic | #1433 |
| chronic inflammatory | #1435 |
| exhaled nitric | #1440 |
| irak4 | #1442 |
| induced airway | #1443 |
| inflammatory pathways | #1444 |
| centres | #1444 |
| overweight | #1445 |
| studies europe | #1445 |
| age 5 years | #1446 |
| bronchodilator response | #1448 |
| airway responses | #1451 |
| factors prevalence | #1454 |
| asthma clinical | #1460 |
| agricultural workers | #1460 |
| infancy | #1461 |
| unique opportunity | #1461 |
| immunizations | #1463 |
| 706 | #1464 |
| barcelona | #1464 |
| a20 | #1466 |
| association polymorphism | #1468 |
| hand eczema | #1468 |
| surveys questionnaires | #1470 |
| recognition receptors | #1470 |
| asthma compared | #1472 |
| immunity | #1473 |
| operating characteristics | #1474 |
| leur | #1474 |
| adolescence | #1475 |
| nod2 signaling | #1476 |
| 362 | #1477 |
| innate immune responses | #1478 |
| 1 levels | #1478 |
| meeting | #1479 |
| dgge | #1480 |
| otitis | #1482 |
| paediatricians | #1490 |
| immunologic mechanisms | #1493 |
| strongest predictor | #1494 |
| peptidases | #1494 |
| populationbased cohort | #1504 |
| ionomycin | #1505 |
| flexural | #1505 |
| tlr2 | #1506 |
| birch pollen | #1507 |
| structured interviews | #1508 |
| tlr2 tlr4 | #1509 |
| igg1 | #1511 |
| understood | #1512 |
| sulphur dioxide | #1514 |
| bacterial composition | #1514 |
| ergosterol | #1515 |
| moderate asthma | #1517 |
| epidemiological data | #1517 |
| living environment | #1517 |
| pasteurized | #1518 |
| latent class | #1520 |
| child welfare | #1521 |
| rôle | #1524 |
| pollution levels | #1524 |
| 153 | #1527 |
| hladq | #1527 |
| respiratory tract infections | #1530 |
| differences prevalence | #1533 |
| underlying mechanisms | #1536 |
| jia | #1536 |
| dust | #1542 |
| 245 | #1551 |
| factors development | #1552 |
| wisconsin | #1555 |
| previous 12 months | #1558 |
| birthday | #1558 |
| children aged | #1564 |
| children increased | #1566 |
| antibiotic exposure | #1567 |
| austrian | #1573 |
| born children | #1578 |
| china female humans | #1579 |
| licheniformis | #1584 |
| children risk | #1584 |
| current studies | #1588 |
| treatment asthma | #1595 |
| explained | #1596 |
| trans fatty | #1596 |
| breastfed infants | #1598 |
| study populations | #1599 |
| tract diseases | #1602 |
| development progression | #1603 |
| 775 | #1603 |
| air microbiology | #1604 |
| regulatory | #1605 |
| disease process | #1607 |
| ascariasis | #1610 |
| male prospective | #1611 |
| neuropeptide | #1612 |
| erythrocyte membranes | #1612 |
| cells1 | #1613 |
| peak expiratory | #1613 |
| familial aggregation | #1617 |
| candidate gene | #1622 |
| ige antibodies | #1624 |
| cells th2 | #1624 |
| early gene | #1626 |
| short communication | #1627 |
| precision medicine | #1627 |
| tolerogenic | #1628 |
| questionnaires young | #1632 |
| studies recurrence | #1634 |
| tcell responses | #1635 |
| gata3 | #1641 |
| newborn infants | #1641 |
| th2 cytokines | #1644 |
| th2 | #1645 |
| nutritional factors | #1647 |
| style male | #1653 |
| population based study | #1653 |
| topic surveys | #1653 |
| card | #1655 |
| 034 | #1656 |
| microbial diversity | #1656 |
| traffic volume | #1656 |
| smoke exposure | #1657 |
| cells transcription | #1661 |
| northern europe | #1661 |
| expiratory volume | #1664 |
| respiratory | #1666 |
| opportunity | #1667 |
| linear discriminant analysis | #1671 |
| followup study | #1677 |
| asthmatic agents | #1678 |
| epidemiologic evidence | #1688 |
| cheese | #1688 |
| employment | #1692 |
| microbiome | #1693 |
| innate immune | #1694 |
| early introduction | #1694 |
| obesity risk | #1694 |
| gitr | #1696 |
| health‐related quality | #1697 |
| aux | #1701 |
| th2 th17 | #1702 |
| phenotyping | #1704 |
| gene interaction | #1704 |
| adulthood | #1706 |
| 476 | #1710 |
| fungal diversity | #1712 |
| provocative | #1716 |
| singlenucleotide polymorphisms | #1717 |
| house dust mite | #1718 |
| mere | #1718 |
| 029 | #1723 |
| life hrqol | #1730 |
| airflow obstruction | #1732 |
| gabon | #1733 |
| asthma control | #1733 |
| genotyping | #1734 |
| anti asthmatic | #1735 |
| innate adaptive | #1739 |
| factors breast | #1742 |
| factors children | #1746 |
| cytokine genes | #1746 |
| 5 7 | #1748 |
| helminth parasites | #1749 |
| inverse relationship | #1749 |
| preschool clinical trials | #1751 |
| inconsistencies | #1753 |
| molds | #1754 |
| masks | #1756 |
| male polymorphism | #1756 |
| gstm1 gstt1 | #1760 |
| fivefold | #1760 |
| refugees | #1761 |
| chronic airway | #1761 |
| bacterial diversity | #1764 |
| susceptibility gene | #1767 |
| street | #1768 |
| environmental tobacco smoke | #1769 |
| association body mass | #1772 |
| cells airway | #1778 |
| soot | #1778 |
| helminth infections | #1779 |
| cd4cd25 | #1782 |
| occupational exposure | #1782 |
| peptidoglycan | #1782 |
| allergic reaction | #1788 |
| exposure assessment | #1789 |
| nucleotide polymorphisms | #1799 |
| generations | #1800 |
| 054 | #1801 |
| key feature | #1801 |
| helminths | #1801 |
| rubella | #1807 |
| life factors | #1809 |
| treg cells | #1812 |
| single nucleotide receptors | #1812 |
| feno | #1817 |
| protein 3 | #1821 |
| censoring | #1821 |
| factors health | #1822 |
| dna fingerprinting | #1823 |
| breastfeeding | #1825 |
| signal transducer | #1828 |
| asthma morbidity | #1828 |
| 112 | #1831 |
| respiratory illnesses | #1831 |
| leisure time | #1834 |
| generational | #1837 |
| vocational | #1838 |
| foxp3 expression | #1841 |
| regulatory cells | #1843 |
| heterogeneous disease | #1843 |
| il4 | #1843 |
| otus | #1845 |
| fetal growth | #1845 |
| forkhead transcription | #1849 |
| sampling methods | #1854 |
| causally | #1855 |
| idiopathic arthritis | #1857 |
| 95 risk factors | #1859 |
| disease incidence | #1878 |
| hypertonic | #1879 |
| friend | #1884 |
| unraveling | #1886 |
| diseases lung | #1886 |
| interleukin33 | #1891 |
| predispose | #1892 |
| age 4 | #1893 |
| aor | #1894 |
| age 2 | #1895 |
| life | #1898 |
| microbe | #1899 |
| lung male | #1900 |
| population level | #1901 |
| interleukin5 | #1901 |
| hrqol | #1903 |
| occupational stress | #1904 |
| jedoch | #1908 |
| brought | #1909 |
| vital capacity | #1909 |
| predictive models | #1914 |
| feeding practices | #1917 |
| coeliac disease | #1918 |
| confounded | #1924 |
| weight breast | #1929 |
| basics | #1932 |
| experimental models | #1932 |
| p0012 | #1933 |
| helminthiasis | #1934 |
| pregnancy prevalence | #1936 |
| child humans | #1938 |
| barrier function | #1941 |
| european commission | #1944 |
| aetiology | #1945 |
| percentiles | #1946 |
| juvenile idiopathic | #1946 |
| cell markers | #1949 |
| galactans | #1951 |
| moisture | #1959 |
| raised | #1959 |
| invading | #1960 |
| blood eosinophil | #1960 |
| immune mediated | #1960 |
| asthmatic subjects | #1960 |
| child female | #1966 |
| lps stimulation | #1966 |
| regulatory region | #1973 |
| 658 | #1975 |
| phenomena infant | #1977 |
| dwellings | #1985 |
| children severe | #1991 |
| dollar | #1994 |
| natural environments | #1997 |
| helper type | #1998 |
| studie | #1999 |
| descriptions | #2000 |
| agriculture | #2000 |
| 041 | #2004 |
| respiratory viral | #2010 |
| infectious agents | #2011 |
| richness | #2012 |
| physical activity pa | #2014 |
| lower frequencies | #2015 |
| life risk | #2018 |
| postnatal exposure | #2019 |
| diary | #2020 |
| regulation genetic | #2020 |
| children data | #2020 |
| physician diagnosis | #2021 |
| bedding | #2024 |
| underline | #2025 |
| relate | #2026 |
| age | #2027 |
| 939 | #2030 |
| chymase | #2038 |
| bovine milk | #2038 |
| ige mediated | #2040 |
| outdoor air | #2041 |
| subsamples | #2046 |
| mass child | #2047 |
| conflicting | #2056 |
| cx3c | #2057 |
| 858 | #2059 |
| schoolage children | #2063 |
| peanuts | #2068 |
| association snps | #2070 |
| standardize | #2072 |
| asthma diagnosis | #2073 |
| bronchial epithelial cells | #2075 |
| early childhood | #2075 |
| polarizing | #2076 |
| discrepant | #2080 |
| asthma quality | #2086 |
| women association | #2087 |
| gastrointestinal microbiome | #2095 |
| confounders | #2097 |
| clinical phenotypes | #2098 |
| abstracts | #2098 |
| dusts | #2099 |
| environment interaction | #2100 |
| symptoms age | #2101 |
| male maternal | #2103 |
| 19th century | #2103 |
| disequilibrium | #2104 |
| tregs | #2109 |
| bacterial colonization | #2111 |
| reduced levels | #2111 |
| dairy products | #2114 |
| permutation | #2116 |
| alternata | #2118 |
| prevalence children | #2118 |
| children higher | #2121 |
| 5q | #2125 |
| child preschool | #2128 |
| protection | #2128 |
| glucans | #2132 |
| year | #2133 |
| th2 cell | #2134 |
| common disease | #2139 |
| mild asthma | #2141 |
| dietary interventions | #2142 |
| exhalation | #2145 |
| animals child | #2145 |
| indoors | #2149 |
| sibling | #2153 |
| offspring mothers | #2154 |
| epigenetic regulation | #2155 |
| immune modulation | #2157 |
| schoolchildren | #2157 |
| ionization time | #2158 |
| studies food | #2161 |
| interleukin4 | #2163 |
| blood samples | #2166 |
| food allergy | #2173 |
| blood sampling | #2175 |
| west | #2178 |
| stat6 | #2178 |
| consumption | #2180 |
| spirometry | #2181 |
| forced expiratory | #2184 |
| utero exposure | #2186 |
| industrialized | #2190 |
| children age | #2192 |
| subsequent risk | #2193 |
| respiratory infections | #2196 |
| topic united states | #2207 |
| occupational diseases | #2208 |
| actinomycetales | #2210 |
| acinetobacter | #2212 |
| 146 | #2213 |
| communicable | #2213 |
| indoor outdoor | #2215 |
| lung epithelial cells | #2215 |
| onset disease | #2220 |
| early development | #2220 |
| female finland | #2221 |
| lung mice | #2229 |
| guardians | #2231 |
| preschool | #2232 |
| 079 | #2234 |
| 18 months | #2236 |
| diesel exhaust | #2242 |
| 12th | #2242 |
| childhood overweight | #2245 |
| th17 cell | #2246 |
| spirometric | #2247 |
| bacteria fungi | #2247 |
| immune regulation | #2248 |
| preventive | #2249 |
| whooping | #2249 |
| bacterial load | #2251 |
| functional relevance | #2252 |
| bmi risk | #2257 |
| christianity | #2258 |
| specific immunoglobulin | #2259 |
| 108 | #2259 |
| patients responders | #2267 |
| résultats | #2268 |
| environmental influences | #2271 |
| decanoic | #2274 |
| consistently | #2277 |
| preventative | #2280 |
| commensals | #2282 |
| cla | #2282 |
| 031 | #2286 |
| objective measures | #2287 |
| association childhood | #2292 |
| foxp3 cells | #2293 |
| avenues | #2296 |
| gene interactions | #2299 |
| 11 years | #2301 |
| asthma study | #2312 |
| normal children | #2318 |
| receptor 2 | #2322 |
| box protein | #2325 |
| 0042 | #2326 |
| limulus | #2329 |
| 056 | #2334 |
| studies children | #2336 |
| methodsthe | #2338 |
| 064 | #2338 |
| variation genotype | #2341 |
| ascaris | #2349 |
| omega3 fatty acids | #2352 |
| prrs | #2353 |
| 922 | #2353 |
| spss | #2354 |
| 035 | #2358 |
| treg | #2361 |
| strongest | #2364 |
| adaptive immune response | #2366 |
| regular | #2368 |
| throat | #2371 |
| microbial composition | #2376 |
| viral respiratory | #2377 |
| populationbased cohort study | #2379 |
| diseases respiratory | #2380 |
| immunologically | #2386 |
| expiratory | #2386 |
| breath | #2395 |
| genetic variation | #2396 |
| human immune | #2397 |
| urban environments | #2401 |
| blood institute | #2402 |
| bronchodilator agents | #2405 |
| diaries | #2405 |
| models male | #2413 |
| cord | #2416 |
| adequately | #2417 |
| ripk1 | #2419 |
| 7000 | #2422 |
| finnish | #2423 |
| gstt1 | #2428 |
| pathway genes | #2430 |
| early adulthood | #2435 |
| african ancestry | #2443 |
| partly | #2445 |
| toll receptor | #2457 |
| attributable | #2459 |
| motor vehicles | #2461 |
| questionnaires sweden | #2462 |
| luciferase reporter | #2464 |
| vitamin intake | #2468 |
| disease review | #2468 |
| enhancer elements | #2474 |
| genetic ancestry | #2477 |
| crosssectional survey | #2479 |
| 095 | #2496 |
| peers | #2497 |
| case control study | #2498 |
| questionnaire | #2500 |
| cytokines humans | #2508 |
| children adolescent | #2508 |
| forkhead box | #2509 |
| tolllike receptors | #2512 |
| tolllike receptor | #2525 |
| interleukin13 | #2525 |
| airway responsiveness | #2525 |
| 239 | #2527 |
| style | #2528 |
| common cold | #2528 |
| artemisia | #2530 |
| uncontrolled | #2540 |
| forced expiratory volume | #2541 |
| young adulthood | #2552 |
| inverse | #2553 |
| switzerland | #2553 |
| modify | #2556 |
| european countries | #2564 |
| pregnancy prenatal | #2568 |
| 060 | #2569 |
| siblings | #2572 |
| th2 response | #2576 |
| suggested | #2584 |
| activator | #2584 |
| myristate | #2585 |
| disease development | #2586 |
| sectional survey | #2586 |
| human microbiome | #2588 |
| ω3 | #2590 |
| 030 | #2590 |
| air pollutant | #2602 |
| immunoglobulin levels | #2603 |
| damp | #2605 |
| large sample | #2608 |
| health children | #2616 |
| viral infections | #2623 |
| humans immunoglobulin | #2624 |
| 241 | #2625 |
| mold | #2626 |
| adverse health effects | #2628 |
| polymorphism | #2633 |
| chronic respiratory diseases | #2637 |
| prenatal exposure | #2638 |
| illness surveys | #2638 |
| translate | #2640 |
| imputation | #2641 |
| molecular patterns | #2641 |
| cb | #2643 |
| 141 | #2643 |
| early | #2646 |
| evenness | #2647 |
| life illness | #2651 |
| stockholm | #2652 |
| virus diseases | #2657 |
| exhaled nitric oxide | #2657 |
| groups children | #2665 |
| 739 | #2668 |
| urban rural | #2672 |
| il4 il5 | #2673 |
| gene expression levels | #2678 |
| confounder | #2678 |
| urgently | #2684 |
| girls boys | #2684 |
| categorised | #2687 |
| onwards | #2687 |
| positive association | #2689 |
| 0048 | #2696 |
| host factors | #2699 |
| 061 | #2699 |
| effects prenatal | #2700 |
| 793 | #2703 |
| 063 | #2712 |
| leukocytes mononuclear | #2717 |
| il23r | #2721 |
| prenatally | #2721 |
| respiratory function | #2731 |
| progression disease | #2732 |
| interaction genetic | #2738 |
| worldwide | #2739 |
| risk allele | #2739 |
| reaction polymorphism | #2739 |
| contacted | #2742 |
| 95 children | #2754 |
| preschool chromosomes | #2755 |
| complete data | #2756 |
| female fetal | #2760 |
| modern | #2764 |
| milk | #2766 |
| species level | #2770 |
| effects air | #2770 |
| potential benefits | #2771 |
| rhinovirus | #2775 |
| urban health | #2778 |
| centile | #2786 |
| gstm1 | #2787 |
| messenger receptors | #2787 |
| questionnaire study | #2796 |
| prematurely | #2800 |
| emergency department visits | #2801 |
| 893 | #2802 |
| prospective longitudinal | #2809 |
| functional variants | #2810 |
| personalized treatment | #2812 |
| 812 | #2815 |
| detailed | #2816 |
| package | #2826 |
| stat1 | #2827 |
| standardized | #2829 |
| nocturnal | #2831 |
| toll | #2843 |
| dietary factors | #2848 |
| asthma patients | #2853 |
| alternaria | #2854 |
| infant formula | #2856 |
| children mothers | #2861 |
| antibiotic treatment | #2871 |
| deubiquitinating | #2878 |
| tobacco smoke | #2878 |
| lci | #2886 |
| living | #2887 |
| respondent | #2888 |
| human bronchial | #2894 |
| persistence | #2899 |
| east | #2902 |
| complement receptors | #2906 |
| male parents | #2911 |
| intrapulmonary | #2914 |
| life span | #2915 |
| 3 mm | #2916 |
| epidemiologic methods | #2917 |
| 645 | #2919 |
| 913 | #2923 |
| transitioning | #2925 |
| male gender | #2928 |
| virtually | #2928 |
| il33 | #2940 |
| listeria | #2942 |
| matrix assisted | #2944 |
| antibiotic | #2947 |
| clinical manifestation | #2956 |
| pollen | #2957 |
| visiting | #2958 |
| reduced risk | #2961 |
| written | #2965 |
| notification | #2966 |
| 074 | #2968 |
| asthma management | #2969 |
| birth | #2974 |
| study prevalence | #2975 |
| mould | #2979 |
| 073 | #2982 |
| 8th | #2983 |
| patients asthma | #2985 |
| 804 | #2985 |
| primary prevention | #2989 |
| 2 months | #2990 |
| year age | #2996 |
| critical period | #2996 |
| forced vital | #3004 |
| 293 | #3010 |
| allergic inflammation | #3011 |
| genetic receptor | #3013 |
| tlr5 | #3022 |
| forced | #3024 |
| confounding factors | #3040 |
| methodological issues | #3047 |
| polymorphism single | #3050 |
| fungal dna | #3054 |
| frequency genetic | #3059 |
| 3 years | #3060 |
| epigenetic mechanisms | #3065 |
| doubt | #3065 |
| tlrs | #3068 |
| findings studies | #3069 |
| dna extraction | #3069 |
| snps genes | #3071 |
| vaccinations | #3079 |
| economic development | #3082 |
| adaptive immune responses | #3087 |
| preschool children | #3087 |
| rural area | #3089 |
| rapid increase | #3089 |
| viewpoints | #3090 |
| overweight obesity | #3093 |
| 066 | #3096 |
| genetic variations | #3098 |
| homes | #3099 |
| analysed | #3103 |
| malditof | #3106 |
| invited | #3110 |
| delayed effects | #3119 |
| environment | #3123 |
| 0036 | #3125 |
| inhalation exposure | #3126 |
| europe humans | #3126 |
| menarche | #3129 |
| hdm | #3131 |
| 12 months | #3141 |
| filaggrin | #3142 |
| cow | #3143 |
| preschool dna | #3154 |
| vital | #3157 |
| pha | #3159 |
| baseline follow | #3182 |
| multifaceted | #3184 |
| clarified | #3188 |
| distinct | #3192 |
| bronchodilator | #3194 |
| pleiotropy | #3196 |
| genetic receptors | #3197 |
| monitoring female | #3197 |
| aor 95 | #3198 |
| 037 | #3201 |
| development disease | #3206 |
| disease genotype | #3207 |
| volume 1 | #3208 |
| 069 | #3209 |
| suburban | #3211 |
| bronchial asthma | #3213 |
| surveys | #3214 |
| messages | #3216 |
| university students | #3218 |
| epidemiological | #3227 |
| housekeeping | #3227 |
| catarrhalis | #3235 |
| functional effects | #3245 |
| 050 | #3251 |
| agents child | #3252 |
| beds | #3257 |
| health surveys | #3257 |
| 08 | #3258 |
| 360 | #3259 |
| genetic epigenesis | #3260 |
| missing data | #3261 |
| systemic inflammation | #3261 |
| prospective cohort | #3264 |
| eventually | #3266 |
| enhanced expression | #3270 |
| spores | #3271 |
| automobiles | #3272 |
| 3rd | #3275 |
| nested case | #3280 |
| premature birth | #3283 |
| 4th | #3289 |
| appreciation | #3296 |
| 19th | #3300 |
| european ancestry | #3301 |
| 098 | #3306 |
| lab | #3308 |
| cells toll | #3314 |
| influential | #3317 |
| corynebacterium | #3318 |
| surveys humans | #3318 |
| weight children | #3327 |
| child | #3332 |
| idiotypic | #3338 |
| subtle | #3341 |
| logistic regression models | #3343 |
| th17 cells | #3349 |
| age children | #3352 |
| noncommunicable diseases | #3354 |
| acid receptor | #3354 |
| influencing | #3358 |
| 509 | #3361 |
| 086 | #3367 |
| ifn γ | #3371 |
| 166 | #3372 |
| manifests | #3374 |
| polymorphisms genes | #3377 |
| 566 | #3377 |
| genetic variants | #3379 |
| rooms | #3380 |
| gut microbiome | #3384 |
| genetic background | #3388 |
| differed | #3397 |
| 0004 | #3398 |
| genetic protein structure | #3408 |
| benzene | #3408 |
| protecting | #3409 |
| turn | #3409 |
| alternaria alternata | #3418 |
| gg | #3421 |
| tlr | #3421 |
| occupational asthma | #3423 |
| maternal health | #3433 |
| sociodemographics | #3436 |
| 092 | #3443 |
| air pollution | #3445 |
| factors smoking | #3445 |
| guangzhou | #3448 |
| epithelial barrier | #3461 |
| disease genetic | #3465 |
| trends prevalence | #3467 |
| 049 | #3468 |
| airflow limitation | #3468 |
| cytokine responses | #3469 |
| th2 cytokine | #3470 |
| omega6 | #3470 |
| rye | #3480 |
| 043 | #3484 |
| humans linkage | #3484 |
| 089 | #3484 |
| 18s | #3488 |
| ambient air pollution | #3494 |
| counselling | #3496 |
| skin patients | #3497 |
| aged children | #3500 |
| total population | #3501 |
| evidences | #3507 |
| postal | #3507 |
| raw | #3512 |
| heating | #3515 |
| onset symptoms | #3519 |
| 95th | #3523 |
| 032 | #3525 |
| respiratory mucosa | #3525 |
| analysing | #3529 |
| schoolaged children | #3540 |
| innate immune response | #3541 |
| older children | #3542 |
| microbiota | #3544 |
| 059 | #3548 |
| bronchial epithelial | #3550 |
| seasonal | #3551 |
| parent | #3557 |
| 5p | #3565 |
| molecular biomarkers | #3566 |
| microbiota composition | #3568 |
| 042 | #3570 |
| coevolution | #3578 |
| tract humans | #3594 |
| minor allele | #3596 |
| plausibility | #3603 |
| children parents | #3604 |
| birch | #3605 |
| parents children | #3606 |
| linkage disequilibrium | #3610 |
| cough | #3612 |
| association polymorphisms | #3618 |
| objectively | #3623 |
| genotype humans | #3626 |
| cats | #3627 |
| claimed | #3628 |
| relating | #3629 |
| environment female | #3630 |
| pollution | #3634 |
| risk alleles | #3638 |
| broad spectrum | #3641 |
| hej | #3643 |
| odds | #3644 |
| 0011 | #3652 |
| lung volume | #3654 |
| skewed | #3670 |
| contact | #3674 |
| publication child child | #3677 |
| resides | #3679 |
| complex diseases | #3680 |
| 251 | #3681 |
| 1995 | #3684 |
| genetic control | #3686 |
| toxoplasma | #3686 |
| disequilibrium male | #3686 |
| 046 | #3688 |
| monocytogenes | #3691 |
| adult blood | #3691 |
| host immune | #3691 |
| 655 | #3695 |
| gene frequency | #3697 |
| il17 | #3701 |
| biological agents | #3703 |
| gloves | #3704 |
| 456 | #3704 |
| study gwas | #3705 |
| cette | #3725 |
| mice models | #3726 |
| 577 | #3727 |
| allocate | #3730 |
| genetic gene | #3735 |
| desorption ionization | #3735 |
| hyper | #3748 |
| ovalbumin ova | #3753 |
| 094 | #3755 |
| glutathione transferase | #3755 |
| vehicle emissions | #3759 |
| helperinducer | #3763 |
| adaptive immunity | #3764 |
| coeliac | #3765 |
| regressions | #3766 |
| positive bacteria | #3766 |
| function decline | #3771 |
| 824 | #3786 |
| housing | #3795 |
| gm csf | #3797 |
| time trends | #3798 |
| sympathomimetics | #3802 |
| multicenter studies | #3807 |
| nutrition examination | #3820 |
| weight child | #3825 |
| tcells | #3832 |
| girls | #3834 |
| bethesda | #3837 |
| health problem | #3838 |
| relation | #3838 |
| receptors immunologic | #3843 |
| 076 | #3846 |
| models immunological | #3854 |
| exposure risk | #3861 |
| epistasis | #3865 |
| tremendous | #3867 |
| loci genetic | #3869 |
| immunoglobulin | #3873 |
| utero | #3873 |
| respiratory diseases | #3876 |
| berlin | #3876 |
| maternal smoking | #3881 |
| lymphoid cells | #3891 |
| parental | #3899 |
| positively | #3912 |
| 319 | #3920 |
| 368 | #3920 |
| colonisation | #3922 |
| volatile organic compounds | #3934 |
| confounding | #3940 |
| arthropod | #3942 |
| 051 | #3943 |
| maternal serum | #3946 |
| airway resistance | #3947 |
| maternal fetal | #3948 |
| human milk | #3950 |
| denaturing | #3950 |
| asthma exacerbations | #3957 |
| progeny | #3957 |
| faced | #3958 |
| genetic predisposition | #3958 |
| exacerbations | #3960 |
| epigenetic modifications | #3970 |
| culturing | #3971 |
| viable | #3982 |
| ecuador | #3991 |
| congresses | #3995 |
| health utilization | #3999 |
| ndvi | #4004 |
| 381 | #4005 |
| r5 | #4019 |
| newborn infant premature | #4023 |
| messenger reverse | #4026 |
| variation humans | #4026 |
| capita | #4029 |
| infant nutritional | #4032 |
| pellucida | #4033 |
| phase 2 | #4035 |
| environments | #4036 |
| ema | #4036 |
| single nucleotide | #4050 |
| occupational | #4052 |
| dipeptidyl | #4055 |
| genetic risk | #4060 |
| positive associations | #4061 |
| tlr9 | #4064 |
| humans polymorphism | #4069 |
| reverse | #4070 |
| prevotella | #4081 |
| dairy | #4093 |
| 493 | #4094 |
| 023 | #4107 |
| unbalanced | #4109 |
| clarification | #4112 |
| coding region | #4113 |
| 052 | #4118 |
| chronic disease | #4118 |
| ethnically | #4120 |
| effects exposure | #4120 |
| children 2 | #4126 |
| 087 | #4136 |
| positional | #4136 |
| salmeterol | #4139 |
| urban population | #4151 |
| luminex | #4154 |
| th17 | #4162 |
| chronic respiratory | #4163 |
| researcher | #4163 |
| 011 | #4170 |
| husbandry | #4180 |
| mrna expression | #4180 |
| sulfur dioxide | #4182 |
| th1 cells | #4183 |
| 424 | #4185 |
| rgs | #4187 |
| ruled | #4189 |
| respiratory infection | #4193 |
| protected | #4194 |
| zealand | #4204 |
| lifestyle | #4210 |
| risk loci | #4212 |
| finland | #4213 |
| preterm delivery | #4220 |
| populationbased sample | #4221 |
| growing body | #4222 |
| whey | #4236 |
| androstadienes | #4237 |
| inflammatory disease | #4243 |
| disease genotype humans | #4247 |
| body height | #4248 |
| adult onset | #4250 |
| increasing trend | #4252 |
| inhaled | #4253 |
| indoor environments | #4256 |
| participated | #4256 |
| neonatal mice | #4262 |
| children born | #4269 |
| healthy individuals | #4289 |
| metagenome | #4300 |
| ordinal | #4303 |
| influenced | #4314 |
| ephedrine | #4318 |
| cx3cl1 | #4318 |
| immunologic receptors | #4322 |
| activity pa | #4324 |
| 1 gene | #4337 |
| male mothers | #4339 |
| male obesity | #4345 |
| years life | #4346 |
| phytohemagglutinins | #4349 |
| nucleotide | #4353 |
| children study | #4356 |
| 093 | #4358 |
| diagnostics | #4359 |
| healthy children | #4370 |
| 410 | #4375 |
| urban area | #4379 |
| rationale | #4393 |
| poaceae | #4397 |
| protects | #4404 |
| fluticasone | #4405 |
| age 12 | #4405 |
| stratified | #4414 |
| lpa | #4417 |
| exposure levels | #4418 |
| cephalometry | #4418 |
| percentile | #4421 |
| hypopharynx | #4424 |
| 95ci | #4425 |
| female sex | #4428 |
| 15 years | #4429 |
| onset | #4434 |
| crohn disease | #4437 |
| participating | #4439 |
| pupils | #4442 |
| dr3 | #4449 |
| secondary prevention | #4449 |
| receptors protein | #4451 |
| rash | #4457 |
| chances | #4457 |
| goblet | #4459 |
| confers | #4461 |
| patients cystic fibrosis | #4466 |
| respiratory viruses | #4468 |
| increased prevalence | #4468 |
| 457 | #4474 |
| 0022 | #4496 |
| culture techniques | #4499 |
| prevalence risk factors | #4499 |
| severe asthma | #4499 |
| microorganisms | #4511 |
| genetic effects | #4516 |
| infant | #4517 |
| trajectories | #4530 |
| no2 | #4538 |
| inflammatory diseases | #4542 |
| statistical | #4545 |
| butter | #4551 |
| assisted laser | #4555 |
| gramnegative bacteria | #4558 |
| structural equation modeling | #4559 |
| receptor alpha | #4564 |
| control children | #4572 |
| 49 | #4573 |
| population prevalence | #4583 |
| ahr | #4583 |
| prevalence estimates | #4588 |
| 080 | #4591 |
| neutrophilic | #4598 |
| adaptor protein | #4600 |
| haplotypes humans | #4600 |
| airway | #4601 |
| knowledge gaps | #4603 |
| strikingly | #4630 |
| daily practice | #4632 |
| lactis | #4634 |
| detectability | #4660 |
| str | #4661 |
| random | #4676 |
| aiming | #4676 |
| pef | #4683 |
| 299 | #4688 |
| accumulating | #4695 |
| measles | #4697 |
| 1014 | #4699 |
| hscrp | #4700 |
| gstp1 | #4725 |
| current evidence | #4730 |
| tlc | #4741 |
| associations | #4745 |
| bacterial communities | #4747 |
| immune | #4749 |
| obstructive lung | #4753 |
| lactic acid bacteria | #4754 |
| genetic risk factors | #4755 |
| transcriptomics | #4768 |
| lifestyle factors | #4772 |
| pathophysiologic | #4775 |
| lung development | #4777 |
| unclear | #4782 |
| exposure air | #4785 |
| immune responses | #4795 |
| quantity | #4804 |
| pulmonary function | #4809 |
| filament proteins | #4812 |
| plateau | #4814 |
| helminth | #4821 |
| albuterol | #4823 |
| respects | #4823 |
| adult air | #4837 |
| 399 | #4838 |
| female food | #4841 |
| implicating | #4844 |
| pointed | #4848 |
| feeding | #4851 |
| new cases | #4858 |
| haplotype analysis | #4874 |
| ont | #4886 |
| hcs | #4889 |
| occupations | #4896 |
| 624 | #4896 |
| respiratory illness | #4897 |
| newborn male | #4902 |
| studies effects | #4919 |
| hyperventilation | #4927 |
| asthma chronic | #4928 |
| dans | #4930 |
| contributors | #4940 |
| postnatal development | #4944 |
| respective | #4955 |
| starts | #4964 |
| tolerance induction | #4965 |
| blood mononuclear | #4969 |
| natal | #4973 |
| airway disease | #4975 |
| 322 | #4975 |
| predisposition disease | #4986 |
| eosinophils | #4994 |
| potential effects | #5005 |
| explore | #5011 |
| adaptor | #5012 |
| laser desorption | #5018 |
| epidemiology | #5018 |
| serine protease | #5020 |
| functionality | #5023 |
| inbred c57bl models | #5024 |
| inhalation | #5049 |
| livestock | #5058 |
| 95 | #5062 |
| paediatric | #5065 |
| manifestation | #5069 |
| milk human | #5071 |
| inflammatory markers | #5072 |
| grass | #5072 |
| 219 | #5083 |
| genetic analyses | #5084 |
| covariates | #5089 |
| held | #5091 |
| hormonal | #5091 |
| alpha1 | #5092 |
| urgent | #5094 |
| habits | #5099 |
| unexposed | #5099 |
| 097 | #5100 |
| genomewide significance | #5100 |
| il3 | #5102 |
| highrisk | #5105 |
| lysate | #5106 |
| gwas | #5119 |
| latent | #5125 |
| smoke | #5126 |
| 103 | #5130 |
| crucial | #5133 |
| 12 years | #5134 |
| regional differences | #5144 |
| mononuclear | #5153 |
| traffic | #5159 |
| decades | #5159 |
| dysbiosis | #5183 |
| 383 | #5186 |
| lung epithelial | #5191 |
| fingerprinting | #5191 |
| reflect | #5193 |
| p40 | #5196 |
| butyrates | #5200 |
| 070 | #5204 |
| age onset | #5209 |
| airways | #5210 |
| window | #5232 |
| hallmarks | #5241 |
| taxa | #5242 |
| recruited | #5243 |
| bronchopulmonary | #5247 |
| isotype | #5247 |
| crp levels | #5256 |
| psychosocial factors | #5267 |
| quartile | #5274 |
| inflammatory disorders | #5279 |
| dietary supplementation | #5280 |
| gprotein | #5283 |
| international | #5289 |
| early phase | #5305 |
| 123 | #5306 |
| environmental variables | #5314 |
| cutoff | #5318 |
| coupled receptor | #5329 |
| excessive | #5333 |
| 136 | #5336 |
| comprehensively | #5339 |
| suppressive | #5348 |
| immunology | #5348 |
| gene expression | #5348 |
| meat | #5350 |
| disease susceptibility | #5359 |
| supernatants | #5369 |
| new strategies | #5380 |
| illumina | #5384 |
| serum proteins | #5392 |
| 233 | #5406 |
| substantial | #5412 |
| discussions | #5423 |
| smad3 | #5429 |
| vitamin supplementation | #5436 |
| sensitized | #5441 |
| certainty | #5443 |
| 337 | #5450 |
| geometric | #5456 |
| 224 | #5465 |
| marks | #5470 |
| hypothesis | #5473 |
| growing evidence | #5475 |
| challenge | #5476 |
| epidemiologic | #5476 |
| phenotype | #5481 |
| healthy control subjects | #5495 |
| cytokines disease | #5496 |
| floor | #5496 |
| 373 | #5496 |
| road | #5504 |
| aged asthma | #5537 |
| alter | #5539 |
| 556 | #5544 |
| term exposure | #5547 |
| 454 | #5550 |
| coexpression | #5570 |
| predisposition | #5574 |
| 512 | #5578 |
| 45 | #5580 |
| lose | #5584 |
| 321 | #5595 |
| figures | #5602 |
| methacholine | #5602 |
| 258 | #5610 |
| 2nd | #5610 |
| 062 | #5630 |
| ld | #5634 |
| 14 years | #5637 |
| airflow | #5642 |
| contribute | #5645 |
| aa | #5661 |
| bacterial species | #5667 |
| 081 | #5668 |
| protein coupled | #5668 |
| notable | #5679 |
| contraceptives | #5682 |
| hints | #5688 |
| cytokine expression | #5693 |
| prebiotics | #5694 |
| commission | #5700 |
| 134 | #5704 |
| offspring | #5704 |
| cows | #5713 |
| cytokine production | #5722 |
| tlr7 | #5725 |
| presentations | #5727 |
| stepwise | #5729 |
| fecal samples | #5753 |
| animal humans | #5764 |
| 021 | #5770 |
| house | #5777 |
| rna expression | #5788 |
| cold | #5790 |
| maternal | #5797 |
| predominance | #5812 |
| persists | #5817 |
| comprehensive | #5824 |
| humans immunity | #5824 |
| cholecalciferol | #5831 |
| snps | #5833 |
| hen | #5848 |
| commensal | #5856 |
| 384 | #5863 |
| mites | #5878 |
| 078 | #5881 |
| bangladesh | #5887 |
| study genotype | #5888 |
| drug development | #5891 |
| sleeping | #5898 |
| workplace | #5900 |
| immunoglobulin igg | #5902 |
| paf | #5910 |
| study associations | #5924 |
| adjust | #5930 |
| encourage | #5930 |
| helper | #5938 |
| differ | #5944 |
| western europe | #5945 |
| questionnaire survey | #5947 |
| investigate association | #5947 |
| male risk | #5953 |
| 0017 | #5958 |
| 216 | #5963 |
| eastern europe | #5978 |
| promoter polymorphism | #5989 |
| disease prevalence | #5991 |
| longitudinal data | #5995 |
| interleukin15 | #5996 |
| adaptive immune | #5999 |
| calling | #6002 |
| patients symptoms | #6008 |
| 367 | #6008 |
| panels | #6009 |
| doseresponse relationship | #6012 |
| box | #6020 |
| pathogen interactions | #6022 |
| immune tolerance | #6023 |
| tract infections | #6029 |
| adult population | #6032 |
| obese children | #6032 |
| diversity | #6047 |
| existing methods | #6054 |
| risk variants | #6060 |
| prevalent | #6063 |
| eastern | #6064 |
| gmcsf | #6064 |
| modifier | #6066 |
| persisted | #6067 |
| restricted | #6068 |
| comparability | #6070 |
| 122 | #6072 |
| implication | #6077 |
| ors | #6082 |
| unselected | #6082 |
| ovalbumin | #6086 |
| microflora | #6091 |
| interleukin17 | #6094 |
| time flight | #6103 |
| 099 | #6113 |
| conferred | #6117 |
| recruiting | #6117 |
| genetic polymorphisms | #6122 |
| causality | #6128 |
| repeated | #6132 |
| fev1 | #6134 |
| fecal | #6135 |
| ahead | #6140 |
| 24 years | #6146 |
| programme | #6152 |
| 16 years | #6157 |
| town | #6158 |
| intermediate filament | #6161 |
| avec | #6163 |
| welfare | #6164 |
| gathered | #6166 |
| keeping | #6173 |
| constituent | #6182 |
| toluene | #6192 |
| determining | #6193 |
| genomewide association study | #6196 |
| narcotic | #6202 |
| conferring | #6205 |
| gross | #6216 |
| populations | #6233 |
| genuine | #6233 |
| illnesses | #6241 |
| institute | #6243 |
| administration inhalation | #6246 |
| prematurity | #6246 |
| protease inhibitor | #6252 |
| odds ratio 95 | #6262 |
| parents | #6266 |
| indoor environment | #6270 |
| study groups | #6270 |
| proposal | #6285 |
| offers | #6287 |
| irr | #6291 |
| communicable diseases | #6301 |
| nested | #6303 |
| alpha 1 | #6304 |
| tests | #6307 |
| young age | #6316 |
| outdoor | #6321 |
| infrequent | #6326 |
| allele frequencies | #6326 |
| interferons | #6343 |
| peptidase | #6346 |
| immunity mucosal | #6349 |
| 067 | #6355 |
| lymphocytes helper | #6360 |
| studies association | #6370 |
| 090 | #6375 |
| adjustments | #6385 |
| bivariate | #6388 |
| protective factor | #6390 |
| iu | #6394 |
| levels serum | #6400 |
| decreased risk | #6401 |
| immunological | #6409 |
| selection bias | #6410 |
| cell subsets | #6411 |
| genetic determinants | #6417 |
| infant premature | #6418 |
| 119 | #6439 |
| questions | #6448 |
| hypothesized | #6466 |
| mmp9 | #6467 |
| lower respiratory | #6475 |
| adverse health | #6475 |
| 287 | #6486 |
| 274 | #6490 |
| premature | #6493 |
| omalizumab | #6501 |
| 238 | #6507 |
| sleep disturbance | #6507 |
| gst | #6507 |
| links | #6512 |
| murine model | #6515 |
| infant feeding | #6523 |
| adam | #6524 |
| repeated measurements | #6527 |
| increased expression | #6529 |
| fev1 fvc | #6530 |
| diseases risk | #6548 |
| implied | #6555 |
| centers | #6567 |
| 1012 | #6571 |
| statements | #6572 |
| completion | #6598 |
| 283 | #6602 |
| disease onset | #6602 |
| children adults | #6604 |
| pollutant | #6605 |
| hospital admissions | #6617 |
| promoter region | #6624 |
| consumed | #6647 |
| accessible | #6653 |
| host pathogen | #6653 |
| adjusted 95 | #6654 |
| intervention studies | #6660 |
| playing | #6672 |
| 138 | #6684 |
| candidate genes | #6684 |
| bacterium | #6709 |
| cell responses | #6711 |
| systematic search | #6715 |
| cytokines dendritic | #6716 |
| washout | #6720 |
| nod2 | #6730 |
| haplotypes | #6732 |
| impulse | #6732 |
| cells disease | #6734 |
| 0009 | #6734 |
| ova | #6739 |
| focuses | #6745 |
| 126 | #6750 |
| n10 | #6757 |
| cities | #6761 |
| quartiles | #6763 |
| height weight | #6765 |
| mumps | #6769 |
| plethysmography | #6771 |
| eosinophilic | #6783 |
| disease mechanisms | #6787 |
| 065 | #6794 |
| developing | #6798 |
| 330 | #6807 |
| remained | #6813 |
| chronic exposure | #6823 |
| microbiology | #6831 |
| elucidated | #6846 |
| growing | #6846 |
| mz | #6852 |
| microorganism | #6861 |
| 305 | #6868 |
| cream | #6874 |
| lower incidence | #6887 |
| functional studies | #6890 |
| beef | #6896 |
| incidences | #6900 |
| inert | #6911 |
| academia | #6924 |
| supplementary | #6934 |
| zona | #6939 |
| multivariate logistic | #6941 |
| tertiles | #6948 |
| specific effects | #6949 |
| 1 diabetes | #6962 |
| 044 | #6965 |
| lung | #6972 |
| pathogenic bacteria | #6972 |
| maturation | #6975 |
| specialists | #6986 |
| infections | #6991 |
| transducer | #6998 |
| obesity bmi | #6999 |
| attendance | #7012 |
| summarizes | #7024 |
| infectious diseases | #7025 |
| shaping | #7027 |
| ribosomal 16s | #7033 |
| organic compounds | #7037 |
| 231 | #7041 |
| 028 | #7042 |
| confirming | #7043 |
| evidence association | #7046 |
| explaining | #7053 |
| amelioration | #7060 |
| concert | #7095 |
| 313 | #7102 |
| 019 | #7109 |
| linoleic acid | #7111 |
| type 1 diabetes | #7111 |
| triggering | #7114 |
| breath tests | #7117 |
| serum total | #7117 |
| 164 | #7122 |
| increased incidence | #7128 |
| th1 | #7132 |
| homeobox | #7134 |
| male membrane | #7135 |
| health humans | #7136 |
| homozygote | #7150 |
| consenting | #7153 |
| compare | #7155 |
| daily life | #7165 |
| increased risks | #7167 |
| agents anti | #7184 |
| likewise | #7184 |
| spatial variation | #7197 |
| develop | #7209 |
| health nutrition | #7223 |
| irritable bowel syndrome | #7227 |
| helper cell | #7228 |
| discusses | #7228 |
| spore | #7229 |
| cohort | #7231 |
| grow | #7238 |
| 163 | #7243 |
| beta1 | #7244 |
| influences | #7244 |
| analyses | #7255 |
| 0015 | #7268 |
| standardised | #7277 |
| 058 | #7278 |
| 053 | #7283 |
| handling | #7288 |
| herpesviridae | #7299 |
| urbanization | #7299 |
| 022 | #7309 |
| internationality | #7310 |
| single nucleotide polymorphisms | #7317 |
| personalized | #7355 |
| attending | #7374 |
| air pollutants | #7376 |
| 199 | #7387 |
| rome | #7392 |
| university | #7411 |
| linoleic | #7424 |
| potential risk | #7443 |
| histories | #7457 |
| 9 months | #7467 |
| human body | #7474 |
| boiling | #7486 |
| stratification | #7488 |
| bronchi | #7493 |
| alps | #7515 |
| spp | #7515 |
| enrollment | #7519 |
| intestinal diseases | #7523 |
| pediatrics | #7535 |
| toxoplasmosis | #7551 |
| bowel diseases | #7561 |
| allele | #7582 |
| eosinophil | #7586 |
| oropharyngeal | #7591 |
| considerably | #7612 |
| diseases animals | #7613 |
| overt | #7613 |
| worked | #7643 |
| school | #7649 |
| 316 | #7658 |
| haemophilus | #7669 |
| health conditions | #7671 |
| prenatal | #7684 |
| peanut | #7684 |
| rna ribosomal | #7700 |
| 161 | #7725 |
| nox | #7726 |
| europe | #7728 |
| leukocytes | #7731 |
| population | #7736 |
| characterised | #7744 |
| vehicles | #7748 |
| 308 | #7763 |
| single | #7777 |
| flora | #7792 |
| clinical examination | #7797 |
| infant male | #7799 |
| attended | #7802 |
| sputum | #7804 |
| reader | #7805 |
| lymphocyte subsets | #7808 |
| 66 | #7809 |
| 171 | #7839 |
| pyrosequencing | #7845 |
| conjunction | #7848 |
| m3 | #7856 |
| pa | #7859 |
| participation | #7865 |
| 1996 | #7881 |
| investigators | #7882 |
| specific | #7895 |
| deficiencies | #7898 |
| asked | #7899 |
| specificities | #7907 |
| months age | #7912 |
| parasitic | #7915 |
| epigenesis genetic | #7919 |
| neisseria | #7922 |
| 160 | #7928 |
| protective role | #7929 |
| egg | #7933 |
| therapeutic intervention | #7939 |
| listeria monocytogenes | #7941 |
| pbmcs | #7944 |
| fall | #7947 |
| unresolved | #7949 |
| prevalence incidence | #7950 |
| lockdown | #7950 |
| immune function | #7953 |
| altering | #7959 |
| human subjects | #7966 |
| collecting | #7980 |
| explanatory | #7997 |
| fatty acid composition | #8002 |
| lacking | #8024 |
| 264 | #8040 |
| bordetella | #8049 |
| phorbol | #8077 |
| separately | #8084 |
| rising | #8086 |
| 304 | #8087 |
| helper inducer | #8091 |
| weight infant | #8101 |
| 088 | #8109 |
| regarded | #8119 |
| determinants | #8119 |
| multiple logistic | #8132 |
| career | #8149 |
| factor binding | #8160 |
| polymorphism genetic | #8162 |
| gene regulation | #8172 |
| etiologies | #8201 |
| omega3 | #8202 |
| mutually | #8209 |
| initiative | #8212 |
| sophisticated | #8214 |
| 140 | #8224 |
| community based | #8228 |
| epigenesis | #8236 |
| emerged | #8237 |
| 266 | #8255 |
| hypotheses | #8257 |
| cars | #8265 |
| examination | #8283 |
| modifiable | #8285 |
| adolescent | #8294 |
| 242 | #8295 |
| hc | #8303 |
| belonged | #8306 |
| humans immunization | #8308 |
| based cohort | #8312 |
| nights | #8331 |
| objectives | #8337 |
| critical roles | #8342 |
| 111 | #8348 |
| nasal mucosa | #8351 |
| nineteen | #8357 |
| genera | #8357 |
| pylori infection | #8359 |
| normal weight | #8367 |
| instillation | #8385 |
| interleukin10 | #8388 |
| relative abundance | #8412 |
| latest | #8415 |
| author | #8420 |
| spearman | #8422 |
| infant low | #8429 |
| covariate | #8435 |
| authorities | #8438 |
| aspergillosis | #8440 |
| reduce risk | #8441 |
| 16s | #8447 |
| 113 | #8460 |
| multifactorial | #8460 |
| anhydride | #8462 |
| syncytial | #8462 |
| contrasting | #8463 |
| minor | #8478 |
| similarities | #8478 |
| profound | #8479 |
| investigate | #8497 |
| asthmatic patients | #8506 |
| resembles | #8511 |
| mass body | #8521 |
| genetic factors | #8538 |
| relations | #8543 |
| cytokines | #8544 |
| so2 | #8558 |
| prospective cohort study | #8565 |
| extract | #8568 |
| 4 years | #8590 |
| inclusion | #8598 |
| genetic loci | #8618 |
| humidity | #8633 |
| facilitates | #8642 |
| strong evidence | #8645 |
| logistic | #8648 |
| animal | #8656 |
| dendritic cells dcs | #8665 |
| adaptive | #8676 |
| 101 | #8677 |
| oropharynx | #8681 |
| defines | #8685 |
| histamine | #8716 |
| responsiveness | #8726 |
| increased odds | #8730 |
| choosing | #8732 |
| prevention | #8737 |
| 193 | #8776 |
| exploring | #8780 |
| 30 years | #8799 |
| airborne | #8805 |
| vdr | #8811 |
| incidence infant | #8815 |
| integrates | #8824 |
| unknown | #8840 |
| alveoli | #8852 |
| antibody levels | #8861 |
| traditional | #8865 |
| 155 | #8867 |
| association analysis | #8868 |
| humans logistic | #8879 |
| cesarean | #8884 |
| ears | #8884 |
| burden disease | #8884 |
| utilization | #8888 |
| residence | #8903 |
| bdnf | #8911 |
| pools | #8916 |
| 273 | #8926 |
| processed | #8935 |
| reactive protein | #8944 |
| pattern recognition | #8957 |
| lipopolysaccharide lps | #8958 |
| olive | #8963 |
| phase | #8966 |
| 177 | #8983 |
| 194 | #8996 |
| 0007 | #8998 |
| underlying | #9006 |
| 172 | #9017 |
| preschool humans | #9028 |
| surveyed | #9029 |
| humans lung | #9031 |
| sequelae | #9032 |
| receptor 4 | #9040 |
| population surveillance | #9046 |
| transferase | #9049 |
| cytokine | #9057 |
| boys girls | #9070 |
| london | #9088 |
| lower risk | #9095 |
| median duration | #9096 |
| parturition | #9101 |
| flanking | #9109 |
| nutritional physiological | #9139 |
| determinant | #9154 |
| statistical methods | #9170 |
| differing | #9175 |
| study selection | #9180 |
| butyrate | #9182 |
| secretions | #9187 |
| food | #9198 |
| exert | #9209 |
| dogs | #9217 |
| fungi | #9222 |
| 186 | #9234 |
| accompanying | #9239 |
| pattern | #9248 |
| human skin | #9259 |
| popularity | #9269 |
| multivariate analyses | #9269 |
| 04 | #9278 |
| 275 | #9282 |
| counts | #9296 |
| quintile | #9297 |
| controversial | #9299 |
| tract | #9302 |
| 95 women | #9304 |
| haplotype | #9306 |
| allele frequency | #9306 |
| outcome measures | #9309 |
| 345 | #9313 |
| anova | #9328 |
| prospectively | #9334 |
| eosinophilia | #9338 |
| vocs | #9351 |
| logistic regression analysis | #9353 |
| funded | #9360 |
| olds | #9364 |
| responders | #9364 |
| proteinase | #9366 |
| urban | #9376 |
| tlr4 | #9383 |
| infantile | #9386 |
| numerous | #9388 |
| 232 | #9392 |
| maldi | #9404 |
| ages | #9407 |
| newborn | #9409 |
| incidence | #9412 |
| 286 | #9422 |
| 5000 | #9432 |
| streptococcus | #9438 |
| extrinsic | #9445 |
| sick | #9460 |
| countries | #9478 |
| 016 | #9481 |
| anthropometric | #9495 |
| worker | #9498 |
| fatty acids | #9509 |
| longitudinally | #9512 |
| comprise | #9517 |
| markers | #9532 |
| antigen presenting | #9554 |
| 256 | #9559 |
| body composition | #9561 |
| airway obstruction | #9573 |
| 165 | #9574 |
| pharyngeal | #9579 |
| global health | #9583 |
| social class | #9585 |
| ifn gamma | #9589 |
| actinobacteria | #9597 |
| nutritive | #9598 |
| replicated | #9599 |
| occurrence | #9605 |
| lessons | #9617 |
| increases risk | #9627 |
| substances | #9659 |
| mucous | #9666 |
| adult mice | #9669 |
| crude | #9672 |
| dietary supplements | #9672 |
| child child | #9678 |
| reference | #9687 |
| obesity | #9698 |
| common genetic | #9743 |
| diagnoses | #9743 |
| populationbased study | #9744 |
| 9 | #9746 |
| p004 | #9752 |
| mothers | #9753 |
| mononuclear cells | #9760 |
| proinflammatory | #9761 |
| il10 | #9761 |
| publications | #9772 |
| directly | #9772 |
| 1 protein | #9773 |
| obstruction | #9774 |
| body mass bmi | #9788 |
| reliable | #9790 |
| 158 | #9800 |
| electrophoretic | #9807 |
| therapeutic strategies | #9818 |
| prove | #9826 |
| 20th | #9843 |
| random allocation | #9844 |
| cluster | #9849 |
| 102 | #9849 |
| modifying | #9850 |
| rrna | #9873 |
| nps | #9884 |
| restrictive | #9899 |
| altogether | #9903 |
| reality | #9904 |
| receptors | #9909 |
| immunomodulatory | #9920 |
| tagging | #9925 |
| intranasal | #9929 |
| century | #9933 |
| 39 | #9935 |
| southern | #9938 |
| bacterial infections | #9964 |
| 1991 | #9964 |
| tnf α | #9973 |
| 0002 | #9995 |
| exclusively | #10002 |
| 152 | #10006 |
| presenting cells | #10012 |
| lavage fluid | #10012 |
| particulate matter | #10015 |
| mass bmi | #10020 |
| health outcomes | #10050 |
| reproducible | #10052 |
| 57 | #10065 |
| disappeared | #10087 |
| 87 | #10096 |
| elucidation | #10099 |
| parts | #10121 |
| superoxide dismutase | #10123 |
| immune cell | #10127 |
| 072 | #10143 |
| nasal | #10159 |
| exist | #10160 |
| bias | #10162 |
| expression genes | #10164 |
| ascertained | #10166 |
| sedentary behavior | #10168 |
| 4 months | #10169 |
| exclusions | #10169 |
| timing | #10174 |
| incidence prevalence | #10175 |
| discover | #10203 |
| western | #10210 |
| microbial communities | #10218 |
| fungal | #10222 |
| adaptor proteins | #10226 |
| alpha subunit | #10236 |
| weaker | #10259 |
| influenzae | #10264 |
| 212 | #10290 |
| study children | #10303 |
| ghana | #10324 |
| aim | #10332 |
| analyze | #10356 |
| factorial | #10361 |
| interleukin12 | #10361 |
| 142 | #10364 |
| concepts | #10386 |
| centrally | #10386 |
| methodologies | #10387 |
| ulcerative colitis | #10399 |
| respiratory disease | #10403 |
| 17 | #10408 |
| polyunsaturated | #10422 |
| parasites | #10430 |
| scientific | #10436 |
| modelled | #10448 |
| nose | #10465 |
| flow rate | #10471 |
| bronchiolitis | #10473 |
| exposed | #10477 |
| 07 | #10499 |
| realtime pcr | #10503 |
| c3h | #10522 |
| twothirds | #10527 |
| interquartile range | #10528 |
| adjusted | #10532 |
| acetates | #10561 |
| 94 | #10565 |
| new zealand | #10576 |
| 010 | #10595 |
| biodiversity | #10595 |
| societal | #10603 |
| france | #10605 |
| priming | #10614 |
| homeodomain | #10623 |
| time pcr | #10638 |
| boys | #10643 |
| indirectly | #10650 |
| bacteriological | #10653 |
| 206 | #10664 |
| 004 | #10665 |
| ribosomal | #10691 |
| vitamins | #10703 |
| bidirectional | #10706 |
| positivity | #10711 |
| possibilities | #10723 |
| 008 | #10728 |
| items | #10729 |
| newborn infant | #10763 |
| ancestry female | #10768 |
| nitrous | #10770 |
| swabs | #10771 |
| entered | #10774 |
| regulation humans | #10776 |
| female gastrointestinal | #10776 |
| responses | #10786 |
| skin | #10787 |
| transferases | #10789 |
| increased production | #10799 |
| national institute | #10805 |
| suppressing | #10825 |
| workshop | #10850 |
| physical activity | #10855 |
| postnatal | #10859 |
| prevent | #10862 |
| bronchoalveolar | #10864 |
| fvc | #10873 |
| km2 | #10911 |
| functional role | #10915 |
| standardization | #10926 |
| 2002 | #10934 |
| 036 | #10944 |
| carriers | #10949 |
| subclinical | #10957 |
| microbiological | #10968 |
| subsequent | #10971 |
| 16s rrna | #10983 |
| immunoglobulins | #10986 |
| lps | #10988 |
| 217 | #10992 |
| roc | #10992 |
| constituents | #10993 |
| 191 | #10993 |
| harm | #10994 |
| 197 | #10996 |
| aerosol | #11002 |
| swiss | #11006 |
| inconsistent | #11009 |
| chance | #11022 |
| poland | #11028 |
| antibody responses | #11043 |
| amniotic | #11054 |
| 6 12 | #11055 |
| low birth | #11092 |
| serology | #11092 |
| passive | #11120 |
| chromosomes human | #11127 |
| ulcerative | #11134 |
| disturbed | #11159 |
| 235 | #11177 |
| crohn | #11187 |
| community | #11188 |
| 144 | #11222 |
| gut | #11232 |
| il12 | #11233 |
| confined | #11247 |
| environmental pollutants | #11258 |
| fourth | #11270 |
| 157 | #11286 |
| rna messenger | #11289 |
| duration | #11314 |
| regulatory mechanisms | #11327 |
| highest risk | #11328 |
| intron | #11330 |
| studies diet | #11351 |
| persistent | #11353 |
| chronic diseases | #11376 |
| 040 | #11389 |
| birth weight | #11397 |
| juvenile | #11415 |
| nitrogen dioxide | #11427 |
| cell function | #11428 |
| modulate | #11435 |
| supplements | #11440 |
| 18 years | #11446 |
| discuss | #11455 |
| female | #11457 |
| 105 | #11459 |
| epigenetics | #11463 |
| gut microbiota | #11475 |
| quinolines | #11485 |
| genetic susceptibility | #11493 |
| 128 | #11502 |
| factor1 | #11515 |
| 86 | #11521 |
| haemophilus influenzae | #11522 |
| late onset | #11524 |
| helicobacter | #11533 |
| biomarker | #11536 |
| 012 | #11542 |
| cd28 | #11550 |
| interact | #11564 |
| 78 | #11583 |
| proteases | #11587 |
| households | #11587 |
| variant | #11588 |
| physiological phenomena | #11594 |
| healthy control | #11597 |
| 130 | #11601 |
| celiac | #11633 |
| risk disease | #11636 |
| dispersion | #11666 |
| narrative | #11668 |
| interquartile | #11709 |
| gene polymorphisms | #11736 |
| introduction | #11752 |
| trimester pregnancy | #11755 |
| confirmation | #11758 |
| harmful | #11806 |
| lipopolysaccharides | #11813 |
| gram negative | #11824 |
| 222 | #11824 |
| irrespective | #11831 |
| 075 | #11858 |
| subtypes | #11860 |
| episodes | #11867 |
| incident | #11881 |
| insight | #11899 |
| fetal | #11900 |
| 230 | #11904 |
| air | #11924 |
| started | #11931 |
| genetic | #11936 |
| ifn | #11939 |
| 1990 | #11944 |
| autoantigens | #11967 |
| natural | #11982 |
| lowest | #11990 |
| genetic association | #11992 |
| protein levels | #11997 |
| finding | #12007 |
| initially | #12014 |
| 151 | #12047 |
| solely | #12055 |
| quantifying | #12075 |
| pcr | #12106 |
| case control | #12121 |
| ultimately | #12124 |
| upregulation | #12127 |
| immunologic factors | #12176 |
| subsets | #12179 |
| estimating | #12184 |
| country | #12201 |
| young children | #12219 |
| 149 | #12221 |
| inflammatory response | #12238 |
| leukocyte count | #12248 |
| fish oil | #12249 |
| december | #12256 |
| sle | #12270 |
| shifted | #12297 |
| began | #12327 |
| relapsing | #12330 |
| antibiotics | #12339 |
| 006 | #12341 |
| gm | #12351 |
| completed | #12354 |
| european continental | #12371 |
| minority | #12421 |
| linkage | #12422 |
| reasons | #12444 |
| ifngamma | #12445 |
| relevance | #12447 |
| lung tissue | #12462 |
| colonization | #12463 |
| 170 | #12467 |
| inflammatory cytokine | #12469 |
| european | #12469 |
| lymphocyte activation | #12520 |
| saline | #12546 |
| scarce | #12583 |
| 17 years | #12583 |
| 117 | #12590 |
| defense | #12609 |
| length polymorphism | #12616 |
| predictors | #12620 |
| tobacco | #12634 |
| crohns disease | #12638 |
| discriminating | #12641 |
| 203 | #12655 |
| residence characteristics | #12657 |
| tested | #12664 |
| collect | #12680 |
| detectable | #12682 |
| 156 | #12683 |
| cd3 | #12684 |
| total | #12687 |
| child development | #12695 |
| cystic fibrosis | #12696 |
| contributing | #12697 |
| residential | #12708 |
| multicentre | #12731 |
| beta2 | #12735 |
| aspect | #12741 |
| swedish | #12751 |
| enhancer | #12752 |
| 204 | #12773 |
| clinical manifestations | #12796 |
| 184 | #12815 |
| lung diseases | #12819 |
| combinations | #12856 |
| 104 | #12860 |
| pregnancy | #12873 |
| aspects | #12899 |
| sedentary | #12908 |
| translated | #12918 |
| infants | #12943 |
| elevated levels | #12943 |
| united kingdom | #12946 |
| debate | #12955 |
| human genome | #12959 |
| inflammatory bowel | #12963 |
| coded | #12998 |
| 154 | #13016 |
| annually | #13056 |
| 52 | #13056 |
| 220 | #13057 |
| elusive | #13067 |
| extracellular vesicles | #13082 |
| future | #13086 |
| suffer | #13086 |
| genetic rna | #13096 |
| glucocorticoids humans | #13096 |
| intrauterine | #13097 |
| measurable | #13120 |
| delayed | #13147 |
| conversely | #13160 |
| schistosomiasis | #13161 |
| differential effects | #13191 |
| strong association | #13209 |
| glucocorticoid | #13217 |
| methodological | #13236 |
| great | #13255 |
| developing countries | #13257 |
| 127 | #13262 |
| consultation | #13264 |
| 276 | #13267 |
| 018 | #13274 |
| proportions | #13279 |
| stimulated | #13297 |
| weaning | #13299 |
| hallmark | #13313 |
| 017 | #13323 |
| manifestations | #13333 |
| gene | #13338 |
| odds ratios | #13351 |
| nucleotide risk | #13354 |
| pediatric | #13397 |
| crp | #13407 |
| initiate | #13419 |
| 11 | #13424 |
| burden | #13446 |
| bowel | #13447 |
| kingdom | #13448 |
| auc | #13449 |
| mechanisms underlying | #13450 |
| 210 | #13457 |
| 20th century | #13476 |
| younger | #13480 |
| secretion | #13500 |
| 129 | #13518 |
| considerable | #13527 |
| 045 | #13543 |
| relevant | #13545 |
| confirm | #13567 |
| beijing | #13578 |
| visits | #13581 |
| 188 | #13602 |
| statistically | #13612 |
| respiratory syncytial | #13621 |
| 1989 | #13652 |
| inheritance | #13663 |
| 181 | #13690 |
| argue | #13695 |
| 020 | #13702 |
| depending | #13723 |
| lavage | #13735 |
| 014 | #13736 |
| pneumonia | #13774 |
| study association | #13782 |
| neighboring | #13790 |
| impairment | #13810 |
| sweden | #13833 |
| schistosoma | #13835 |
| severe | #13852 |
| cohorts | #13856 |
| concerns | #13856 |
| establishing | #13859 |
| genomics humans | #13875 |
| human pair | #13893 |
| ranged | #13900 |
| multiplex | #13937 |
| loci | #13953 |
| membrane glycoproteins | #14048 |
| mental health | #14054 |
| additionally | #14064 |
| chromosomes | #14069 |
| fat mass | #14090 |
| restore | #14107 |
| tendency | #14138 |
| nucleotide polymorphism | #14141 |
| establish | #14142 |
| subgroups | #14166 |
| immigrants | #14182 |
| randomly selected | #14189 |
| examples | #14202 |
| fetal development | #14226 |
| expand | #14234 |
| 183 | #14237 |
| concomitant | #14257 |
| socioeconomic status | #14258 |
| multigene | #14259 |
| disease genome | #14278 |
| refined | #14314 |
| breast | #14318 |
| unsaturated | #14320 |
| addresses | #14337 |
| independently | #14350 |
| health organization | #14355 |
| tightly | #14399 |
| amniotic fluid | #14424 |
| severity | #14432 |
| 121 | #14439 |
| penicillium | #14441 |
| epidemiologic studies | #14443 |
| tuberculosis | #14444 |
| 1 month | #14454 |
| studying | #14492 |
| 007 | #14492 |
| derivation | #14517 |
| tolerance | #14521 |
| contributed | #14529 |
| conclude | #14532 |
| systematically | #14533 |
| elevated | #14573 |
| humans | #14580 |
| factors socioeconomic | #14586 |
| cystic | #14593 |
| stranded | #14599 |
| food intake | #14600 |
| horse | #14606 |
| animals antigens | #14624 |
| 6 | #14638 |
| differentially expressed | #14641 |
| effector cells | #14675 |
| 205 | #14693 |
| striking | #14700 |
| lymphocyte count | #14703 |
| lipopolysaccharide | #14704 |
| filament | #14706 |
| transcription | #14707 |
| representative | #14726 |
| tetradecanoylphorbol | #14755 |
| classify | #14766 |
| trimester | #14772 |
| operate | #14777 |
| represents | #14788 |
| glycoproteins | #14799 |
| maximal | #14801 |
| cells patients | #14821 |
| determines | #14831 |
| 2 years | #14850 |
| seropositivity | #14866 |
| genetic analysis | #14890 |
| mice mice | #14912 |
| 002 | #14917 |
| ancestry | #14925 |
| maternal age | #14929 |
| clostridium | #14981 |
| marker | #14999 |
| ctla4 | #15005 |
| 162 | #15012 |
| ethnic | #15032 |
| male | #15042 |
| receptor | #15068 |
| compared healthy | #15084 |
| modulates | #15087 |
| disparities | #15118 |
| 00001 | #15123 |
| stronger | #15140 |
| p00001 | #15177 |
| luciferase | #15184 |
| gram | #15200 |
| longitudinal studies | #15223 |
| immune cells | #15233 |
| 131 | #15264 |
| hong kong | #15269 |
| cumulative | #15330 |
| copd | #15346 |
| nfkappab | #15356 |
| environmental monitoring | #15362 |
| socioeconomic | #15368 |
| gestational age | #15392 |
| curve | #15407 |
| physician | #15419 |
| integrate | #15467 |
| induce | #15469 |
| assessing | #15476 |
| modulated | #15501 |
| cells dcs | #15509 |
| perinatal | #15516 |
| pregnancy risk | #15527 |
| gonadal | #15550 |
| marked | #15553 |
| dysregulation | #15556 |
| 003 | #15556 |
| feces | #15556 |
| 110 | #15569 |
| built | #15581 |
| archaea | #15621 |
| tgfβ | #15667 |
| cytometry | #15669 |
| controlling | #15688 |
| inflammatory agents | #15708 |
| dietary fats | #15739 |
| cell surface receptors | #15743 |
| igg | #15765 |
| genotype | #15766 |
| il1 | #15772 |
| imply | #15830 |
| pregnant | #15831 |
| exclusive | #15843 |
| developed countries | #15863 |
| 47 | #15874 |
| cells animals | #15894 |
| 116 | #15895 |
| socioeconomic factors | #15901 |
| sensitivity specificity | #15922 |
| reflected | #15966 |
| humans inflammation | #15992 |
| agreement | #16016 |
| varies | #16017 |
| diagnosed | #16043 |
| unrelated | #16046 |
| casecontrol study | #16049 |
| filled | #16050 |
| transient | #16060 |
| conditional | #16084 |
| interleukin1beta | #16103 |
| major | #16105 |
| 12 | #16129 |
| located | #16168 |
| homozygous | #16182 |
| effector | #16208 |
| inducer | #16232 |
| anti inflammatory | #16238 |
| transducing | #16239 |
| psychosocial | #16242 |
| 93 | #16314 |
| born | #16347 |
| dendritic cells | #16365 |
| define | #16372 |
| causing | #16382 |
| bacterial | #16387 |
| 7 | #16394 |
| genome wide | #16420 |
| varied | #16428 |
| squared | #16431 |
| volatile | #16432 |
| 082 | #16433 |
| bacteria | #16447 |
| represented | #16476 |
| height | #16488 |
| ibd | #16518 |
| established | #16536 |
| identifying | #16549 |
| participants | #16561 |
| thought | #16634 |
| triggered | #16636 |
| areas | #16662 |
| broad | #16671 |
| academic | #16675 |
| functionally | #16694 |
| microsatellite | #16697 |
| genetic polymorphism | #16725 |
| characterizing | #16726 |
| 0006 | #16756 |
| dendritic | #16762 |
| centre | #16765 |
| 084 | #16783 |
| distributed | #16795 |
| agricultural | #16798 |
| dead | #16800 |
| nitric oxide | #16855 |
| chromosome | #16895 |
| bowel disease | #16898 |
| personal | #16912 |
| 09 | #16918 |
| 91 | #16918 |
| investigating | #16978 |
| utilize | #16980 |
| opportunities | #17033 |
| promoter | #17034 |
| steroid | #17056 |
| anti bacterial | #17061 |
| dna bacterial | #17074 |
| 81 | #17089 |
| mother | #17091 |
| epigenetic | #17095 |
| continuing | #17105 |
| messenger | #17106 |
| progression | #17115 |
| monocytes | #17130 |
| genotypes | #17190 |
| confirms | #17201 |
| individual | #17225 |
| seasons | #17244 |
| 53 | #17287 |
| untranslated | #17292 |
| denmark | #17301 |
| 137 | #17321 |
| retinoic | #17351 |
| earlier | #17361 |
| drug therapy | #17361 |
| cross | #17377 |
| encountered | #17387 |
| taxonomic | #17423 |
| visible | #17455 |
| strong | #17549 |
| excluding | #17551 |
| tnfalpha | #17598 |
| heterozygote | #17605 |
| alleles | #17619 |
| avoidance | #17647 |
| bronchoalveolar lavage | #17656 |
| bacterial agents | #17666 |
| introduced | #17690 |
| cd4 cells | #17717 |
| dcs | #17724 |
| initiating | #17727 |
| comparing | #17740 |
| newborns | #17784 |
| quantified | #17787 |
| regression | #17798 |
| lesser | #17810 |
| geographical | #17857 |
| interviewed | #17866 |
| 84 | #17903 |
| covering | #17927 |
| prospective | #17949 |
| bmi | #17963 |
| animals | #17994 |
| 009 | #18003 |
| drawn | #18014 |
| disease chronic | #18024 |
| longitudinal | #18047 |
| particulate | #18073 |
| monthly | #18086 |
| 77 | #18100 |
| altered | #18146 |
| 085 | #18150 |
| publication administration | #18171 |
| children adolescents | #18178 |
| snp | #18187 |
| neurotrophic | #18224 |
| systemic lupus erythematosus | #18235 |
| samples | #18263 |
| restriction fragment | #18268 |
| negative | #18269 |
| dismutase | #18321 |
| susceptibility | #18324 |
| demographics | #18339 |
| recognize | #18347 |
| inflammatory responses | #18460 |
| inflammatory bowel disease | #18499 |
| chemokines | #18511 |
| served | #18518 |
| difference | #18526 |
| mast cell | #18536 |
| 148 | #18545 |
| replication | #18548 |
| exists | #18580 |
| immunization | #18589 |
| remain | #18590 |
| intervals | #18593 |
| secretory | #18604 |
| carried | #18634 |
| fold | #18655 |
| provided | #18675 |
| 83 | #18683 |
| 36 | #18709 |
| symptom | #18710 |
| differentially | #18718 |
| variation genome | #18742 |
| rise | #18757 |
| weight | #18797 |
| epithelial cells | #18798 |
| candidate | #18807 |
| sum | #18807 |
| additional | #18812 |
| immunophenotyping | #18818 |
| families | #18838 |
| basis | #18843 |
| 1997 | #18843 |
| 28 | #18854 |
| maintain | #18856 |
| variants | #18858 |
| 13 | #18882 |
| fragment length | #18919 |
| missing | #18966 |
| lower | #18985 |
| sampling | #19004 |
| receptors cell | #19024 |
| intake | #19030 |
| vitamin | #19034 |
| experiencing | #19122 |
| susceptible | #19133 |
| fats | #19173 |
| balb mice | #19208 |
| crosssectional study | #19250 |
| c57bl mice | #19256 |
| promoter regions | #19283 |
| polymerase | #19291 |
| locus | #19302 |
| clinical presentation | #19308 |
| 1992 | #19352 |
| contributes | #19382 |
| termed | #19414 |
| mouse model | #19415 |
| trait loci | #19415 |
| clear | #19476 |
| partially | #19504 |
| completely | #19506 |
| elucidate | #19510 |
| socio | #19512 |
| × 10 | #19521 |
| pollutants | #19552 |
| validated | #19554 |
| necrosis | #19582 |
| illustrate | #19602 |
| lasting | #19718 |
| time polymerase | #19720 |
| healthrelated quality | #19789 |
| polymerase chain | #19797 |
| inbred balb mice | #19855 |
| 1998 | #19855 |
| chronic obstructive | #19868 |
| 5 years | #19869 |
| selecting | #19937 |
| carrying | #19967 |
| context | #19977 |
| baseline | #19977 |
| negatively | #19998 |
| 95 confidence interval | #20023 |
| inbred balb | #20051 |
| interferon gamma | #20056 |
| easy | #20065 |
| acetaminophen | #20066 |
| shared | #20130 |
| 74 | #20150 |
| 64 | #20157 |
| health | #20163 |
| activates | #20164 |
| summary | #20181 |
| reporter | #20212 |
| serological | #20244 |
| adjusting | #20271 |
| 1 year | #20289 |
| interacting | #20295 |
| autoimmune diseases | #20301 |
| 61 | #20339 |
| stimulation | #20363 |
| 14 | #20418 |
| identifies | #20457 |
| demonstrating | #20473 |
| 2003 | #20528 |
| humans longitudinal | #20557 |
| returned | #20566 |
| ratio | #20593 |
| 26 | #20613 |
| inflammatory | #20615 |
| interactions | #20618 |
| behavior female | #20629 |
| nitric | #20636 |
| chain reaction | #20655 |
| upregulated | #20694 |
| highest | #20707 |
| genetically | #20746 |
| immunologic | #20771 |
| recurrent | #20779 |
| cells female | #20794 |
| interleukin | #20806 |
| wide | #20813 |
| clarify | #20844 |
| blood | #20864 |
| 51 | #20870 |
| cd4 cell | #20884 |
| rodents | #20894 |
| infectious | #20895 |
| causal | #20898 |
| create | #20974 |
| mucosal | #20983 |
| named | #20988 |
| obstructive | #20991 |
| interval | #21015 |
| suggesting | #21054 |
| 59 | #21130 |
| hereditary | #21187 |
| identical | #21192 |
| followup | #21199 |
| regulation | #21207 |
| epithelial cell | #21236 |
| essentially | #21325 |
| kappab | #21354 |
| variety | #21563 |
| mast | #21565 |
| celiac disease | #21617 |
| infection | #21622 |
| endpoint | #21718 |
| tumor necrosis | #21799 |
| reduced | #21829 |
| 10 years | #21837 |
| measures | #21851 |
| stress psychological | #21874 |
| alterations | #22024 |
| definitive | #22102 |
| assess | #22118 |
| continued | #22161 |
| correlate | #22201 |
| familial | #22235 |
| ensure | #22257 |
| frequency | #22288 |
| abolished | #22332 |
| continental ancestry | #22431 |
| reflecting | #22432 |
| unchanged | #22438 |
| validation | #22455 |
| score | #22546 |
| frequent | #22558 |
| tumor necrosis factor | #22615 |
| 95 confidence | #22620 |
| balb | #22645 |
| closely | #22684 |
| genes | #22753 |
| coupled | #22803 |
| continuously | #22829 |
| reactive | #22841 |
| indicating | #22843 |
| comparable | #22875 |
| murine | #22957 |
| 22 | #22977 |
| neonatal | #22988 |
| supported | #23008 |
| introduce | #23009 |
| type 1 | #23013 |
| report | #23048 |
| ifnγ | #23104 |
| necrosis factor | #23137 |
| predict | #23148 |
| lived | #23179 |
| increasingly | #23205 |
| rich | #23217 |
| count | #23292 |
| smoking | #23305 |
| modulating | #23348 |
| late | #23357 |
| mechanisms | #23394 |
| confidence | #23438 |
| 1 | #23526 |
| young | #23528 |
| adjustment | #23611 |
| exclude | #23665 |
| endopeptidases | #23709 |
| adolescents | #23720 |
| factors united | #23849 |
| defined | #23927 |
| extensive | #23929 |
| body | #24002 |
| dietary | #24027 |
| intracellular | #24110 |
| 5 | #24167 |
| 3 | #24232 |
| lymphocytes | #24242 |
| aimed | #24342 |
| increasing | #24355 |
| symptomatic | #24455 |
| depend | #24530 |
| reduces | #24548 |
| interaction | #24609 |
| collected | #24626 |
| adults | #24658 |
| remains | #24734 |
| needed | #24798 |
| responsible | #24851 |
| rsv | #24888 |
| 15 | #24969 |
| putative | #25032 |
| identification | #25068 |
| enrolled | #25223 |
| representing | #25239 |
| yielded | #25263 |
| determine | #25273 |
| extracellular | #25281 |
| analysis performed | #25297 |
| sex factors | #25359 |
| documented | #25522 |
| anti | #25535 |
| describing | #25574 |
| comprised | #25660 |
| matter | #25795 |
| transcriptase polymerase | #25871 |
| continue | #25896 |
| lymphocyte | #25994 |
| decreased | #26047 |
| enabling | #26157 |
| diminished | #26261 |
| previous | #26271 |
| healthy | #26310 |
| 16 | #26319 |
| profiling gene | #26374 |
| implicated | #26377 |
| dioxide | #26380 |
| inflammation | #26386 |
| tended | #26519 |
| applied | #26644 |
| contained | #26780 |
| describes | #26787 |
| generally | #26891 |
| multivariate | #26969 |
| capable | #27003 |
| unaffected | #27064 |
| presenting | #27110 |
| moderate | #27144 |
| 18 | #27195 |
| heterozygous | #27203 |
| acquired | #27213 |
| oligonucleotide | #27226 |
| concluded | #27331 |
| undergone | #27359 |
| topic | #27376 |
| proteins signal | #27393 |
| reached | #27432 |
| large | #27637 |
| recognized | #27654 |
| positive lymphocytes | #27691 |
| 001 | #27802 |
| linked | #27832 |
| preschool female | #27932 |
| models genetic | #27987 |
| predicted | #28046 |
| 0005 | #28071 |
| subsequently | #28087 |
| quantitative | #28099 |
| respect | #28131 |
| represent | #28157 |
| impaired | #28234 |
| reverse transcriptase | #28434 |
| continental | #28581 |
| plays | #28633 |
| positive | #28648 |
| immunoenzyme | #28655 |
| occurring | #28707 |
| screened | #28708 |
| square distribution | #28750 |
| transcriptase | #29017 |
| quantitative trait | #29137 |
| versus | #29158 |
| allowed | #29194 |
| comparison | #29267 |
| affect | #29339 |
| administered | #29469 |
| easily | #29520 |
| human | #29690 |
| weak | #29736 |
| possess | #29786 |
| physical | #29792 |
| pair | #29885 |
| correlated | #29909 |
| chain | #29911 |
| characterize | #29984 |
| gastrointestinal | #30316 |
| providing | #30537 |
| 005 | #30590 |
| aims | #30608 |
| factual | #30658 |
| 2 | #30659 |
| confirmed | #30719 |
| markedly | #30761 |
| 4 | #30907 |
| eligible | #31311 |
| fatty | #31332 |
| upper | #31437 |
| frequently | #32564 |
| mice knockout | #32696 |
| predictive tests | #32836 |
| peripheral | #32944 |
| humanized | #33092 |
| expression | #33163 |
| registered | #33261 |
| functional | #33617 |
| dominated | #33759 |
| selected | #33999 |
| mediated | #34372 |
| independent | #34407 |
| activate | #34542 |
| acids | #34703 |
| occur | #34769 |
| mediate | #35225 |
| conducted | #35568 |
| national | #35610 |
| evaluate | #35821 |
| 0001 | #35859 |
| developed | #36145 |
| characterized | #36394 |
| measurements | #36573 |
| express | #37054 |
| measured | #37778 |
| follow studies | #37967 |
| appears | #37978 |
| biological | #38141 |
| examined | #38373 |
| include | #39853 |
| adult | #39859 |
| clinically | #40140 |
| united | #42200 |
| mice inbred | #42559 |
| consistent | #42590 |
| excluded | #42832 |
| expression regulation | #43143 |
| inbred | #45657 |
Kjør rapport | |
Prominent publications by Erika RM von Mutius
KOL-Index: 23349
BACKGROUND: Exposure to paracetamol during intrauterine life, childhood, and adult life may increase the risk of developing asthma. We studied 6-7-year-old children from Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) programme to investigate the association between paracetamol consumption and asthma.
METHODS: As part of Phase Three of ISAAC, parents or guardians of children aged 6-7 years completed written questionnaires about symptoms of asthma, ...
| Kjent for Risk Asthma | 7 Years | Year Life | Children Aged | Rhinoconjunctivitis Eczema |
KOL-Index: 18397
BACKGROUND: Phase III of the International Study of Asthma and Allergies in Childhood measured the global prevalence of symptoms of asthma, rhinoconjunctivitis, and eczema in children.
OBJECTIVE: To investigate the associations between the use of antibiotics in the first year of life and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old.
METHODS: Parents or guardians of children 6 and 7 years old completed written questionnaires on current symptoms and ...
| Kjent for International Study | Rhinoconjunctivitis Eczema | Year Life | Symptoms Asthma | 95 Risk Factors |
Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood
[ PUBLICATION ]
Importance: Atopic dermatitis is an inflammatory, pruritic skin disease that often occurs in early infancy with a chronic course. However, a specific description of subtypes of atopic dermatitis depending on the timing of onset and progression of the disease in childhood is lacking.
Objective: To identify different phenotypes of atopic dermatitis using a definition based on symptoms before age 6 years and to determine whether some subtypes are more at risk for developing other allergic ...
| Kjent for Atopic Dermatitis | 6 Years | Age Children | Allergic Diseases | Food Allergy |
KOL-Index: 17686
BACKGROUND: Associations between exposure to cats and dogs and respiratory and allergic outcomes in children have been reported in affluent countries, but little is known about such associations in less-affluent countries.
METHODS: The International Study of Asthma and Allergies in Childhood, phase 3 was carried out in children aged 6-7 years and adolescents aged 13-14 years across the world. Questions about cats and dogs in the home were included in an additional questionnaire. Using ...
| Kjent for Cats Dogs | Asthma Rhinoconjunctivitis | Affluent Countries | Children Adolescents | International Study |
KOL-Index: 15451
BACKGROUND: There is increasing evidence that environmental exposures determining childhood illnesses operate early in life. Prenatal exposure to a farming environment through the mother might also play an important role.
OBJECTIVE: We sought to investigate the role of maternal exposures to environments rich in microbial compounds for the development of atopic sensitization, asthma, and corresponding alterations in the innate immune system in offspring.
METHODS: In the children of the ...
| Kjent for Atopic Sensitization | Innate Immunity | Farm Exposure | Microbial Compounds | Expression Receptors |
Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study
[ PUBLICATION ]
BACKGROUND: Reduced lung function is a feature of chronic asthma, which becomes apparent at school age. Unknown factors between birth and school age determine the progressive loss of pulmonary function in children with persistent asthma. We investigated the role of allergic sensitisation and allergen exposure early in life.
METHODS: The German Multicentre Allergy Study followed 1314 children from birth to 13 years of age. We regularly interviewed parents about their child's asthma and ...
| Kjent for Chronic Asthma | School Age | Life Children | Birth Cohort | Allergen Exposure |
Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison.
[ PUBLICATION ]
OBJECTIVES: To compare the prevalence of asthma and allergic disorders among children in Munich, western Germany, and Leipzig, eastern Germany, where environmental exposure, particularly air concentrations of sulphur dioxide and particulate matter, and living conditions have differed over the past 45 years.
DESIGN: Prevalence surveys among school-children aged 9-11 years in Leipzig and Munich. Self completion of written questionnaire by the children's parents and lung function ...
| Kjent for Allergic Disorders | Munich Leipzig | Prevalence Asthma | Seasonal Surveys | Living Conditions |
KOL-Index: 14833
BACKGROUND: Asthma is a complex disease that has genetic and environmental causes. The genetic factors associated with susceptibility to asthma remain largely unknown.
METHODS: We carried out a genomewide association study involving children with asthma. The sample included 793 North American children of European ancestry with persistent asthma who required daily inhaled glucocorticoid therapy and 1988 matched controls (the discovery set). We also tested for genomewide association in an ...
| Kjent for European Ancestry | Association Asthma | Single Nucleotide Receptors | Tumor Necrosis Factor | Human Pair |
Early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema: an ISAAC Phase Three Study
[ PUBLICATION ]
BACKGROUND: Associations between early life exposure to farm animals and respiratory symptoms and allergy in children have been reported in developed countries, but little is known about such associations in developing countries.
OBJECTIVE: To study the association between early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema in a worldwide study.
METHODS: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) was carried ...
| Kjent for Farm Animals | Asthma Rhinoconjunctivitis | Isaac Phase | Early Life | Affluent Countries |
KOL-Index: 14598
The German reunification offers a unique opportunity to study the impact of environmental factors on the development of childhood respiratory and allergic disorders in ethnically similar populations. We investigated the prevalence of asthma, hay fever, atopy, and bronchial hyperresponsiveness (BHR) in 9- to 11-year old children in West Germany (n = 5,030) and East Germany (n = 2,623). A self-administered questionnaire was distributed to the parents. Children underwent cold air challenge ...
| Kjent for East Germany | Asthma Fever | Prevalence Bhr | Environmental Factors | Atopic Sensitization |
Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods
[ PUBLICATION ]
International comparative studies, investigating whether disease incidence or prevalence rates differ between populations and, if so, which factors explain the observed differences, have made important contributions to the understanding of disease aetiology in many areas. In Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC), the prevalence rates of symptoms of asthma, allergic rhinitis and atopic eczema in 13-14-yr-olds, assessed by standardised ...
| Kjent for International Study | Asthma Allergies | Prevalence Rates | Atopic Eczema | Childhood Isaac |
KOL-Index: 13844
BACKGROUND: Mutations in the filaggrin gene (FLG) have been shown to play a significant role in ichthyosis vulgaris and eczema, 2 common chronic skin diseases. However, their role in the development of other atopic diseases such as asthma and rhinitis has not yet been clarified in large population-based studies.
OBJECTIVES: To study the effect of FLG mutations at the population level and their effect on other atopic phenotypes.
METHODS: Association analysis of the 2 common FLG-null ...
| Kjent for Filaggrin Mutations | Atopic Eczema | Allergic Rhinitis Asthma | Role Development | Disease Genotype Humans |
Increased food diversity in the first year of life is inversely associated with allergic diseases
[ PUBLICATION ]
BACKGROUND: The role of dietary factors in the development of allergies is a topic of debate, especially the potential associations between infant feeding practices and allergic diseases. Previously, we reported that increased food diversity introduced during the first year of life reduced the risk of atopic dermatitis.
OBJECTIVE: In this study we investigated the association between the introduction of food during the first year of life and the development of asthma, allergic rhinitis, ...
| Kjent for Food Diversity | Allergic Diseases | Year Life | Development Asthma | Atopic Sensitization |
Nøkkelpersoner for Atopic Dermatitis
Toppkols i verden
Velg et søkefrase atopic dermatitis , atopic dermatitis patients , atopic dermatitis psoriasis , atopic dermatitis children , atopic dermatitis asthma
Erika RM von Mutius:Ekspertvirkning
Konsepter somErika RM von Mutiushar direkte innflytelse:Atopic dermatitis, Childhood asthma, Allergic diseases, Atopic sensitization, Allergic rhinitis, International study, Farm milk, East germany.
Erika RM von Mutius:Kol Impact
Konsepter relatert til arbeidet til andre forfattere somfor which Erika RM von Mutius har innflytelse:Atopic dermatitis, Allergic rhinitis, Childhood asthma, Food allergy, Lung function, Air pollution, Early life.
Tools
Er dette profilen din? Krev profilen din Kopier url Legg inn lenke til profilen din |